https://www.pharmafocus.com/daily0.5https://www.pharmafocus.com/articlesdaily0.5https://www.pharmafocus.com/articles/aaps-national-biotechnology-conference-1e3e2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/aax-recruits-ionut-gabriel-dumitru-and-kushal-sejwal2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/cluepoints-selects-usama-dar-as-new-chief-product-and-technology2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/cold-chain-technologies-acquires-global-cold-chain-solutions2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/comment-95482025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/communique-awards-2025-a8da2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/contents-75652025-05-02T09:02:29.000Zweekly0.6https://www.pharmafocus.com/articles/corcept-s-relacorilant-improves-ovarian-cancer-survival-in-phase2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/curium-pharma-s-deal-with-monrol-boosts-its-position-in-nuclear2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/dupixent-approved-in-japan-as-first-biologic-medicine-for-copd2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/eu-regulatory-momentum-could-catalyse-clinical-trial-innovation2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/european-biotech-project-aims-to-develop-next-generation-targete2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/five-european-countries-account-for-68-of-the-region-s-pharma2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-mental-health-20252025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/flypharma-amsterdam2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/galapagos-confirms-new-leadership-as-planned-company-split-nears2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/gary-lyons-joins-coronado-as-evp-medical-affairs2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/gergely-sved-to-move-to-ellab-as-its-new-chief-executive-officer2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/green-light-for-moderna-to-upscale-uk-m-rna-vaccine-manufacturing2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/gri-bio-wins-europe-and-japan-patents2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/johnson-johnson-s-darzalex-gains-boost-over-conventional-chemo2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/mehilainen-strikes-deal-with-regina-maria-and-medi-group2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/mind-the-gap-men-s-health-and-the-need-for-progress2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/new-hormonal-treatment-launched-to-help-prevent-miscarriage2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/novo-s-rybelsus-found-to-reduce-major-adverse-cardiovascular-eve2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-e6982025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/potential-rare-eye-disease-treatment-sees-phase-1-success2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/pro-bio-gen-promotes-alfred-merz-to-chief-executive-officer2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-pharmaceutical-publishers2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/sanofi-s-chlamydia-vaccine-put-on-fda-fast-track2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/scottish-medicines-consortium-approves-ipsen-s-iqirvo2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/shane-olwill-joins-asgard-as-chief-development-officer2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/tau-rx-builds-on-its-alzheimer-s-momentum-after-tablet-found-to-s2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/the-landscape-of-menopause-care-in-the-uk2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/the-unbearable-lightness-of-creativity2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/articles/aaps-national-biotechnology-conference2025-03-13T12:50:33.000Zweekly0.6https://www.pharmafocus.com/articles/acquisition-of-exploristics-by-mms-reinforces-its-biostatistics2025-03-13T13:05:41.000Zweekly0.6https://www.pharmafocus.com/articles/ai-powered-authentication-solution-launched-by-systech2025-03-13T13:06:43.000Zweekly0.6https://www.pharmafocus.com/articles/bridge-bio-announces-ec-approval-for-acoramidis-in-attr-cm2025-03-13T13:08:54.000Zweekly0.6https://www.pharmafocus.com/articles/clinical-registry-for-adolescent-alopecia-areata-launched-by-the2025-03-13T13:12:51.000Zweekly0.6https://www.pharmafocus.com/articles/comment-72522025-03-13T13:13:39.000Zweekly0.6https://www.pharmafocus.com/articles/communique-awards-20252025-03-13T13:14:29.000Zweekly0.6https://www.pharmafocus.com/articles/covid-19-five-years-later-successes-and-remaining-challenges2025-03-13T12:58:06.000Zweekly0.6https://www.pharmafocus.com/articles/data-shows-long-term-success-for-biosimilar-switch-in-ibd2025-03-13T13:10:14.000Zweekly0.6https://www.pharmafocus.com/articles/edx-medical-reveals-new-test-for-prostate-cancer2025-03-13T13:13:12.000Zweekly0.6https://www.pharmafocus.com/articles/eikon-therapeutics-closes-series-d-funding-round-with-350-7m2025-03-13T13:06:24.000Zweekly0.6https://www.pharmafocus.com/articles/eleva-appoints-martin-bauer-as-chief-medical-officer2025-03-13T13:03:58.000Zweekly0.6https://www.pharmafocus.com/articles/emalex-bioscience-s-candidate-for-tourette-syndrome-meets-phase2025-03-13T13:10:35.000Zweekly0.6https://www.pharmafocus.com/articles/empowering-women-leaders-a-journey-into-stem2025-03-13T12:55:01.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-samsung-bioepis-denosumab-biosimilars2025-03-13T13:08:30.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-women-s-health-b38a2025-03-13T12:52:28.000Zweekly0.6https://www.pharmafocus.com/articles/fly-pharma-f7bb2025-03-13T13:11:52.000Zweekly0.6https://www.pharmafocus.com/articles/get-in-touch-pharmafocus2025-03-13T12:51:50.000Zweekly0.6https://www.pharmafocus.com/articles/glox-appoints-michael-murray-as-chair-and-nel-moore-as-scientifi2025-03-13T13:03:00.000Zweekly0.6https://www.pharmafocus.com/articles/menopause-in-the-workplace-why-you-should-care2025-03-13T12:56:10.000Zweekly0.6https://www.pharmafocus.com/articles/mhra-approves-telix-s-prostate-cancer-imaging-agent-illuccix2025-03-13T13:08:13.000Zweekly0.6https://www.pharmafocus.com/articles/novo-nordisk-uk-appoints-sebnem-avsar-tuna-as-general-manager2025-03-13T13:03:20.000Zweekly0.6https://www.pharmafocus.com/articles/nuclera-appoints-seth-benson-as-chief-financial-officer2025-03-13T13:02:37.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-19372025-03-13T13:13:53.000Zweekly0.6https://www.pharmafocus.com/articles/product-life-group-acquires-herax-life-science-to-boost-r-d-and-i2025-03-13T13:05:17.000Zweekly0.6https://www.pharmafocus.com/articles/pulse-sight-therapeutics-closes-series-a-financing-for-dry-amd-ph2025-03-13T13:10:55.000Zweekly0.6https://www.pharmafocus.com/articles/recce-pharmaceuticals-reports-positive-phase-2-data-for-skin-inf2025-03-13T13:11:25.000Zweekly0.6https://www.pharmafocus.com/articles/rishi-sunak-supports-national-screening-programme-as-prostate-ca2025-03-13T13:14:48.000Zweekly0.6https://www.pharmafocus.com/articles/rznomics-confirms-fda-fast-track-designation-for-liver-cancer-tr2025-03-13T13:07:56.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-99ee2025-03-13T13:04:11.000Zweekly0.6https://www.pharmafocus.com/articles/sanofi-s-bullous-pemphigoid-treatment-given-fda-priority-review2025-03-13T13:07:24.000Zweekly0.6https://www.pharmafocus.com/articles/sapio-appoints-mike-hampton-as-chief-commercial-officer2025-03-13T13:02:16.000Zweekly0.6https://www.pharmafocus.com/articles/solventum-s-purification-and-filtration-business-sold-to-thermo2025-03-13T13:04:56.000Zweekly0.6https://www.pharmafocus.com/articles/successfully-navigating-the-complexity-of-market-access-across-e2025-03-13T12:53:53.000Zweekly0.6https://www.pharmafocus.com/articles/ucb-s-fintepla-receives-nice-recommendation-for-lennox-gastaut-s2025-03-13T13:09:41.000Zweekly0.6https://www.pharmafocus.com/articles/uk-government-announces-national-cancer-plan-for-england2025-03-13T13:12:30.000Zweekly0.6https://www.pharmafocus.com/articles/university-of-manchester-launches-british-heart-foundation-centr2025-03-13T13:14:21.000Zweekly0.6https://www.pharmafocus.com/articles/vi-centra-appoints-tom-arnold-as-chief-executive-officer2025-03-13T13:03:39.000Zweekly0.6https://www.pharmafocus.com/articles/what-awaits-attendees-at-bio-europe-in-milan-this-spring2025-03-13T12:59:09.000Zweekly0.6https://www.pharmafocus.com/articles/world-vaccine-congress2025-03-13T12:51:24.000Zweekly0.6https://www.pharmafocus.com/articles/takeda-launches-framework-to-support-patient-access-to-combination-therapies2025-02-25T15:03:32.000Zweekly0.6https://www.pharmafocus.com/articles/7m-financing-announced-to-further-clinical-trials-in-thrombo-in2025-02-12T17:18:06.000Zweekly0.6https://www.pharmafocus.com/articles/alvogen-issues-voluntary-us-recall-of-fentanyl-patch-amid-concer2025-02-12T17:28:01.000Zweekly0.6https://www.pharmafocus.com/articles/ana-cardio-raises-19m-in-funding-round-for-heart-failure-candida2025-02-12T17:16:19.000Zweekly0.6https://www.pharmafocus.com/articles/biomarkers-used-in-trial-to-prevent-systematic-onset-of-disease2025-02-12T16:59:23.000Zweekly0.6https://www.pharmafocus.com/articles/candor-bioscience-acquired-by-medix-biochemica2025-02-12T16:48:23.000Zweekly0.6https://www.pharmafocus.com/articles/combination-first-in-line-treatment-approved-for-patients-with-n2025-02-12T17:07:29.000Zweekly0.6https://www.pharmafocus.com/articles/comment-f7172025-02-12T17:29:41.000Zweekly0.6https://www.pharmafocus.com/articles/contents-9bcd2025-02-12T17:29:50.000Zweekly0.6https://www.pharmafocus.com/articles/david-loose-appointed-ceo-of-essex-management2025-02-12T16:31:36.000Zweekly0.6https://www.pharmafocus.com/articles/dr-joerg-moeller-appointed-ceo-of-antag-therapeutics2025-02-12T16:04:01.000Zweekly0.6https://www.pharmafocus.com/articles/european-commission-launches-new-biotech-and-biomanufacturing-hu2025-02-12T17:28:39.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-on-clinical-trials-in-the-uk2025-02-12T16:00:17.000Zweekly0.6https://www.pharmafocus.com/articles/fly-pharma-europe22025-02-13T12:42:40.000Zweekly0.6https://www.pharmafocus.com/articles/how-digital-researchers-will-transform-drug-discovery2025-02-12T16:41:00.000Zweekly0.6https://www.pharmafocus.com/articles/iddi-announces-two-new-appointments-to-its-leadership-team2025-02-12T16:30:26.000Zweekly0.6https://www.pharmafocus.com/articles/jerome-berger-announced-as-strategy-and-finance-executive-at-vec2025-02-12T16:07:39.000Zweekly0.6https://www.pharmafocus.com/articles/mhra-approves-new-treatment-combo-for-transplant-ineligible-mult2025-02-12T17:06:35.000Zweekly0.6https://www.pharmafocus.com/articles/mhra-grants-marketing-authorisation-to-andembry-for-hereditary-a2025-02-12T17:08:51.000Zweekly0.6https://www.pharmafocus.com/articles/moderna-named-the-largest-industry-sponsor-of-clinical-trials-in2025-02-12T17:31:52.000Zweekly0.6https://www.pharmafocus.com/articles/national-biotechnology-conference2025-02-12T15:58:29.000Zweekly0.6https://www.pharmafocus.com/articles/nda-in-china-receives-priority-review-status-for-lung-cancer-tre2025-02-12T17:26:37.000Zweekly0.6https://www.pharmafocus.com/articles/new-7m-sterile-manufacturing-plant-opens-in-nottingham-uk2025-02-12T16:57:23.000Zweekly0.6https://www.pharmafocus.com/articles/nice-issues-positive-final-guidance-for-treatment-of-duchenne-mu2025-02-12T17:05:40.000Zweekly0.6https://www.pharmafocus.com/articles/opportunities-to-reduce-steroid-toxicity-and-embrace-new-treatme2025-02-12T16:37:10.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-209f2025-02-12T17:29:56.000Zweekly0.6https://www.pharmafocus.com/articles/phillips-medisize-closes-acquisition-of-vectura-group-ltd2025-02-12T16:50:09.000Zweekly0.6https://www.pharmafocus.com/articles/pmlive-a8212025-02-12T15:58:08.000Zweekly0.6https://www.pharmafocus.com/articles/pmlive-d85f2025-02-12T17:31:05.000Zweekly0.6https://www.pharmafocus.com/articles/positive-topline-results-announced-in-phase-2-alcohol-use-disord2025-02-12T17:12:29.000Zweekly0.6https://www.pharmafocus.com/articles/precision-life-appoints-new-leadership-member-bill-keating-as-c2025-02-12T16:13:08.000Zweekly0.6https://www.pharmafocus.com/articles/prenatal-care-could-be-revolutionised-suggests-studies-from-brig2025-02-12T17:30:59.000Zweekly0.6https://www.pharmafocus.com/articles/research-collaboration-announced-between-oxford-university-and-g2025-02-12T17:00:54.000Zweekly0.6https://www.pharmafocus.com/articles/results-from-novadip-phase-1b-2a-trial-reveal-88-efficacy2025-02-12T17:14:36.000Zweekly0.6https://www.pharmafocus.com/articles/salary-survey2025-02-12T17:29:24.000Zweekly0.6https://www.pharmafocus.com/articles/samedanltd-38982025-02-12T16:00:28.000Zweekly0.6https://www.pharmafocus.com/articles/samedanltd-5de92025-02-12T16:44:51.000Zweekly0.6https://www.pharmafocus.com/articles/solving-common-challenges-in-rare-disease-trials2025-02-12T16:34:56.000Zweekly0.6https://www.pharmafocus.com/articles/stragen-services-acquired-by-product-life-group2025-02-12T16:47:17.000Zweekly0.6https://www.pharmafocus.com/articles/terrapinn2025-02-12T16:35:28.000Zweekly0.6https://www.pharmafocus.com/articles/the-future-of-pharma-how-ai-will-reshape-drug-development-and-p2025-02-12T16:44:04.000Zweekly0.6https://www.pharmafocus.com/articles/university-of-sheffield-trial-highlights-immunotherapy-related-i2025-02-12T17:29:17.000Zweekly0.6https://www.pharmafocus.com/articles/university-of-southern-denmark-pairs-with-argobio-to-launch-next2025-02-12T17:04:19.000Zweekly0.6https://www.pharmafocus.com/articles/adipo-pharma-secures-funding-for-clinical-trial-into-its-insulin2024-12-06T14:37:07.000Zweekly0.6https://www.pharmafocus.com/articles/antibacterial-peptides-instrumental-in-efficiency-against-resist2024-12-06T14:38:09.000Zweekly0.6https://www.pharmafocus.com/articles/aravax-expands-to-oxford-science-park-boosting-uk-pharma-manufa2024-12-06T14:34:05.000Zweekly0.6https://www.pharmafocus.com/articles/comment-aed62024-12-06T14:40:02.000Zweekly0.6https://www.pharmafocus.com/articles/communique-11802024-12-06T14:41:36.000Zweekly0.6https://www.pharmafocus.com/articles/contents-16032024-12-06T14:41:01.000Zweekly0.6https://www.pharmafocus.com/articles/cytomos-raises-5m-for-scale-up-process2025-02-05T12:35:39.000Zweekly0.6https://www.pharmafocus.com/articles/double-acquisition-by-astoriom-helps-cement-its-uk-and-us-presen2024-12-06T14:33:58.000Zweekly0.6https://www.pharmafocus.com/articles/double-hiring-strengthens-biosynth-upper-management2024-12-06T14:32:27.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-medical-maggot-therapy2024-12-06T14:31:51.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-s-linerixibat-shows-positive-phase-3-results-for-cholestatic2024-12-06T14:37:01.000Zweekly0.6https://www.pharmafocus.com/articles/improving-the-patient-experience-insights-from-uganda-the-uk-a2024-12-06T14:33:29.000Zweekly0.6https://www.pharmafocus.com/articles/infrareal-acquires-former-takeda-pharma-and-biotech-site-in-aust2024-12-06T14:34:36.000Zweekly0.6https://www.pharmafocus.com/articles/interphex-18622024-12-06T14:31:45.000Zweekly0.6https://www.pharmafocus.com/articles/j-j-seeks-approval-for-first-drug-to-treat-high-risk-smouldering2024-12-06T14:34:56.000Zweekly0.6https://www.pharmafocus.com/articles/johnson-johnson-receives-mhra-approval-for-balversa2024-12-06T14:36:09.000Zweekly0.6https://www.pharmafocus.com/articles/mhra-greenlights-adapted-nuvaxovid-jn-1-covid-19-vaccine-for-age2024-12-06T14:35:43.000Zweekly0.6https://www.pharmafocus.com/articles/michael-garrett-appointed-as-new-chief-executive-officer-at-exe-v2024-12-06T14:33:19.000Zweekly0.6https://www.pharmafocus.com/articles/ozempic-potentially-dethroned-by-cagri-sema-but-weight-loss-stil2024-12-06T14:37:47.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-72f92024-12-06T14:41:18.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-salary-survey-81592024-12-06T14:38:15.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-a1622024-12-06T14:31:39.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-c7342024-12-06T14:38:01.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafocus-d96f2024-12-06T14:32:17.000Zweekly0.6https://www.pharmafocus.com/articles/phase-2b-results-announced-by-barinthus-biotherapeutics-for-hbv02024-12-06T14:36:53.000Zweekly0.6https://www.pharmafocus.com/articles/puma-biotechnology-initiates-phase-2-trial-for-breast-cancer-dru2024-12-06T14:36:18.000Zweekly0.6https://www.pharmafocus.com/articles/revolutionary-alzheimer-s-diagnostic-blood-test-launches-in-the2025-02-05T12:36:13.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-6b132024-12-06T14:33:36.000Zweekly0.6https://www.pharmafocus.com/articles/solas-cure-partners-with-us-army-for-better-wound-care-technology2024-12-06T14:41:42.000Zweekly0.6https://www.pharmafocus.com/articles/spinal-cord-stimulator-with-ai-technology-receives-ce-mark-certi2024-12-10T09:38:41.000Zweekly0.6https://www.pharmafocus.com/articles/theramex-receives-recommendation-for-yselty-in-scotland2024-12-06T14:35:33.000Zweekly0.6https://www.pharmafocus.com/articles/veronica-gambillara-fonck-nominated-as-chair-of-minerva-x-s-board2024-12-06T14:32:34.000Zweekly0.6https://www.pharmafocus.com/articles/almirall-s-immunoskin-event-returns-for-a-third-year-discussing-cab82024-11-15T15:31:33.000Zweekly0.6https://www.pharmafocus.com/articles/aravax-successfully-recruits-for-phase-3-peanut-allergy-treatmen-0fe62024-11-15T12:28:13.000Zweekly0.6https://www.pharmafocus.com/articles/automated-drug-screening-laboratory-jointly-launched-in-china-by-19692024-11-15T12:14:45.000Zweekly0.6https://www.pharmafocus.com/articles/axol-bioscience-acquires-phenocell-b8ea2024-11-15T12:12:39.000Zweekly0.6https://www.pharmafocus.com/articles/bayer-and-liveo-research-pair-to-launch-new-sustainable-blister-4a152024-11-15T12:35:27.000Zweekly0.6https://www.pharmafocus.com/articles/best-in-class-ai-model-from-bioptimus-integrated-into-proscia-s-5dd52024-11-15T15:37:30.000Zweekly0.6https://www.pharmafocus.com/articles/biosynth-opens-new-state-of-the-art-biotech-facility-in-suzhou-44a92024-11-15T12:13:46.000Zweekly0.6https://www.pharmafocus.com/articles/chiesi-announces-phase-3-results-from-enzyme-replacement-study-c9962024-11-15T15:14:58.000Zweekly0.6https://www.pharmafocus.com/articles/chmp-adopts-positive-opinion-for-new-breast-cancer-drug-kisqual-db012024-11-15T12:24:30.000Zweekly0.6https://www.pharmafocus.com/articles/clue-points-appoint-richard-young-as-chief-strategy-officer-94fe2024-11-15T11:22:23.000Zweekly0.6https://www.pharmafocus.com/articles/comment-bb4a2024-11-15T12:45:18.000Zweekly0.6https://www.pharmafocus.com/articles/contents-823e2024-11-15T12:45:55.000Zweekly0.6https://www.pharmafocus.com/articles/cytex-ortho-receives-fda-greenlight-for-clinical-trials-into-join-f46a2024-11-15T12:16:08.000Zweekly0.6https://www.pharmafocus.com/articles/darrin-schellin-appointed-new-ceo-at-pharma-tech-industries-cc9c2024-11-15T11:25:14.000Zweekly0.6https://www.pharmafocus.com/articles/disrupting-drug-discovery-to-take-on-the-impossible2024-11-18T15:59:23.000Zweekly0.6https://www.pharmafocus.com/articles/dr-souad-kechairi-appointed-chief-medical-officer-at-pll-therape-d0392024-11-15T14:57:04.000Zweekly0.6https://www.pharmafocus.com/articles/eco-vadis-platinum-medal-given-to-liveo-research-s-singapore-phar-2ff82024-11-15T15:30:36.000Zweekly0.6https://www.pharmafocus.com/articles/eplontersen-recommended-for-eu-approval-by-chmp-for-treatment-of-aaa62024-11-15T12:19:20.000Zweekly0.6https://www.pharmafocus.com/articles/exhibitor-numbers-for-cphi-india-grow-for-third-year-in-a-row-w-ee822024-11-15T12:41:15.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-artificial-intelligence-ai-13732024-11-15T11:19:21.000Zweekly0.6https://www.pharmafocus.com/articles/hiv-vaccine-candidate-successfully-optimised-for-industrial-prod-07d52024-11-15T15:28:02.000Zweekly0.6https://www.pharmafocus.com/articles/hutchmed-set-to-receive-20m-in-funding-from-takeda-for-colorect-ebe12024-11-15T12:43:30.000Zweekly0.6https://www.pharmafocus.com/articles/interphex-eaa12024-11-15T11:17:54.000Zweekly0.6https://www.pharmafocus.com/articles/nice-gives-positive-recommendation-for-santen-s-roclanda-e19d2024-11-15T12:22:20.000Zweekly0.6https://www.pharmafocus.com/articles/nrg-therapeutics-secures-funding-for-development-of-treatment-fo-35cf2024-11-15T12:36:39.000Zweekly0.6https://www.pharmafocus.com/articles/pac-bio-announces-update-to-sequencing-system-to-bring-down-cost-7ecd2024-11-15T12:39:10.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-f2a82024-11-15T12:46:04.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-salary-survey-8feb2024-11-15T12:45:32.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-b8892024-11-15T11:17:37.000Zweekly0.6https://www.pharmafocus.com/articles/pmea-a57b2024-11-15T12:48:10.000Zweekly0.6https://www.pharmafocus.com/articles/rallybio-s-application-for-a-phase-2-trial-in-pregnant-women-app-13872024-11-15T15:11:59.000Zweekly0.6https://www.pharmafocus.com/articles/shawn-cross-appointed-as-chief-financial-officer-for-pacira-bios-f0ba2024-11-15T11:21:02.000Zweekly0.6https://www.pharmafocus.com/articles/stelis-strides-and-steriscience-merge-to-form-new-cdmo-b1942024-11-15T12:11:20.000Zweekly0.6https://www.pharmafocus.com/articles/survey-from-roche-finds-worryingly-low-understandings-about-hpv-a2ec2024-11-15T12:49:04.000Zweekly0.6https://www.pharmafocus.com/articles/university-of-edinburgh-spinout-kynos-therapeutics-acquire-d-by-4e3c2024-11-15T15:00:20.000Zweekly0.6https://www.pharmafocus.com/articles/valiant-phase-3-trial-results-highlight-potential-treatment-for-f5772024-11-15T15:13:38.000Zweekly0.6https://www.pharmafocus.com/articles/biologic-medicine-dupixent-approved-by-fda-for-copd-patients-in2024-10-11T12:05:04.000Zweekly0.6https://www.pharmafocus.com/articles/clue-points-launches-medical-safety-review-msr-software-for-c2024-10-11T13:39:54.000Zweekly0.6https://www.pharmafocus.com/articles/dr-anada-gubbi-appointed-by-sfa-therapeutics-as-director-of-bios2024-10-11T11:51:09.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lilly-expands-with-two-senior-hires-in-public-affairs-and-co2024-10-11T11:46:46.000Zweekly0.6https://www.pharmafocus.com/articles/european-commission-approves-astellas-pharma-s-gej-adenocarcinom2024-10-11T12:05:11.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-diversity-equity-and-inclusion-in-pharma2024-10-11T11:54:30.000Zweekly0.6https://www.pharmafocus.com/articles/genentech-agrees-to-acquire-regor-s-next-gen-cdk-inhibitors2024-10-11T11:33:24.000Zweekly0.6https://www.pharmafocus.com/articles/genomics-has-a-diversity-deficit-it-s-time-to-fix-it2024-10-11T11:55:45.000Zweekly0.6https://www.pharmafocus.com/articles/headlands-research-opens-new-clinical-trials-site-in-el-paso-te2024-11-11T10:46:34.000Zweekly0.6https://www.pharmafocus.com/articles/hemgenix-approved-for-national-reimbursement-in-spain2024-10-11T12:07:35.000Zweekly0.6https://www.pharmafocus.com/articles/interphex-895c2024-10-11T11:54:50.000Zweekly0.6https://www.pharmafocus.com/articles/johnson-johnson-innovative-medicine-s-carvykti-significantly-e2024-10-11T12:04:44.000Zweekly0.6https://www.pharmafocus.com/articles/looking-ahead-the-future-of-corneal-transplants2024-10-11T13:53:16.000Zweekly0.6https://www.pharmafocus.com/articles/ministry-of-health-labour-and-welfare-of-japan-approves-new-dru2024-10-11T12:07:41.000Zweekly0.6https://www.pharmafocus.com/articles/new-collaboration-agreement-announced-between-emih-association-a2024-10-11T12:07:50.000Zweekly0.6https://www.pharmafocus.com/articles/next-generation-sequencing-partnership-announced-between-angle-p2024-10-11T12:08:04.000Zweekly0.6https://www.pharmafocus.com/articles/part-of-3m-cystic-fibrosis-programme-fund-awarded-to-oxford-dru2024-10-11T11:23:13.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-focus2024-10-11T11:54:43.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-f17f2024-10-11T11:54:57.000Zweekly0.6https://www.pharmafocus.com/articles/preclinical-development-started-for-pol-treg-s-car-treg-neuroinfl2024-10-11T11:14:05.000Zweekly0.6https://www.pharmafocus.com/articles/prilenia-appoints-new-staff-to-advance-company-s-development-and2024-10-11T11:55:31.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-d6222024-10-11T11:33:53.000Zweekly0.6https://www.pharmafocus.com/articles/steriline-s-founder-passes-torch-to-children-with-ceo-and-cso2024-10-11T11:43:07.000Zweekly0.6https://www.pharmafocus.com/articles/strategic-alliance-announced-between-recipharm-and-exela-for-ste2024-10-11T09:17:44.000Zweekly0.6https://www.pharmafocus.com/articles/tiziana-life-sciences-awarded-4m-grant-by-nih-to-study-anti-cd32024-10-11T12:04:58.000Zweekly0.6https://www.pharmafocus.com/articles/uncovering-a-lesser-known-cause-of-heart-failure2024-10-16T10:45:24.000Zweekly0.6https://www.pharmafocus.com/articles/162f4770-86f9-11ef-8b79-42010a8000172024-10-10T16:33:56.000Zweekly0.6https://www.pharmafocus.com/articles/comment-9b0e2024-10-10T16:31:56.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-first-drug-in-50-years-for-treatment-of-schizophren2024-10-11T12:08:39.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-93282024-10-10T16:34:37.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-acaf2024-10-10T16:33:29.000Zweekly0.6https://www.pharmafocus.com/articles/pmea-731a2024-10-10T16:33:20.000Zweekly0.6https://www.pharmafocus.com/articles/research-collaboration-between-fda-and-owlstone-medical-set-to-s2024-10-10T16:31:08.000Zweekly0.6https://www.pharmafocus.com/articles/santhera-pharmaceuticals-announces-lionheart-study-results-for-c2024-10-11T12:08:21.000Zweekly0.6https://www.pharmafocus.com/articles/third-application-for-orion-s-prostate-cancer-drug-submitted-by2024-10-11T12:08:13.000Zweekly0.6https://www.pharmafocus.com/articles/abb-vie-acquires-cerevel-therap-eutics2024-09-09T10:38:09.000Zweekly0.6https://www.pharmafocus.com/articles/adaptimmune-receives-us-fda-accelerated-approval-for-engineered2024-09-09T10:34:53.000Zweekly0.6https://www.pharmafocus.com/articles/calliditas-therapeutics-announces-positive-phase-2b-data-in-prim2024-09-09T10:29:35.000Zweekly0.6https://www.pharmafocus.com/articles/chmp-gives-positive-opinion-for-merck-s-keytruda-for-unresectabl2024-09-09T10:31:46.000Zweekly0.6https://www.pharmafocus.com/articles/clinical-trials-for-personalised-cancer-vaccine-used-to-tackle-a2024-09-09T10:32:16.000Zweekly0.6https://www.pharmafocus.com/articles/collaboration-between-global-cancer-center-and-absci-to-use-gene2024-09-09T10:41:05.000Zweekly0.6https://www.pharmafocus.com/articles/comment-68232024-09-06T16:35:23.000Zweekly0.6https://www.pharmafocus.com/articles/contents-93722024-09-06T16:35:12.000Zweekly0.6https://www.pharmafocus.com/articles/cresset-collaborates-with-enamine-to-enable-the-design-of-new-ta2024-09-09T10:27:50.000Zweekly0.6https://www.pharmafocus.com/articles/david-wheadon-appointed-to-board-of-directors-at-seaport-therape2024-09-06T16:41:38.000Zweekly0.6https://www.pharmafocus.com/articles/dive-into-the-heart-of-pharma-at-cphi-milan-20242024-09-09T10:43:42.000Zweekly0.6https://www.pharmafocus.com/articles/eisai-and-eco-navi-sta-enter-dementia-collaboration2024-09-09T10:35:10.000Zweekly0.6https://www.pharmafocus.com/articles/european-commission-approves-combination-chemotherapy-for-treatm2024-09-09T10:34:20.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-drug-for-primary-biliary-cholangitis2024-09-10T12:19:04.000Zweekly0.6https://www.pharmafocus.com/articles/first-nasal-spray-for-treatment-of-anaphylaxis-approved-by-fda2024-09-06T16:34:09.000Zweekly0.6https://www.pharmafocus.com/articles/first-oral-treatment-for-hormone-sensitive-prostate-cancer-recom2024-09-09T10:27:20.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-primary-biliary-cholangitis2024-09-06T16:42:03.000Zweekly0.6https://www.pharmafocus.com/articles/fly-pharma-europe-00e22024-09-06T16:41:13.000Zweekly0.6https://www.pharmafocus.com/articles/get-in-touch2024-09-06T16:42:12.000Zweekly0.6https://www.pharmafocus.com/articles/how-the-surging-interest-in-oral-peptides-is-opening-new-horizon2024-09-09T10:45:45.000Zweekly0.6https://www.pharmafocus.com/articles/interphex2024-09-06T16:40:47.000Zweekly0.6https://www.pharmafocus.com/articles/johnson-johnson-s-med-tech-announce-orthopaedics-receives-501k2024-09-09T10:36:44.000Zweekly0.6https://www.pharmafocus.com/articles/marketer2024-09-06T16:38:52.000Zweekly0.6https://www.pharmafocus.com/articles/merck-and-daiichi-sankyo-expand-development-and-commericalisatio2024-09-09T10:37:16.000Zweekly0.6https://www.pharmafocus.com/articles/merck-to-acquire-curon-biopharmaceutical-s-b-cell-depletion-ther2024-09-09T10:39:29.000Zweekly0.6https://www.pharmafocus.com/articles/novo-holdings-invests-in-oxford-nanopore-technologies2024-09-06T16:36:13.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-340f2024-09-10T12:18:15.000Zweekly0.6https://www.pharmafocus.com/articles/pmea-47052024-09-06T16:34:26.000Zweekly0.6https://www.pharmafocus.com/articles/positive-results-announced-for-levicept-s-moderate-to-severe-ost2024-09-09T10:29:16.000Zweekly0.6https://www.pharmafocus.com/articles/postersindustry-partners2024-09-06T16:41:56.000Zweekly0.6https://www.pharmafocus.com/articles/precision-medicine-and-the-role-of-pathologists-in-multidiscipli2024-09-09T10:45:25.000Zweekly0.6https://www.pharmafocus.com/articles/richmond-promotes-liz-romano-as-new-director-of-communications-a2024-09-06T16:41:49.000Zweekly0.6https://www.pharmafocus.com/articles/sameda-nl2024-09-06T16:35:32.000Zweekly0.6https://www.pharmafocus.com/articles/the-national-institute-for-health-and-care-excellence-announce-t2024-09-09T10:33:22.000Zweekly0.6https://www.pharmafocus.com/articles/unmet-needs-in-primary-biliary-cholangitis-understanding-challe2024-09-09T10:44:32.000Zweekly0.6https://www.pharmafocus.com/articles/verisense-announce-opening-of-digital-biobank2024-09-09T10:28:39.000Zweekly0.6https://www.pharmafocus.com/articles/neuro-sense-provides-update-for-als-treatment-programme2024-07-18T11:42:47.000Zweekly0.6https://www.pharmafocus.com/articles/abb-vie-s-skyrizi-approved-by-fda-for-uc-treatment2025-02-17T18:35:52.000Zweekly0.6https://www.pharmafocus.com/articles/adam-rosenberg-replaces-dr-carlo-incerti-as-new-chair-of-the-boa2024-07-18T10:55:07.000Zweekly0.6https://www.pharmafocus.com/articles/chemaxon-to-be-acquired-by-certara-for-drug-discovery2024-07-18T11:27:16.000Zweekly0.6https://www.pharmafocus.com/articles/chmp-grants-positive-opinion-to-abb-vie-s-tepkinly-for-follicular2024-07-18T11:48:25.000Zweekly0.6https://www.pharmafocus.com/articles/comment-4aea2024-07-18T11:49:46.000Zweekly0.6https://www.pharmafocus.com/articles/contents-2c152024-07-18T11:50:12.000Zweekly0.6https://www.pharmafocus.com/articles/cphi2024-07-18T11:43:34.000Zweekly0.6https://www.pharmafocus.com/articles/curve-therapeutics-bolsters-its-leadership-team-with-appointment2024-07-18T10:55:59.000Zweekly0.6https://www.pharmafocus.com/articles/dr-jonathan-appleby-appointed-by-mogrify-as-chief-scientific-off2024-07-18T10:54:16.000Zweekly0.6https://www.pharmafocus.com/articles/ec-approves-astra-zeneca-s-tagrisso-for-lung-cancer-treatment2024-07-18T11:52:13.000Zweekly0.6https://www.pharmafocus.com/articles/eisai-and-biogen-s-leqembi-launched-for-ad-in-china-d7602024-07-18T11:49:19.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lilly-and-unicef-extend-partnership-for-risk-of-non-communic2024-07-18T11:47:39.000Zweekly0.6https://www.pharmafocus.com/articles/evotec-provides-update-in-bristol-myers-squibb-neuroscience-coll2024-07-18T11:31:24.000Zweekly0.6https://www.pharmafocus.com/articles/exploring-disease-modification-to-change-the-future-of-epilepsy2024-07-18T11:13:34.000Zweekly0.6https://www.pharmafocus.com/articles/eye-bio-to-be-acquired-by-merck-for-an-upfront-1-3bn2024-07-18T11:28:18.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-eli-lilly-s-kisunla-for-alzheimer-s-treatment-b1c22024-07-18T11:39:41.000Zweekly0.6https://www.pharmafocus.com/articles/fda-expands-approval-for-sarepta-therapeutics-dmd-treatment2024-07-18T11:36:01.000Zweekly0.6https://www.pharmafocus.com/articles/fda-grants-expanded-odd-to-immunotherapy-created-at-roswell-park2024-07-18T11:46:37.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-blood-transfusions2024-07-18T10:50:10.000Zweekly0.6https://www.pharmafocus.com/articles/flypharma-vienna-20242024-07-18T10:57:00.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-and-cure-vac-announce-licensing-agreement-following-collabora2024-07-18T11:32:06.000Zweekly0.6https://www.pharmafocus.com/articles/icon-group-acquires-pharmaxo-as-part-of-strategic-partnership2024-07-18T11:25:09.000Zweekly0.6https://www.pharmafocus.com/articles/innovate-uk-provides-nuclera-with-1-14m-funding2024-07-18T11:30:34.000Zweekly0.6https://www.pharmafocus.com/articles/iptonline-70fa2024-07-18T11:36:30.000Zweekly0.6https://www.pharmafocus.com/articles/merck-s-capvaxive-approved-by-fda-for-prevention-of-pneumococcal2024-07-18T11:41:53.000Zweekly0.6https://www.pharmafocus.com/articles/move-of-the-month-75bc2024-07-18T10:52:23.000Zweekly0.6https://www.pharmafocus.com/articles/oxolife-announces-phase-2-trial-results-for-infertility-drug2024-07-18T11:51:11.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-e9732024-07-18T11:50:23.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-63a02024-07-18T11:51:22.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-ce282024-07-18T11:42:05.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafocus-09992024-07-18T11:03:54.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafocus-5bab2024-07-18T10:49:36.000Zweekly0.6https://www.pharmafocus.com/articles/pmea-65442024-07-18T11:30:48.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-bdf32024-07-18T11:49:35.000Zweekly0.6https://www.pharmafocus.com/articles/sanofi-announces-phase-2-data-from-trial-for-frexalimab-for-ms-t2024-07-18T11:43:14.000Zweekly0.6https://www.pharmafocus.com/articles/sustainable-drug-delivery-devices-striking-a-balance-between-fu2024-07-18T11:10:12.000Zweekly0.6https://www.pharmafocus.com/articles/syngene-announces-launch-of-new-protein-production-platform2024-07-18T11:28:46.000Zweekly0.6https://www.pharmafocus.com/articles/takeda-announces-phase-3-results-from-trial-of-cipd-treatment2024-07-18T11:44:11.000Zweekly0.6https://www.pharmafocus.com/articles/the-infe-cte-d-blood-sc-andal-a-timeline2024-07-18T11:03:41.000Zweekly0.6https://www.pharmafocus.com/articles/the-role-of-ai-in-patient-support2024-07-18T11:05:02.000Zweekly0.6https://www.pharmafocus.com/articles/gilead-announces-data-from-phase-3-hiv-prevention-trial-e2262024-07-18T11:44:52.000Zweekly0.6https://www.pharmafocus.com/articles/20-years-of-egfr-in-nsclc-how-precision-medicine-helps-navigate2024-06-05T14:00:50.000Zweekly0.6https://www.pharmafocus.com/articles/amgen-s-imdelltra-approved-by-fda-for-extensive-stage-small-cell2024-06-05T13:35:16.000Zweekly0.6https://www.pharmafocus.com/articles/asco-20242024-06-05T12:22:16.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-and-benevolent-ai-add-new-heart-failure-target-throug2024-06-05T12:27:07.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-announces-data-from-covid-19-prevention-drug-phase-32024-06-05T13:40:03.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-invests-1-5bn-to-build-adc-facility-in-singapore2024-06-05T13:45:32.000Zweekly0.6https://www.pharmafocus.com/articles/bayer-and-evote-cannounce-collaboration-for-precision-cardiology2024-06-05T12:28:08.000Zweekly0.6https://www.pharmafocus.com/articles/beckman-coulter-life-sciences-and-watchmaker-genomics-to-collabo2024-06-05T12:26:31.000Zweekly0.6https://www.pharmafocus.com/articles/boehringer-ingelheim-and-ose-immunotherapeutics-to-collaborate-o2024-06-05T13:43:28.000Zweekly0.6https://www.pharmafocus.com/articles/chmp-grants-positive-opinion-for-j-j-s-rybrevant-for-lung-cancer2024-06-05T13:34:15.000Zweekly0.6https://www.pharmafocus.com/articles/circular-genomics-shares-study-results-predicting-patient-respon2024-06-05T13:37:55.000Zweekly0.6https://www.pharmafocus.com/articles/closed-loop-medicine-appoints-paul-johnson-as-non-executive-dire2024-06-05T12:16:11.000Zweekly0.6https://www.pharmafocus.com/articles/comment-69f32024-06-05T13:48:53.000Zweekly0.6https://www.pharmafocus.com/articles/communique-9d362024-06-05T13:40:20.000Zweekly0.6https://www.pharmafocus.com/articles/contents-a2b52024-06-05T13:49:28.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lilly-increases-investment-for-manufacturing-to-9bn-at-new2024-06-05T13:44:34.000Zweekly0.6https://www.pharmafocus.com/articles/enhanc3d-genomics-appoints-hazel-jones-as-ceo2024-06-05T12:18:29.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-pfizer-s-beqvez-for-treatment-of-haemophilia-b2024-06-05T13:52:35.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-lgbtq-healthcare2024-06-05T13:53:37.000Zweekly0.6https://www.pharmafocus.com/articles/fly-pharma2024-06-05T12:18:50.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-announces-positive-outcome-from-phase-3-trials-for-asthma-tr2024-06-05T13:41:11.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-invests-45m-with-fleming-initiative-to-combat-amr2024-06-05T13:48:17.000Zweekly0.6https://www.pharmafocus.com/articles/human-immunology-biosciences-to-be-aquired-by-biogen-for-1-15bn2024-06-05T12:25:04.000Zweekly0.6https://www.pharmafocus.com/articles/iptonline2024-06-05T12:25:22.000Zweekly0.6https://www.pharmafocus.com/articles/j-j-s-tremfya-meets-endpoints-in-uc-study2024-06-05T13:41:58.000Zweekly0.6https://www.pharmafocus.com/articles/mhra-approves-ascendis-pharma-s-yorvipath-for-hypoparathyroidism2024-06-05T12:31:11.000Zweekly0.6https://www.pharmafocus.com/articles/mirus-bio-to-be-acquired-by-merck-for-600m2024-06-05T12:24:00.000Zweekly0.6https://www.pharmafocus.com/articles/move-of-the-month-dr-alison-evans-appointed-head-of-education-an2024-06-18T11:20:28.000Zweekly0.6https://www.pharmafocus.com/articles/nexus-pharmaceuticals-manufacturing-facility-acquired-by-eli-li2024-06-05T12:23:26.000Zweekly0.6https://www.pharmafocus.com/articles/niea2024-06-05T13:36:48.000Zweekly0.6https://www.pharmafocus.com/articles/paediatric-clinical-trials-for-obesity-treatment2024-06-05T13:58:44.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-6ec32024-06-05T13:50:03.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-5ecd2024-06-05T13:51:47.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafocus-26052024-06-05T12:20:52.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafocus-fc662024-06-05T12:13:50.000Zweekly0.6https://www.pharmafocus.com/articles/pharmatimes-93f92024-06-05T12:30:23.000Zweekly0.6https://www.pharmafocus.com/articles/pmea-open2024-06-05T12:28:39.000Zweekly0.6https://www.pharmafocus.com/articles/pride-month-and-lgbtq-healthcare2024-06-05T13:56:00.000Zweekly0.6https://www.pharmafocus.com/articles/roche-s-hpv-self-collection-screening-option-approved-by-fda2024-06-05T13:36:34.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-98912024-06-05T13:48:39.000Zweekly0.6https://www.pharmafocus.com/articles/sanofi-and-novavex-sign-exclusive-licensing-agreement-to-commerc2024-06-05T12:30:05.000Zweekly0.6https://www.pharmafocus.com/articles/sanofi-formation-bio-and-open-ai-announce-new-ai-collaboration2024-06-05T13:51:01.000Zweekly0.6https://www.pharmafocus.com/articles/sphere-fluidics-appoints-curtis-nicholson-as-director-of-sales-e2024-06-05T12:17:38.000Zweekly0.6https://www.pharmafocus.com/articles/abb-vie-s-migraine-treatment-recommended-by-nice-for-nhs-use2024-04-29T11:05:13.000Zweekly0.6https://www.pharmafocus.com/articles/alpine-immune-sciences-to-be-acquired-by-vertex-for-4-9bn2024-04-29T10:41:38.000Zweekly0.6https://www.pharmafocus.com/articles/ardena-gains-first-gmp-approval-and-announces-20m-expansion2024-04-29T10:48:29.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-and-daiichi-sankyo-s-bla-for-datopotamab-deruxtecan2024-04-29T11:01:38.000Zweekly0.6https://www.pharmafocus.com/articles/bob-kain-joins-single-technologies-as-advisor2024-04-29T10:32:54.000Zweekly0.6https://www.pharmafocus.com/articles/candel-therapeutics-pancreatic-cancer-treatment-granted-odd-by2024-04-29T10:59:49.000Zweekly0.6https://www.pharmafocus.com/articles/comment-00dc2024-04-29T11:02:18.000Zweekly0.6https://www.pharmafocus.com/articles/communique-awards-12024-04-29T11:03:40.000Zweekly0.6https://www.pharmafocus.com/articles/curve-therapeutics-cso-publishes-research-on-hif-inhibition-for2024-04-29T10:47:04.000Zweekly0.6https://www.pharmafocus.com/articles/ef9eae1d-03a9-11ef-84d3-42010a8000152024-04-29T11:03:11.000Zweekly0.6https://www.pharmafocus.com/articles/eko-health-s-ai-for-heart-failure-detection-approved-by-fda2024-04-29T11:04:08.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lilly-shares-results-from-phase-3-trial-for-tirzepatide-in-r2024-04-29T10:58:11.000Zweekly0.6https://www.pharmafocus.com/articles/epilepsy-and-brain-health-a-call-for-global-action-and-unity2024-04-30T11:24:16.000Zweekly0.6https://www.pharmafocus.com/articles/fda-accepts-gsk-s-meningococcal-vaccine-candidate-bla-for-review2024-04-29T10:51:51.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-roche-s-alecensa-lung-cancer-treatment2024-04-29T10:51:10.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-sustainability-in-the-pharma-industry2024-04-29T11:11:12.000Zweekly0.6https://www.pharmafocus.com/articles/flypharma-vienna2024-04-29T10:36:16.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-announces-results-from-phase-3-gonorrhoea-treatment-trial2024-04-29T10:58:44.000Zweekly0.6https://www.pharmafocus.com/articles/immunity-bio-s-anktiva-bladder-cancer-treatment-approved-by-fda2024-04-29T10:50:14.000Zweekly0.6https://www.pharmafocus.com/articles/ipt-online-20242024-04-29T10:46:03.000Zweekly0.6https://www.pharmafocus.com/articles/ironic-biotech-gains-1m-funding-for-development-of-iron-deficie2024-04-29T10:47:36.000Zweekly0.6https://www.pharmafocus.com/articles/jaap-stuut-appointed-as-president-and-general-manager-of-sakura2024-04-29T10:34:13.000Zweekly0.6https://www.pharmafocus.com/articles/johnson-johnson-announces-acquisition-of-shockwave-medical-for2024-04-29T10:44:36.000Zweekly0.6https://www.pharmafocus.com/articles/landos-biopharma-to-be-acquired-by-abb-vie-for-approximately-1372024-04-29T10:45:22.000Zweekly0.6https://www.pharmafocus.com/articles/margrethe-s-rgaard-appointed-senior-vice-president-of-clinical-o2024-04-29T10:35:40.000Zweekly0.6https://www.pharmafocus.com/articles/medincell-and-abb-vie-collaborate-for-next-generation-injectables2024-04-29T11:02:05.000Zweekly0.6https://www.pharmafocus.com/articles/meenu-chhabra-karson-appointed-board-chair-of-harness-therapeuti2024-04-29T10:33:39.000Zweekly0.6https://www.pharmafocus.com/articles/neurolentech-and-kaerus-bioscience-collaborate-on-neurodevelopme2024-04-29T10:49:01.000Zweekly0.6https://www.pharmafocus.com/articles/novartis-announces-phase-3-results-for-fabhalta-for-ig-an-treatme2024-04-29T10:53:07.000Zweekly0.6https://www.pharmafocus.com/articles/pfizer-s-emblaveo-approved-in-eu-for-multidrug-resistant-infecti2024-04-29T10:50:42.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-may2024-04-29T10:30:52.000Zweekly0.6https://www.pharmafocus.com/articles/pharmarole-12024-04-29T11:02:48.000Zweekly0.6https://www.pharmafocus.com/articles/pharmatimes-msea-awards2024-04-29T10:49:31.000Zweekly0.6https://www.pharmafocus.com/articles/pharmatimes-msea-awards-12024-04-29T10:52:22.000Zweekly0.6https://www.pharmafocus.com/articles/psychedelic-medicines-and-the-treatment-of-neurological-conditio2024-04-29T11:20:12.000Zweekly0.6https://www.pharmafocus.com/articles/psychoactives-in-mental-health-treatment2024-04-29T11:18:28.000Zweekly0.6https://www.pharmafocus.com/articles/rare-disease-clinical-trials-the-urgent-need-for-patients-to-be2024-04-30T14:10:44.000Zweekly0.6https://www.pharmafocus.com/articles/samedanltd-20242024-04-29T10:48:03.000Zweekly0.6https://www.pharmafocus.com/articles/sanofi-announces-data-from-phase-3-luna-3-trial-for-immune-throm2024-04-29T10:59:15.000Zweekly0.6https://www.pharmafocus.com/articles/sustainability-in-pharma2024-04-29T11:14:00.000Zweekly0.6https://www.pharmafocus.com/articles/ucb-s-s-bla-for-bimzelx-accepted-by-fda-for-hs-treatment2024-04-29T11:00:23.000Zweekly0.6https://www.pharmafocus.com/articles/us-croy2024-04-29T11:04:29.000Zweekly0.6https://www.pharmafocus.com/articles/yourway-20242024-04-29T10:38:48.000Zweekly0.6https://www.pharmafocus.com/articles/allumiqs-and-prolytix-to-collaborate-for-drug-discovery-and-deve2024-04-08T12:23:05.000Zweekly0.6https://www.pharmafocus.com/articles/ambrx-biopharma-acquired-by-j-j-for-approximately-2bn2024-04-08T12:20:35.000Zweekly0.6https://www.pharmafocus.com/articles/amneal-and-zambon-biotech-to-collaborate-for-parkinson-s-treatme2024-04-08T13:45:02.000Zweekly0.6https://www.pharmafocus.com/articles/an-overview-of-women-s-health-in-20242024-04-08T13:58:45.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-s-ultomiris-approved-by-fda-for-nmosd-treatment2024-04-08T13:39:23.000Zweekly0.6https://www.pharmafocus.com/articles/bayer-and-aignostics-enter-partnership-for-ai-oncology-research2024-04-08T12:24:50.000Zweekly0.6https://www.pharmafocus.com/articles/comment-433f2024-04-08T13:51:04.000Zweekly0.6https://www.pharmafocus.com/articles/communique-awards-20242024-04-08T13:51:54.000Zweekly0.6https://www.pharmafocus.com/articles/compliant-connections-making-instant-messaging-work-for-biophar2024-04-08T14:17:40.000Zweekly0.6https://www.pharmafocus.com/articles/contents-fea42024-04-08T13:51:32.000Zweekly0.6https://www.pharmafocus.com/articles/dr-james-malone-appointed-cto-at-benevolent-ai2024-04-08T12:10:07.000Zweekly0.6https://www.pharmafocus.com/articles/ema-accepts-two-applications-for-datopotamab-deruxtecan-for-onco2024-04-08T13:47:10.000Zweekly0.6https://www.pharmafocus.com/articles/fda-grants-ind-clearance-to-spero-therapeutics-bacterial-infect2024-04-08T13:46:03.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-women-s-health2024-04-08T13:55:39.000Zweekly0.6https://www.pharmafocus.com/articles/flypharma-europe-12024-04-09T10:32:00.000Zweekly0.6https://www.pharmafocus.com/articles/fusion-pharmaceuticals-to-be-acquired-by-astra-zeneca-for-approxi2024-04-08T12:22:05.000Zweekly0.6https://www.pharmafocus.com/articles/gen-ai-and-pharma-the-future-is-now2024-04-15T11:51:55.000Zweekly0.6https://www.pharmafocus.com/articles/gilead-and-merck-share-new-data-from-phase-2-hiv-treatment-trial2024-04-08T13:53:10.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-announces-data-from-phase-3-trial-for-jemperli-combinations-5d112024-04-08T13:43:49.000Zweekly0.6https://www.pharmafocus.com/articles/harpoon-therapeutics-acquired-by-merck-for-650m2024-04-08T12:21:27.000Zweekly0.6https://www.pharmafocus.com/articles/i-nizio2024-04-08T13:40:22.000Zweekly0.6https://www.pharmafocus.com/articles/innovations-in-pharmaceutical-technology-d2ab2024-04-08T12:22:28.000Zweekly0.6https://www.pharmafocus.com/articles/international-women-s-day-remains-a-key-platform-to-keep-inspiri2024-04-08T14:02:25.000Zweekly0.6https://www.pharmafocus.com/articles/j-j-med-tech-and-nvidia-to-col-lab-or-ate-for-surgic-al-ai2024-04-08T12:25:53.000Zweekly0.6https://www.pharmafocus.com/articles/j-j-s-opsy-nv-i-approve-d-in-us-for-pah-tre-atment2024-04-08T12:30:09.000Zweekly0.6https://www.pharmafocus.com/articles/joseph-bertelsen-appointed-cco-of-nuclera2024-04-08T12:07:25.000Zweekly0.6https://www.pharmafocus.com/articles/medical-scientific-excellence-awards2024-04-08T12:26:19.000Zweekly0.6https://www.pharmafocus.com/articles/merck-announces-data-from-phase-3-trial-for-keytruda-in-cervical2024-04-08T13:43:12.000Zweekly0.6https://www.pharmafocus.com/articles/merck-announces-plans-for-hpv-vaccines-trials2024-04-08T12:23:53.000Zweekly0.6https://www.pharmafocus.com/articles/novo-nordisk-s-awiqli-recommended-by-chmp-for-diabetes-treatment2024-04-08T12:29:01.000Zweekly0.6https://www.pharmafocus.com/articles/parexel-announces-new-ceo2024-04-08T12:06:37.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-cd262024-04-08T13:50:40.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-83f12024-04-08T13:53:27.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-be352024-04-08T12:00:46.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafocus-76f72024-04-08T12:01:31.000Zweekly0.6https://www.pharmafocus.com/articles/reducing-unintended-pregnancy-rates-how-innovation-in-contracep2024-04-08T14:07:23.000Zweekly0.6https://www.pharmafocus.com/articles/rezdiffra-approved-by-fda-as-first-treatment-for-liver-scarring2024-04-08T13:54:07.000Zweekly0.6https://www.pharmafocus.com/articles/roche-announces-new-data-for-continuous-glucose-monitoring-syste-693d2024-04-08T13:47:55.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-44d72024-04-08T12:24:15.000Zweekly0.6https://www.pharmafocus.com/articles/sanofi-announces-results-from-phase-2b-for-dermatitis-treatment2024-04-08T13:42:33.000Zweekly0.6https://www.pharmafocus.com/articles/sosei-heptares-announces-first-patient-dosed-in-trial-for-ibd-tr2024-04-08T13:41:08.000Zweekly0.6https://www.pharmafocus.com/articles/takeda-s-hyqvia-gains-mhra-marketing-authorisation-for-chronic-i2024-04-08T12:27:51.000Zweekly0.6https://www.pharmafocus.com/articles/vynamic-appoints-new-head-of-life-sciences-europe2024-04-08T12:03:35.000Zweekly0.6https://www.pharmafocus.com/articles/yourway2024-04-09T10:31:11.000Zweekly0.6https://www.pharmafocus.com/articles/254m-funding-raised-by-freenome-for-early-cancer-detection2024-03-06T15:26:57.000Zweekly0.6https://www.pharmafocus.com/articles/4-9m-raised-for-development-of-vivet-therapeutics-gene-therapi2024-03-06T15:03:22.000Zweekly0.6https://www.pharmafocus.com/articles/abb-vie-and-tentarix-announce-oncology-and-immunology-collaborati2024-03-06T15:05:50.000Zweekly0.6https://www.pharmafocus.com/articles/abb-vie-s-tepkinly-recommended-by-nice-for-sc-treatment-of-dlbcl2024-03-06T15:08:22.000Zweekly0.6https://www.pharmafocus.com/articles/adhere-tech-appoints-paul-sekhri-to-board-of-directors2024-03-06T14:49:15.000Zweekly0.6https://www.pharmafocus.com/articles/amylyx-pharmaceuticals-appoints-andrew-caldwell-as-general-manag2024-03-06T14:51:49.000Zweekly0.6https://www.pharmafocus.com/articles/astellas-and-kelonia-therapeutics-announce-agreement-for-immunoo2024-03-06T15:05:14.000Zweekly0.6https://www.pharmafocus.com/articles/bio-n-tech-and-autolus-collaborate-for-car-t-cell-therapies2024-03-06T15:04:11.000Zweekly0.6https://www.pharmafocus.com/articles/boehringer-ingelheim-shares-data-from-liver-disease-phase-2-tria2024-03-06T15:20:51.000Zweekly0.6https://www.pharmafocus.com/articles/bridging-science-and-data-a-new-era-in-cancer-clinical-trials2024-03-06T15:56:57.000Zweekly0.6https://www.pharmafocus.com/articles/comment-79462024-03-06T15:25:12.000Zweekly0.6https://www.pharmafocus.com/articles/communique-49872024-03-06T15:06:04.000Zweekly0.6https://www.pharmafocus.com/articles/community-pharmacies-need-more-support-to-deliver-pharmacy-first2024-03-06T15:38:04.000Zweekly0.6https://www.pharmafocus.com/articles/contents-42ea2024-03-06T15:25:38.000Zweekly0.6https://www.pharmafocus.com/articles/cuttsy-cuttsy-announces-appointment-of-jon-hume-as-commercial-di2024-03-06T14:50:03.000Zweekly0.6https://www.pharmafocus.com/articles/domainex-announces-opening-of-new-biology-centre-of-excellence-i2024-03-06T15:22:28.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lilly-s-cialis-and-alimta-to-be-acquired-by-zuellig-pharma-i2024-03-06T15:02:07.000Zweekly0.6https://www.pharmafocus.com/articles/european-commission-approves-pfizer-s-velsipity-for-ulcerative-c2024-03-06T15:12:23.000Zweekly0.6https://www.pharmafocus.com/articles/fda-accepts-argenx-s-bla-for-vyvgart-hytrulo-for-cidp-treatment2024-03-06T15:22:58.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-astra-zeneca-s-tagrisso-for-lung-cancer-treatment2024-03-06T15:28:09.000Zweekly0.6https://www.pharmafocus.com/articles/fda-grants-breakthrough-therapy-designation-for-j-j-s-nipocalima2024-03-06T15:23:53.000Zweekly0.6https://www.pharmafocus.com/articles/fda-grants-fast-track-designation-to-gsk-s-chronic-hepatitis-b-t2024-03-06T15:24:34.000Zweekly0.6https://www.pharmafocus.com/articles/first-patient-enrolled-in-tenax-therapeutics-phase-3-trial-for2024-03-06T15:17:35.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-measles2024-03-06T15:29:31.000Zweekly0.6https://www.pharmafocus.com/articles/flypharma2024-03-06T15:12:37.000Zweekly0.6https://www.pharmafocus.com/articles/georges-rawadi-appointed-ceo-of-stroma-care2024-03-06T14:50:56.000Zweekly0.6https://www.pharmafocus.com/articles/get-in-touch-pharmafocu2024-03-06T14:46:31.000Zweekly0.6https://www.pharmafocus.com/articles/ipsen-s-onivyde-approved-by-fda-for-treatment-of-pancreatic-aden2024-03-06T15:11:48.000Zweekly0.6https://www.pharmafocus.com/articles/jazz-pharmaceuticals-to-acquire-rights-to-redx-pharma-s-kras-inh2024-03-06T15:00:11.000Zweekly0.6https://www.pharmafocus.com/articles/measles-the-uk-s-next-epidemic2024-03-06T15:32:47.000Zweekly0.6https://www.pharmafocus.com/articles/morpho-sys-to-be-acquired-by-novartis-for-2-7bn2024-03-06T15:02:41.000Zweekly0.6https://www.pharmafocus.com/articles/next-generation-treatments-and-clinical-trials-for-non-small-cel2024-03-06T16:03:07.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-f42b2024-03-06T15:24:49.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-8be62024-03-06T15:27:09.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-e3542024-03-06T14:58:40.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-0b062024-03-06T15:10:30.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-f4522024-03-06T14:45:41.000Zweekly0.6https://www.pharmafocus.com/articles/roche-announces-results-from-phase-3-study-of-allergy-treatment2024-03-06T15:21:34.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-35192024-03-06T14:52:06.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-920f2024-03-06T15:04:24.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-d71e2024-03-06T15:26:23.000Zweekly0.6https://www.pharmafocus.com/articles/streamlining-patient-support-programmes-a-five-step-approach2024-03-06T15:35:14.000Zweekly0.6https://www.pharmafocus.com/articles/the-landscape-of-blood-cancer-treatments-in-the-uk2024-03-06T15:48:12.000Zweekly0.6https://www.pharmafocus.com/articles/vertex-s-casgevy-for-sickle-cell-disease-treatment-approved-by-e2024-03-06T15:07:38.000Zweekly0.6https://www.pharmafocus.com/articles/vii-v-healthcare-announces-interim-results-from-phase-3-trial-for2024-03-06T15:20:07.000Zweekly0.6https://www.pharmafocus.com/articles/2024-a-tipping-point-for-progress-in-rare-diseases2024-02-07T13:17:04.000Zweekly0.6https://www.pharmafocus.com/articles/ageing-populations-and-geographical-health-disparities-in-the-uk2024-02-07T13:11:48.000Zweekly0.6https://www.pharmafocus.com/articles/aiolos-bio-to-be-acquired-by-gsk-for-1bn2024-02-07T12:38:18.000Zweekly0.6https://www.pharmafocus.com/articles/alphamab-oncology-and-3d-medicines-announce-licensing-agreement-w2024-02-07T12:40:07.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-and-ionis-s-wainua-approved-by-fda2024-02-07T12:45:47.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-pays-c4x-an-11m-milestone-payment2024-02-07T12:56:18.000Zweekly0.6https://www.pharmafocus.com/articles/bio-n-tech-s-rwanda-vaccine-manufacturing-site-achieves-milestone2024-02-07T12:57:50.000Zweekly0.6https://www.pharmafocus.com/articles/comment-17782024-02-07T12:58:32.000Zweekly0.6https://www.pharmafocus.com/articles/communique-8c362024-02-07T12:44:05.000Zweekly0.6https://www.pharmafocus.com/articles/contents-jan-feb-242024-02-07T12:59:07.000Zweekly0.6https://www.pharmafocus.com/articles/daiichi-sankyo-shares-data-from-clinical-trial-for-ezharmia-as-l2024-02-07T12:52:36.000Zweekly0.6https://www.pharmafocus.com/articles/digital-healthcare-platform-launched-by-eli-lilly2024-02-07T12:57:01.000Zweekly0.6https://www.pharmafocus.com/articles/don-t-settle-for-black-box-why-only-explainable-ai-is-built-for2024-02-07T13:20:56.000Zweekly0.6https://www.pharmafocus.com/articles/dr-joerg-moeller-appointed-ceo-of-benevolent-ai2024-02-07T12:14:40.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-calliditas-therapeutics-tarpeyo-to-reduce-loss-of2024-02-07T12:44:52.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-skin-cancer-ai-detection-device2024-02-07T13:00:17.000Zweekly0.6https://www.pharmafocus.com/articles/fda-grants-fast-track-designation-for-verastem-s-combination-nsc2024-02-07T12:55:04.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-the-nhs2024-02-07T13:07:32.000Zweekly0.6https://www.pharmafocus.com/articles/fly-pharma-europe2024-02-07T12:48:14.000Zweekly0.6https://www.pharmafocus.com/articles/genetech-and-nvidia-announce-collaboration-using-ai-for-drug-dis2024-02-07T12:42:18.000Zweekly0.6https://www.pharmafocus.com/articles/gilead-and-compugen-announce-new-agreement-for-immunotherapy-pro2024-02-07T12:43:45.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-s-jemperli-plus-zejula-combination-performs-well-in-trial-as2024-02-07T12:54:15.000Zweekly0.6https://www.pharmafocus.com/articles/harpoon-therapeutics-set-to-be-acquired-by-merck-for-approximate2024-02-07T12:37:34.000Zweekly0.6https://www.pharmafocus.com/articles/inhibrx-to-be-acquired-by-sanofi-for-approximately-1-7bn2024-02-07T12:39:09.000Zweekly0.6https://www.pharmafocus.com/articles/j-j-s-balversa-approved-by-fda-for-bladder-cancer-treatment2024-02-07T12:47:02.000Zweekly0.6https://www.pharmafocus.com/articles/measles-outbreak-possible-advises-ukhsa2024-02-07T13:01:03.000Zweekly0.6https://www.pharmafocus.com/articles/merck-s-keytruda-with-chemoradiotherapy-approved-by-fda-as-treat2024-02-07T12:47:53.000Zweekly0.6https://www.pharmafocus.com/articles/novo-nordisk-announces-data-from-combine-3-phase-3a-trial2024-02-07T12:53:14.000Zweekly0.6https://www.pharmafocus.com/articles/our-winter-of-discontent-nhs-strikes-and-missed-targets2024-02-07T13:09:49.000Zweekly0.6https://www.pharmafocus.com/articles/owkin-and-merck-collaborate-on-cancer-diagnostics-powered-by-ai2024-02-07T12:41:03.000Zweekly0.6https://www.pharmafocus.com/articles/paediatrics-in-the-review-of-the-eu-general-pharmaceutical-legis2024-02-09T16:26:14.000Zweekly0.6https://www.pharmafocus.com/articles/peter-crossley-appointed-coo-of-cellular-origins2024-02-07T12:09:37.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-cee62024-02-07T12:58:04.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-cfa72024-02-07T13:00:31.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-2c202024-02-07T12:46:01.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-99ec2024-02-07T12:04:38.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafocus-24142024-02-07T12:05:26.000Zweekly0.6https://www.pharmafocus.com/articles/pharmatimes-e2242024-02-07T12:33:32.000Zweekly0.6https://www.pharmafocus.com/articles/regeneron-shares-results-from-trial-for-multiple-myeloma-treatme2024-02-07T12:50:13.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-60de2024-02-07T12:41:15.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-7e3c2024-02-07T12:59:40.000Zweekly0.6https://www.pharmafocus.com/articles/samedanltd2024-02-07T12:20:58.000Zweekly0.6https://www.pharmafocus.com/articles/sosei-group-appoints-toshihiro-maeda-as-coo2024-02-07T12:11:40.000Zweekly0.6https://www.pharmafocus.com/articles/the-impact-of-climate-change-on-respiratory-health2024-02-07T13:13:25.000Zweekly0.6https://www.pharmafocus.com/articles/the-risk-of-replicating-social-bias-in-synthetic-patient-data2024-02-07T13:22:10.000Zweekly0.6https://www.pharmafocus.com/articles/x-chem-announces-new-ceo-and-cso2024-02-07T12:11:47.000Zweekly0.6https://www.pharmafocus.com/articles/digital-offerings-2bb62024-01-05T15:00:45.000Zweekly0.6https://www.pharmafocus.com/articles/digital-rates-89672024-01-05T14:58:36.000Zweekly0.6https://www.pharmafocus.com/articles/forward-features-list-20242024-01-05T15:01:51.000Zweekly0.6https://www.pharmafocus.com/articles/increase-your-brand-awareness-9c1c2024-01-05T14:58:57.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-com-a15c2024-01-05T15:01:08.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafocus-a9b02024-01-05T15:02:30.000Zweekly0.6https://www.pharmafocus.com/articles/readership-a2a92024-01-05T15:01:27.000Zweekly0.6https://www.pharmafocus.com/articles/working-with-us-bf6d2024-01-05T15:02:10.000Zweekly0.6https://www.pharmafocus.com/articles/anti-counterfeiting-the-battle-against-fake-pharmaceuticals2023-11-24T12:26:12.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-and-cellectis-announce-collaboration-for-cell-therap2023-11-24T12:38:54.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-s-imfinzi-meets-primary-endpoint-for-liver-cancer-tr2023-11-24T12:59:07.000Zweekly0.6https://www.pharmafocus.com/articles/astrazenecas-truqap-plus-faslodex-approved-by-fda-for-treatment-of-breast-cancer2023-11-24T13:11:12.000Zweekly0.6https://www.pharmafocus.com/articles/autifony-and-jazz-pharmaceuticals-enter-global-licence-and-colla2023-11-24T13:02:12.000Zweekly0.6https://www.pharmafocus.com/articles/bms-s-augtyro-approved-by-fda-for-lung-cancer-treatment2023-11-24T12:50:38.000Zweekly0.6https://www.pharmafocus.com/articles/boan-biotech-enrols-first-patient-for-nivolumab-phase-3-trial-in2023-11-24T12:55:04.000Zweekly0.6https://www.pharmafocus.com/articles/cell-therapy-pipeline-shared-by-bit-bio2023-11-24T13:02:51.000Zweekly0.6https://www.pharmafocus.com/articles/chmp-shares-positive-opinion-for-gsk-s-momelotinib-for-myelofibr2023-11-24T13:05:17.000Zweekly0.6https://www.pharmafocus.com/articles/contents-5cde2023-11-24T13:06:24.000Zweekly0.6https://www.pharmafocus.com/articles/ec-approved-daiichi-sankyo-s-vanflyta-for-acute-myeloid-leukaemi2023-11-24T12:45:59.000Zweekly0.6https://www.pharmafocus.com/articles/embracing-technological-advancements-revolutionising-clinical-t2023-11-24T12:27:16.000Zweekly0.6https://www.pharmafocus.com/articles/evotec-and-dewpoint-therapeutics-announce-that-they-will-enter-s2023-11-24T12:35:38.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approved-eli-lilly-s-zepbound-for-chronic-weight-management2023-11-24T12:44:43.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-antimicrobial-resistance2023-11-24T11:50:47.000Zweekly0.6https://www.pharmafocus.com/articles/fresenius-kabi-s-manufacturing-site-to-be-acquired-by-prange-gro2023-11-24T12:30:05.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-s-ventolin-low-carbon-inhaler-to-progress-to-phase-3-trials2023-11-24T13:01:20.000Zweekly0.6https://www.pharmafocus.com/articles/halozyme-and-acumen-pharmaceuticals-collaborate-for-alzheimer-s2023-11-24T12:33:10.000Zweekly0.6https://www.pharmafocus.com/articles/hazel-jones-appointed-as-enhanc3d-genomics-chief-operating-offi2023-11-24T12:08:56.000Zweekly0.6https://www.pharmafocus.com/articles/innovations-in-pharmaceutical-technology-e4852023-11-24T12:32:00.000Zweekly0.6https://www.pharmafocus.com/articles/international-fertility-experts-appointed-to-oxolife-s-scientifi2023-11-24T12:12:28.000Zweekly0.6https://www.pharmafocus.com/articles/io-biotech-appoints-helen-collins-to-board-of-directors2023-11-24T11:53:05.000Zweekly0.6https://www.pharmafocus.com/articles/j-j-plans-to-submit-surgical-robot-to-regulators-in-20242023-11-24T12:43:20.000Zweekly0.6https://www.pharmafocus.com/articles/merck-s-keytruda-approved-by-fda-for-gastric-cancer-treatment2023-11-24T12:52:47.000Zweekly0.6https://www.pharmafocus.com/articles/nano-syrinx-appoints-anthony-johnson-as-non-executive-director2023-11-24T12:10:09.000Zweekly0.6https://www.pharmafocus.com/articles/new-data-shared-for-leqembi-as-alzheimer-s-treatment2023-11-24T12:56:12.000Zweekly0.6https://www.pharmafocus.com/articles/notable-tech-enabled-solutions-advancing-clinical-trials-with-al2023-11-24T12:16:48.000Zweekly0.6https://www.pharmafocus.com/articles/novo-nordisk-invests-42bn-danish-kroner-in-manufacturing-facilit2023-11-24T13:03:35.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-bf852023-11-24T13:05:54.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-84052023-11-24T12:54:29.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-de9a2023-11-24T11:49:32.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-f5112023-11-24T12:49:29.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafocus-90682023-11-24T11:50:12.000Zweekly0.6https://www.pharmafocus.com/articles/propella-therapeutics-to-be-acquired-by-astellas-pharma-for-1752023-11-24T12:30:49.000Zweekly0.6https://www.pharmafocus.com/articles/roche-to-acquire-telavant-for-7-1bn2023-11-24T12:31:41.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-836f2023-11-24T13:06:43.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-ed5c2023-11-24T12:29:08.000Zweekly0.6https://www.pharmafocus.com/articles/the-biggest-news-of-20232023-11-27T11:18:31.000Zweekly0.6https://www.pharmafocus.com/articles/viro-cell-and-great-ormand-street-hospital-receive-mhra-manufactu2023-11-24T13:07:51.000Zweekly0.6https://www.pharmafocus.com/articles/175m-raised-by-avalyn-pharma-in-series-c-financing-for-inhalati2023-11-02T15:05:57.000Zweekly0.6https://www.pharmafocus.com/articles/45m-series-b-funding-raised-by-acesion-pharma2023-11-02T15:04:07.000Zweekly0.6https://www.pharmafocus.com/articles/alfasigma-acquires-intercept-pharmaceuticals-for-approximately2023-11-02T12:25:45.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-and-daiichi-sankyo-share-results-from-phase-3-trial2023-11-02T13:37:08.000Zweekly0.6https://www.pharmafocus.com/articles/bacti-vac-shared-development-of-bacterial-vaccines-to-prevent-inf2023-11-02T12:32:49.000Zweekly0.6https://www.pharmafocus.com/articles/biogen-s-tofidence-biosimilar-gains-fda-approval2023-11-02T13:30:56.000Zweekly0.6https://www.pharmafocus.com/articles/comment-nov-232023-11-02T15:16:18.000Zweekly0.6https://www.pharmafocus.com/articles/contents-nov-232023-11-02T15:16:51.000Zweekly0.6https://www.pharmafocus.com/articles/dna-test-for-predisposition-to-certain-cancers-granted-marketing2023-11-02T12:34:47.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lilly-and-boehringer-ingelheim-s-jardiance-approved-by-fda-f2023-11-02T13:28:10.000Zweekly0.6https://www.pharmafocus.com/articles/fda-accepts-regeneron-and-sanofi-s-s-bla-for-dupixent-for-priorit2023-11-02T15:09:18.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-health-inequalities2023-11-02T15:33:08.000Zweekly0.6https://www.pharmafocus.com/articles/from-the-margins-a-book-review2023-11-02T15:47:42.000Zweekly0.6https://www.pharmafocus.com/articles/fujifilm-diosynth-biotechnologies-appoints-maja-pedersen-as-chie2023-11-02T12:13:15.000Zweekly0.6https://www.pharmafocus.com/articles/genentech-announces-results-from-two-phase-3-trials-of-retinal-v2023-11-02T15:02:35.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-and-zhifei-announce-partnership-for-promotion-of-shingles-va2023-11-02T12:45:24.000Zweekly0.6https://www.pharmafocus.com/articles/innovations-in-pharmaceutical-technology-ea062023-11-02T12:35:35.000Zweekly0.6https://www.pharmafocus.com/articles/international-clinical-researcher2023-11-02T13:39:32.000Zweekly0.6https://www.pharmafocus.com/articles/invizius-appoints-bernard-canaud-to-clinical-advisory-board2023-11-02T12:12:20.000Zweekly0.6https://www.pharmafocus.com/articles/janssen-and-sanofi-partner-for-e-coli-vaccine-programme2023-11-02T15:20:36.000Zweekly0.6https://www.pharmafocus.com/articles/karuna-therapeutics-nda-submitted-to-fda-for-schizophrenia-trea2023-11-02T15:06:44.000Zweekly0.6https://www.pharmafocus.com/articles/konstantinos-vlassis-appointed-as-closed-loop-medicine-s-chief-t2023-11-02T12:14:04.000Zweekly0.6https://www.pharmafocus.com/articles/mirati-therapeutics-to-be-acquire-d-by-bms-for-4-8bn2023-11-02T12:30:59.000Zweekly0.6https://www.pharmafocus.com/articles/moderna-announces-clinical-trial-results-for-combination-flu-and2023-11-02T13:39:14.000Zweekly0.6https://www.pharmafocus.com/articles/new-vaccine-for-pre-vention-of-malaria-in-paediatric-patients-re2023-11-02T13:30:14.000Zweekly0.6https://www.pharmafocus.com/articles/pfizer-s-rsv-vaccine-provisionally-recommended-by-cdc-advisory-c2023-11-02T13:29:22.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-77472023-11-02T12:14:24.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-acb02023-11-02T12:05:27.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafocus-79e42023-11-02T15:11:26.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafocus-9b172023-11-02T12:07:11.000Zweekly0.6https://www.pharmafocus.com/articles/pheon-appoints-arvin-yang-as-chief-medical-officer2023-11-02T12:11:38.000Zweekly0.6https://www.pharmafocus.com/articles/pmea-181e2023-11-02T15:19:24.000Zweekly0.6https://www.pharmafocus.com/articles/point-biopharma-to-be-acquired-by-eli-lilly-for-1-4bn2023-11-02T12:29:11.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-41e92023-11-02T12:16:45.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-f11a2023-11-02T15:17:06.000Zweekly0.6https://www.pharmafocus.com/articles/sanofi-and-teva-announce-partnership-for-development-of-inflamma2023-11-02T12:42:16.000Zweekly0.6https://www.pharmafocus.com/articles/sanofi-announces-long-term-efficacy-data-for-nexviazyme-for-pomp2023-11-02T14:53:02.000Zweekly0.6https://www.pharmafocus.com/articles/sun-pharma-s-nda-for-deuruxolitinib-accepted-by-fda2023-11-02T15:19:11.000Zweekly0.6https://www.pharmafocus.com/articles/the-role-of-digital-therapeutics-in-central-nervous-system-clini2023-11-02T15:47:01.000Zweekly0.6https://www.pharmafocus.com/articles/abbott-shares-plans-to-acquire-bigfoot-biomedical2023-10-06T11:04:04.000Zweekly0.6https://www.pharmafocus.com/articles/astellas-plans-opening-of-new-facilities-in-cambridge-massachus2023-10-06T12:02:13.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-and-daiichi-sankyo-announce-results-from-destiny-lun2023-10-06T11:47:47.000Zweekly0.6https://www.pharmafocus.com/articles/bms-s-reblozyl-gains-fda-approval-for-anaemia-treatment-in-adult2023-10-06T11:38:27.000Zweekly0.6https://www.pharmafocus.com/articles/chris-tovey-appointed-as-destiny-pharma-s-new-ceo2023-10-06T10:43:20.000Zweekly0.6https://www.pharmafocus.com/articles/comment-3d0b2023-10-06T12:06:24.000Zweekly0.6https://www.pharmafocus.com/articles/contents-72fc2023-10-06T12:06:56.000Zweekly0.6https://www.pharmafocus.com/articles/cyma-bay-announces-results-from-response-trial-of-seladelpar-for2023-10-06T11:44:05.000Zweekly0.6https://www.pharmafocus.com/articles/dr-tomasz-kostrzewski-introduced-as-cn-bio-s-new-chief-scientifi2023-10-06T10:40:46.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lilly-s-retevmo-produces-positive-results-in-libretto-531-tr2023-10-06T11:49:27.000Zweekly0.6https://www.pharmafocus.com/articles/ema-accepts-iveric-bio-s-maa-for-avacincaptad-pegol-for-treatmen2023-10-06T11:56:23.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-new-vyvanse-generics-for-adhd-and-bed-treatment-ami2023-10-06T11:28:28.000Zweekly0.6https://www.pharmafocus.com/articles/fda-grants-odd-to-faron-pharmaceuticals-bexmarilimab-for-aml-tr2023-10-06T11:57:53.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-mental-health2023-10-06T10:38:18.000Zweekly0.6https://www.pharmafocus.com/articles/flypharma-europe-e7262023-10-06T10:57:43.000Zweekly0.6https://www.pharmafocus.com/articles/focusing-on-world-mental-health-day2023-10-06T10:45:12.000Zweekly0.6https://www.pharmafocus.com/articles/hansa-biopharma-appoints-dr-hitto-kaufmann-as-chief-scientific-o2023-10-06T10:41:33.000Zweekly0.6https://www.pharmafocus.com/articles/how-ai-can-advance-today-s-complex-biopharma-launch-landscape2023-10-06T10:56:25.000Zweekly0.6https://www.pharmafocus.com/articles/janssen-s-talvey-approved-by-fda-for-the-treatment-of-multiple-m2023-10-06T12:09:20.000Zweekly0.6https://www.pharmafocus.com/articles/merck-s-phase-3-litespark-005-trial-of-welireg-met-primary-endpo2023-10-06T11:46:19.000Zweekly0.6https://www.pharmafocus.com/articles/mhra-clears-amicus-therapeutics-pompe-disease-treatment-for-use2023-10-06T11:21:56.000Zweekly0.6https://www.pharmafocus.com/articles/mhra-grants-marketing-authorisation-to-abb-vie-s-aquipta-for-migr2023-10-06T11:40:09.000Zweekly0.6https://www.pharmafocus.com/articles/move-of-the-month-a6532023-10-06T10:44:11.000Zweekly0.6https://www.pharmafocus.com/articles/nice-publishes-draft-guidance-surrounding-the-use-of-ai-use-in-r2023-10-06T11:08:30.000Zweekly0.6https://www.pharmafocus.com/articles/novartis-sandoz-gains-fda-approval-for-tyruko-biosimilar-to-tre2023-10-06T11:32:08.000Zweekly0.6https://www.pharmafocus.com/articles/novo-nordisk-acquires-embark-biotech2023-10-06T11:04:51.000Zweekly0.6https://www.pharmafocus.com/articles/novo-nordisk-s-wegovy-semaglutide-injection-made-available-in2023-10-06T12:03:47.000Zweekly0.6https://www.pharmafocus.com/articles/pfizer-s-maternal-vaccine-approved-by-fda-for-prevention-of-rsv2023-10-06T12:05:39.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-a0e62023-10-06T11:42:29.000Zweekly0.6https://www.pharmafocus.com/articles/pharmaceutical-technology2023-10-06T10:44:39.000Zweekly0.6https://www.pharmafocus.com/articles/pharmacy-app-charac-receives-1-2m-funding-from-npa-and-pharmacy2023-10-06T11:19:49.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-1e172023-10-06T10:35:55.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafocus-1f6c2023-10-06T12:06:02.000Zweekly0.6https://www.pharmafocus.com/articles/pharmatimes-d1bb2023-10-06T12:07:08.000Zweekly0.6https://www.pharmafocus.com/articles/pmea-59b32023-10-06T12:07:57.000Zweekly0.6https://www.pharmafocus.com/articles/promising-results-announced-from-gsk-s-shingles-trial-in-china2023-10-06T11:58:32.000Zweekly0.6https://www.pharmafocus.com/articles/regeneron-announces-two-year-results-from-pulsar-trial-for-wet-a2023-10-06T12:07:43.000Zweekly0.6https://www.pharmafocus.com/articles/roche-s-evrysdi-approved-by-ec-for-babies-under-two-months-with2023-10-06T11:39:25.000Zweekly0.6https://www.pharmafocus.com/articles/roche-s-genentech-announces-results-from-phase-3-alk-positive-ea2023-10-06T11:53:34.000Zweekly0.6https://www.pharmafocus.com/articles/sandoz-shares-exclusive-deal-to-commercialise-biosimilar-ustekin2023-10-06T11:16:04.000Zweekly0.6https://www.pharmafocus.com/articles/takeda-and-immuno-gen-announce-collaboration-for-development-and2023-10-06T10:58:53.000Zweekly0.6https://www.pharmafocus.com/articles/tempus-companion-diagnostic-test-gains-breakthrough-device-desi2023-10-06T11:13:15.000Zweekly0.6https://www.pharmafocus.com/articles/unlocking-science-to-discover-novel-solutions-for-breast-cancer2023-10-06T10:55:44.000Zweekly0.6https://www.pharmafocus.com/articles/using-genomics-to-uncover-the-causes-of-rare-diseases-and-improv2023-10-06T10:54:59.000Zweekly0.6https://www.pharmafocus.com/articles/valneva-and-pfizer-s-lyme-disease-vaccine-candidate-performs-wel2023-10-06T11:44:49.000Zweekly0.6https://www.pharmafocus.com/articles/3d-printed-pills-to-enable-time-controlled-release-in-development2023-08-25T12:13:07.000Zweekly0.6https://www.pharmafocus.com/articles/ai-enabled-drug-discovery-developments-trigger-partnership-between-recursion-and-nvidia2023-08-25T12:20:27.000Zweekly0.6https://www.pharmafocus.com/articles/alfonso-quintas-cardama-to-join-foghorn-therapeutics-as-new-chief-medical-officer2023-08-25T11:38:42.000Zweekly0.6https://www.pharmafocus.com/articles/alzheimer-s-disease-drug-leqembi-given-full-approval-by-fda2023-08-25T14:12:09.000Zweekly0.6https://www.pharmafocus.com/articles/american-heart-association-grants-2-1m-for-research-into-possible-link-between-cvd-migraines-and-stroke2023-08-25T13:37:01.000Zweekly0.6https://www.pharmafocus.com/articles/beclu-carbon-neutral-asthma-inhaler-launched-by-lupin-healthcare2023-08-25T12:25:55.000Zweekly0.6https://www.pharmafocus.com/articles/biogen-plans-to-acquire-reata-pharmaceuticals-for-7-3bn2023-08-25T12:10:18.000Zweekly0.6https://www.pharmafocus.com/articles/breast-cancer-treatment-phase-3-trial-results-shared-by-merck2023-08-25T14:20:50.000Zweekly0.6https://www.pharmafocus.com/articles/bristol-myers-squibb-s-sotyktu-recommended-to-treat-adult-patients-with-psoriasis-on-the-nhs2023-08-25T14:09:45.000Zweekly0.6https://www.pharmafocus.com/articles/chmp-grants-positive-opinion-to-vii-v-healthcare-s-cabotegravir-for-hiv-prevention2023-08-25T13:51:28.000Zweekly0.6https://www.pharmafocus.com/articles/comment-55022023-08-25T14:34:20.000Zweekly0.6https://www.pharmafocus.com/articles/contaminated-cough-syrup-leads-to-who-medical-product-alert2023-08-25T14:31:22.000Zweekly0.6https://www.pharmafocus.com/articles/contents-39732023-08-25T14:35:41.000Zweekly0.6https://www.pharmafocus.com/articles/data-from-eli-lilly-s-two-phase-3-tirzepatide-studies-shared2023-08-25T14:26:06.000Zweekly0.6https://www.pharmafocus.com/articles/data-shared-by-sanofi-about-new-drug-for-treatment-of-haemophilia-a-in-children2023-08-25T13:41:42.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lilly-shares-plans-to-acquire-versanis-bio-for-1-9bn2023-08-25T12:05:26.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-first-cellular-therapy-for-treatment-of-patients-wiith-type-1-diabetes2023-08-25T14:06:27.000Zweekly0.6https://www.pharmafocus.com/articles/first-official-long-covid-19-treatment-could-emerge-from-the-nih2023-08-25T14:25:30.000Zweekly0.6https://www.pharmafocus.com/articles/first-over-the-counter-contraceptive-pill-approved-by-fda2023-08-25T14:10:58.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-rare-diseases2023-08-25T11:25:04.000Zweekly0.6https://www.pharmafocus.com/articles/flypharma-europe-a8322023-08-25T12:03:02.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-s-novel-gonorrhoea-vaccine-gains-fast-track-designation-from2023-08-25T14:28:13.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-s-rsv-vaccine-approved-by-mhra2023-08-25T14:40:48.000Zweekly0.6https://www.pharmafocus.com/articles/helmholtz-centre-for-infection-research-appoints-josef-penninger-to-new-scientific-director2023-08-25T11:43:02.000Zweekly0.6https://www.pharmafocus.com/articles/how-statistical-and-data-analysis-can-support-research-innovations-in-rare-diseases2023-08-25T14:54:48.000Zweekly0.6https://www.pharmafocus.com/articles/indication-based-agreements-a-key-enabler-of-uk-access-to-combination-therapies-in-oncology2023-08-25T14:59:11.000Zweekly0.6https://www.pharmafocus.com/articles/innovations-in-pharmaceutical-technology2023-08-25T11:46:26.000Zweekly0.6https://www.pharmafocus.com/articles/jemperli-by-gsk-approved-to-treat-endometrial-cancer2023-08-25T14:17:06.000Zweekly0.6https://www.pharmafocus.com/articles/merck-s-ebola-vaccine-ervebo-approved-by-fda-for-children2023-08-25T14:43:34.000Zweekly0.6https://www.pharmafocus.com/articles/new-crohns-disease-treatment-could-come-from-neonatal-stem-cell-research-shows2023-08-25T13:35:32.000Zweekly0.6https://www.pharmafocus.com/articles/new-open-innovation-hub-opened-by-astellas-for-tumour-microenvironment-research2023-08-25T14:27:21.000Zweekly0.6https://www.pharmafocus.com/articles/olav-hellebo-to-join-cytovation-s-board-of-directors2023-08-25T11:44:19.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-63e52023-08-25T14:18:40.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-19c02023-08-25T11:54:06.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-communications-awards2023-08-25T14:36:45.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-9ad52023-08-25T11:23:48.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafocus-e8872023-08-25T14:33:49.000Zweekly0.6https://www.pharmafocus.com/articles/phase-2-trial-data-from-gbs-maternal-vaccine-candidate-shared-by-pfizer2023-08-25T14:23:30.000Zweekly0.6https://www.pharmafocus.com/articles/phase-3-trial-results-for-datopotamab-deruxtecan-for-nsclc-treatment-announced-by-astrazeneca2023-08-25T14:22:29.000Zweekly0.6https://www.pharmafocus.com/articles/pmea-49cb2023-08-25T14:39:50.000Zweekly0.6https://www.pharmafocus.com/articles/rare-disease-treatments-to-be-researched-in-partnership-between-pfizer-and-astrazenecas-alexion2023-08-25T12:11:36.000Zweekly0.6https://www.pharmafocus.com/articles/reacta-appoints-kevin-hawkins-as-new-head-of-regulatory-affairs2023-08-25T11:45:58.000Zweekly0.6https://www.pharmafocus.com/articles/rnai-treatment-for-hypertension-developed-by-alnylam-and-roche2023-08-25T14:29:23.000Zweekly0.6https://www.pharmafocus.com/articles/seven-ways-to-boost-hcp-engagement-through-field-behavioural-change2023-08-30T10:34:50.000Zweekly0.6https://www.pharmafocus.com/articles/study-shows-wegovy-by-novo-nordisk-reduces-cardiovascular-risk2023-08-25T14:24:27.000Zweekly0.6https://www.pharmafocus.com/articles/treatment-programme-for-cvd-to-be-developed-as-part-of-partnership-between-novartis-and-ionis2023-08-25T14:32:42.000Zweekly0.6https://www.pharmafocus.com/articles/tweet-us-pharmafocus-13f22023-08-25T11:24:10.000Zweekly0.6https://www.pharmafocus.com/articles/ukhsa-opens-new-vaccine-research-centre-in-wiltshire-to-prepare2023-08-25T14:39:33.000Zweekly0.6https://www.pharmafocus.com/articles/why-are-so-many-community-pharmacies-closing-and-what-does-this-mean-for-local-communities2023-08-25T14:48:08.000Zweekly0.6https://www.pharmafocus.com/articles/alzheimer-s-disease-and-age-related-macular-degeneration-how-a2023-07-04T15:47:56.000Zweekly0.6https://www.pharmafocus.com/articles/asieris-pharmaceuticals-and-uro-viu-announce-strategic-collaborat2023-07-04T14:11:32.000Zweekly0.6https://www.pharmafocus.com/articles/astellas-and-sony-enter-collaborative-research-agreement2023-07-04T14:00:45.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-announces-positive-results-from-phase-3-trial-for-ta2023-07-04T14:42:55.000Zweekly0.6https://www.pharmafocus.com/articles/bristol-myers-squibb-s-nda-accepted-by-fda2023-07-04T14:22:51.000Zweekly0.6https://www.pharmafocus.com/articles/comment-july2023-07-04T14:54:42.000Zweekly0.6https://www.pharmafocus.com/articles/contents-july2023-07-04T14:54:26.000Zweekly0.6https://www.pharmafocus.com/articles/engimmune-therapeutics-appoints-annalisa-d-andrea-to-board-of-di2023-07-04T13:36:53.000Zweekly0.6https://www.pharmafocus.com/articles/european-parliament-shares-goal-to-tackle-antimicrobial-resistan2023-07-04T14:51:00.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-abbott-s-assert-iq-insertable-cardiac-monitor2023-07-04T14:19:30.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-first-oral-antiviral-to-treat-adult-patients-with-covid-192023-08-25T09:39:46.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-new-insulin-pump-and-algorithm-software-for-enhance2023-07-04T14:20:37.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-pfizer-s-rsv-vaccine-for-older-adults2023-07-04T14:24:01.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-prescription-nasal-spray-for-opioid-overdose-treatm2023-07-04T14:21:29.000Zweekly0.6https://www.pharmafocus.com/articles/fda-committee-votes-in-favour-of-pfizer-s-rsv-vaccine-for-matern2023-07-04T14:18:07.000Zweekly0.6https://www.pharmafocus.com/articles/fda-relaxes-blood-donation-regulations-for-msm2023-07-04T14:49:03.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-income-and-health2023-07-04T12:20:05.000Zweekly0.6https://www.pharmafocus.com/articles/flypharma-conference-europe2023-07-04T13:56:49.000Zweekly0.6https://www.pharmafocus.com/articles/grail-and-university-of-oxford-showcase-first-prospective-study2023-07-04T14:47:43.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-receives-fda-file-acceptance-for-jemperli-plus-chemotherapy2023-07-04T14:34:19.000Zweekly0.6https://www.pharmafocus.com/articles/immodulon-appoints-josefine-roemmler-zehrer-as-chief-medical-off2023-07-04T13:39:52.000Zweekly0.6https://www.pharmafocus.com/articles/isa-pharmaceuticals-highlights-positive-clinical-data-at-asco2023-07-04T14:38:38.000Zweekly0.6https://www.pharmafocus.com/articles/ken-mariash-appointed-as-sinaptica-s-chief-executive-officer2023-07-04T13:46:42.000Zweekly0.6https://www.pharmafocus.com/articles/l-a-nova-medicines-and-astra-zeneca-sign-global-exclusive-licence2023-07-04T14:16:44.000Zweekly0.6https://www.pharmafocus.com/articles/lonza-to-acquire-sy-naffix-to-strengthen-adc-de-velopment2023-07-04T14:01:55.000Zweekly0.6https://www.pharmafocus.com/articles/merck-invests-35m-in-biosafety-testing-in-scotland2023-07-04T14:46:08.000Zweekly0.6https://www.pharmafocus.com/articles/more-infections-from-contaminated-eyedrops-in-us-increase-death2023-07-04T14:44:19.000Zweekly0.6https://www.pharmafocus.com/articles/move-of-the-month2023-07-04T13:48:19.000Zweekly0.6https://www.pharmafocus.com/articles/nice-recommends-nine-digital-treatment-options-for-depression-and-anxiety2023-08-25T09:28:33.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-time2023-07-04T14:56:36.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-2da82023-07-04T13:48:54.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-b2ea2023-07-04T12:08:57.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafocus-58882023-07-04T14:52:35.000Zweekly0.6https://www.pharmafocus.com/articles/pharmanovia-and-stealth-bio-therapeutics-enter-new-licensing-agre2023-07-04T14:00:00.000Zweekly0.6https://www.pharmafocus.com/articles/pharmarole2023-07-04T14:59:16.000Zweekly0.6https://www.pharmafocus.com/articles/pmea2023-07-04T13:55:06.000Zweekly0.6https://www.pharmafocus.com/articles/radio-medix-and-orano-med-complete-patient-enrolment-for-neuroend2023-07-04T14:36:01.000Zweekly0.6https://www.pharmafocus.com/articles/report-finds-nhs-may-miss-out-on-new-drugs-due-to-rising-costs2023-07-04T14:52:22.000Zweekly0.6https://www.pharmafocus.com/articles/sanofi-announces-positive-phase-2-data-for-ms-drug-frexalimab2023-07-04T14:40:24.000Zweekly0.6https://www.pharmafocus.com/articles/scientists-at-mit-and-mc-master-university-use-ai-to-find-new-ant2023-07-04T14:15:42.000Zweekly0.6https://www.pharmafocus.com/articles/servier-and-aitia-enter-into-r-d-collaboration-for-pancreatic-ca2023-07-04T14:12:16.000Zweekly0.6https://www.pharmafocus.com/articles/snipr-biome-reports-positive-findings-for-first-in-human-crispr2023-07-04T14:37:28.000Zweekly0.6https://www.pharmafocus.com/articles/the-impact-of-the-cost-of-living-crisis-on-health2023-07-04T15:03:58.000Zweekly0.6https://www.pharmafocus.com/articles/us-based-bellerophon-shares-top-line-data-from-phase-3-trial-of2023-07-04T14:39:36.000Zweekly0.6https://www.pharmafocus.com/articles/us-based-nemours-children-s-health-selected-to-conduct-first-gen2023-07-04T14:07:50.000Zweekly0.6https://www.pharmafocus.com/articles/what-are-biomolecular-condensates-and-will-they-be-a-breakthrou2023-07-04T15:10:26.000Zweekly0.6https://www.pharmafocus.com/articles/25-communique-awards-2023-a84d2023-05-26T14:31:13.000Zweekly0.6https://www.pharmafocus.com/articles/3b-pharmaceuticals-and-novartis-enter-into-licensing-agreement-f2023-06-02T15:52:44.000Zweekly0.6https://www.pharmafocus.com/articles/abb-vie-shares-results-from-phase-3-trial-for-atogepant-migraine2023-06-05T14:14:57.000Zweekly0.6https://www.pharmafocus.com/articles/alex-c-sapir-appointed-as-fulcrum-therapeutics-ceo2023-05-26T11:36:26.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-and-ionis-share-positive-results-from-phase-3-trial2023-06-05T14:12:46.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-s-farxiga-approved-to-reduce-risk-of-cardiovascular2023-06-02T16:14:46.000Zweekly0.6https://www.pharmafocus.com/articles/boehringer-ingelheim-and-ginkgo-bioworks-collaborate-over-406m2023-05-26T13:49:44.000Zweekly0.6https://www.pharmafocus.com/articles/companies-showcase-innovative-biotech-at-american-association-fo2023-05-31T07:26:40.000Zweekly0.6https://www.pharmafocus.com/articles/could-climate-change-along-with-pandemics-equal-a-recipe-for-dis2023-05-26T15:58:59.000Zweekly0.6https://www.pharmafocus.com/articles/diabeloop-announces-collaboration-with-novo-nordisk-for-connecte2023-06-02T15:51:09.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lilly-s-tirzepatide-achieves-15-7-weight-loss-in-adult-pati2023-06-05T14:23:53.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lilly-shares-positive-results-from-phase-3-study-of-donanema2023-06-02T16:22:49.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-first-orally-administered-faecal-microbiota-product2023-06-02T16:03:19.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-pfizer-s-pneumococcal-conjugate-vaccine-for-infants2023-06-02T16:00:43.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-world-s-first-rsv-vaccine2023-05-26T14:32:05.000Zweekly0.6https://www.pharmafocus.com/articles/fda-issues-update-around-changes-to-covid-19-vaccines-eu-as2023-06-05T14:23:17.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-climate-change-and-health2023-05-26T11:33:38.000Zweekly0.6https://www.pharmafocus.com/articles/flypharma-europe-vienna-20232023-05-26T12:35:57.000Zweekly0.6https://www.pharmafocus.com/articles/gilead-acquires-xin-thera-to-strengthen-pipeline-in-oncology-and2023-06-02T15:44:55.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-announces-positive-data-from-phase-3-trial-for-new-uti-antib2023-06-02T16:21:30.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-enters-into-1-6bn-deal-to-acquire-bellus-health2023-05-26T12:43:18.000Zweekly0.6https://www.pharmafocus.com/articles/how-regulators-are-keeping-pace-with-technology2023-05-30T12:25:57.000Zweekly0.6https://www.pharmafocus.com/articles/ishwaria-subbiah-appointed-as-scri-s-executive-director-for-canc2023-05-26T11:42:43.000Zweekly0.6https://www.pharmafocus.com/articles/johnson-johnson-warns-of-dangers-of-benadryl-tik-tok-challenge2023-05-26T14:26:24.000Zweekly0.6https://www.pharmafocus.com/articles/june-2023-comment2023-05-26T14:29:49.000Zweekly0.6https://www.pharmafocus.com/articles/june-2023-contents2023-05-31T07:25:21.000Zweekly0.6https://www.pharmafocus.com/articles/leon-appoints-dr-setu-kasera-as-cso2023-05-26T11:38:36.000Zweekly0.6https://www.pharmafocus.com/articles/liberal-states-begin-stockpiling-abortion-medications-following2023-06-05T14:22:23.000Zweekly0.6https://www.pharmafocus.com/articles/merck-s-relapsing-multiple-sclerosis-trial-put-on-fda-partial-cl2023-05-26T14:16:36.000Zweekly0.6https://www.pharmafocus.com/articles/national-institutes-of-health-awards-grant-for-gamma-core-clinica2023-05-26T13:46:49.000Zweekly0.6https://www.pharmafocus.com/articles/neuspera-medical-receives-fda-approval-for-peripheral-nerve-pain2023-05-26T14:06:11.000Zweekly0.6https://www.pharmafocus.com/articles/nice-recommends-otsuka-s-lupkynis-voclosporin-in-combination-t2023-06-02T15:58:06.000Zweekly0.6https://www.pharmafocus.com/articles/nice-recommends-two-car-t-treatments-for-blood-cancers-to-the-ca2023-06-02T15:57:07.000Zweekly0.6https://www.pharmafocus.com/articles/patrick-johnson-appointed-to-aviceda-therapeutics-board-of-dire2023-05-26T11:37:26.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-4ace2023-05-26T14:32:24.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times2023-05-26T11:47:15.000Zweekly0.6https://www.pharmafocus.com/articles/pharmacists-in-england-given-wider-prescribing-powers-to-relieve2023-05-26T14:23:53.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-91492023-05-26T11:30:19.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafocus-3f9f2023-05-26T14:29:13.000Zweekly0.6https://www.pharmafocus.com/articles/retin-ai-and-boehringer-ingelheim-partner-over-ai-treatments-for2023-06-02T15:49:51.000Zweekly0.6https://www.pharmafocus.com/articles/sobi-acquires-cti-bio-pharma-corporation-for-1-7bn2023-06-02T15:43:44.000Zweekly0.6https://www.pharmafocus.com/articles/the-climate-crisis-what-is-it-and-is-pharma-to-blame2023-05-30T12:01:29.000Zweekly0.6https://www.pharmafocus.com/articles/thermo-fisher-and-pfizer-collaborate-on-ngs-based-cancer-tests2023-06-02T15:46:27.000Zweekly0.6https://www.pharmafocus.com/articles/trade-union-unite-calls-for-gsk-staff-walkouts-over-pay-increase2023-06-05T14:20:52.000Zweekly0.6https://www.pharmafocus.com/articles/tweet-us-pharmafocus-969a2023-05-26T11:30:59.000Zweekly0.6https://www.pharmafocus.com/articles/vicore-announces-initiation-of-proof-of-concept-study-for-endoth2023-06-02T16:15:48.000Zweekly0.6https://www.pharmafocus.com/articles/why-modelling-patient-heterogeneity-is-crucial-in-drug-developme2023-05-26T14:56:25.000Zweekly0.6https://www.pharmafocus.com/articles/7e21ecbe-eb2a-11ed-9e1c-42010a80000d2023-05-05T14:27:29.000Zweekly0.6https://www.pharmafocus.com/articles/a-vaxzi-pen-announces-positive-data-for-multiple-diseases-with-nov2023-05-05T13:37:22.000Zweekly0.6https://www.pharmafocus.com/articles/abb-vie-shares-results-from-study-for-new-psoriasis-therapy2023-05-05T13:50:19.000Zweekly0.6https://www.pharmafocus.com/articles/abbott-gains-fda-approval-for-epic-max-tissue-valve-for-the-trea2023-05-05T13:57:13.000Zweekly0.6https://www.pharmafocus.com/articles/alzheimer-s-drug-leqembi-expected-to-generate-12-9bn-in-sales-b2023-05-05T14:34:47.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-reports-positive-results-of-drug-combination-in-late2023-05-05T14:04:45.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-s-lynparza-approved-by-nhs-england2023-05-05T13:56:15.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-s-nmosd-treatment-recommended-marketing2023-05-05T14:26:11.000Zweekly0.6https://www.pharmafocus.com/articles/bio-n-tech-and-onco-c4-to-partner-for-development-and-commercialisa2023-05-05T12:28:05.000Zweekly0.6https://www.pharmafocus.com/articles/bristol-myers-squibb-works-with-space-x-to-study-biomanufacturing2023-05-05T14:31:57.000Zweekly0.6https://www.pharmafocus.com/articles/ca-nbridge-pharmaceuticals-reports-positive-long-term-data-for-gl2023-05-05T14:03:55.000Zweekly0.6https://www.pharmafocus.com/articles/connected-drug-delivery-devices-considerations-for-developing-d2023-05-10T14:10:18.000Zweekly0.6https://www.pharmafocus.com/articles/european-commission-delays-release-of-major-changes-to-pharma-le2023-05-05T14:34:18.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-novartis-tafinlar-and-mekinist-combination2023-05-05T13:55:28.000Zweekly0.6https://www.pharmafocus.com/articles/fe2ea85f-eb29-11ed-9e1c-42010a80000d2023-05-05T14:29:00.000Zweekly0.6https://www.pharmafocus.com/articles/first-over-the-counter-opioid-overdose-treatment-approved-by-fda2023-05-05T13:54:51.000Zweekly0.6https://www.pharmafocus.com/articles/five-health-facts-about-the-gambia-uzbekistan-and-indonesia2023-07-04T11:41:13.000Zweekly0.6https://www.pharmafocus.com/articles/flypharma-europe2023-05-05T12:17:45.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-shares-promising-clinical-trial-results-for-endometrial-canc2023-05-05T14:03:03.000Zweekly0.6https://www.pharmafocus.com/articles/inno-care-announced-first-subject-dosed2023-05-05T14:01:58.000Zweekly0.6https://www.pharmafocus.com/articles/janssen-reports-new-rybrevant-data-for-patients-with-advanced-no2023-05-05T13:44:42.000Zweekly0.6https://www.pharmafocus.com/articles/kite-s-yescarta-car-t-cell-therapy-shows-statistically-significa2023-05-05T13:49:19.000Zweekly0.6https://www.pharmafocus.com/articles/magazine-pharmafile2023-05-05T14:32:26.000Zweekly0.6https://www.pharmafocus.com/articles/merck-receives-fda-approval-for-keytruda-in-combination-with-pad2023-05-05T13:54:18.000Zweekly0.6https://www.pharmafocus.com/articles/molecular-templates-announces-hold-for-phase-1-study2023-05-05T14:11:27.000Zweekly0.6https://www.pharmafocus.com/articles/nanoscope-therapeutics-announces-positive-results-from-phase-2b2023-05-05T13:59:39.000Zweekly0.6https://www.pharmafocus.com/articles/neuro-rpm-announces-fda-clearance-for-ai-monitoring-app-for-parki2023-05-05T13:52:25.000Zweekly0.6https://www.pharmafocus.com/articles/novo-nordisk-to-cut-insulin-prices-by-up-to-75-in-20242023-05-05T14:12:17.000Zweekly0.6https://www.pharmafocus.com/articles/optibrium-appoints-dr-hamed-tabatabaei-ghomi-as-head-of-research2023-05-05T12:10:47.000Zweekly0.6https://www.pharmafocus.com/articles/oxford-nanopore-and-4bases-collaborate-on-kit-for-brca1-and-brca2023-05-05T13:48:05.000Zweekly0.6https://www.pharmafocus.com/articles/pfizer-signs-43bn-deal-to-buy-seagen2023-05-05T12:22:53.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role2023-05-05T12:11:27.000Zweekly0.6https://www.pharmafocus.com/articles/pharmatimes-efec2023-05-05T14:05:04.000Zweekly0.6https://www.pharmafocus.com/articles/pmlive-a9572023-05-05T14:30:45.000Zweekly0.6https://www.pharmafocus.com/articles/promising-ovarian-cancer-drug-enters-phase-3-trial2023-05-05T13:58:34.000Zweekly0.6https://www.pharmafocus.com/articles/roche-and-eli-lilly-collaborate-on-alzheimer-s-disease-blood-tes2023-05-05T13:45:31.000Zweekly0.6https://www.pharmafocus.com/articles/roz-bekker-appointed-managing-director-of-janssen-uk-and-ireland2023-05-05T12:09:58.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-984b2023-05-05T11:49:31.000Zweekly0.6https://www.pharmafocus.com/articles/sanofi-to-cut-insulin-prices-by-78-starting-january-20242023-05-05T14:17:26.000Zweekly0.6https://www.pharmafocus.com/articles/seamless-therapeutics-launches-with-12-5m-in-financing2023-05-05T14:10:29.000Zweekly0.6https://www.pharmafocus.com/articles/steve-jones-appointed-as-ingenza-s-chief-financial-officer2023-05-05T12:07:38.000Zweekly0.6https://www.pharmafocus.com/articles/syncona-appoints-roel-bulthuis-as-managing-partner2023-05-05T11:56:27.000Zweekly0.6https://www.pharmafocus.com/articles/the-cough-syrup-investigation-a-timeline2023-05-09T11:46:59.000Zweekly0.6https://www.pharmafocus.com/articles/thea-open-innovation-and-galimedix-announce-partnership-for-deve2023-05-05T12:20:02.000Zweekly0.6https://www.pharmafocus.com/articles/0085bebf-d46d-11ed-9e1c-42010a80000d2023-04-06T13:52:39.000Zweekly0.6https://www.pharmafocus.com/articles/07da23b1-d469-11ed-9e1c-42010a80000d2023-04-06T11:45:32.000Zweekly0.6https://www.pharmafocus.com/articles/12bb0e63-d46b-11ed-9e1c-42010a80000d2023-04-06T11:36:31.000Zweekly0.6https://www.pharmafocus.com/articles/58719d6e-d46b-11ed-9e1c-42010a80000d2023-05-05T14:47:54.000Zweekly0.6https://www.pharmafocus.com/articles/6377f02e-d46d-11ed-9e1c-42010a80000d2023-04-06T13:53:05.000Zweekly0.6https://www.pharmafocus.com/articles/a6b1f885-d465-11ed-9e1c-42010a80000d2023-04-06T12:00:40.000Zweekly0.6https://www.pharmafocus.com/articles/abb-vie-gains-positive-chmp-opinion-for-upadacitinib-for-the-trea2023-04-06T12:37:36.000Zweekly0.6https://www.pharmafocus.com/articles/abbott-announces-positive-clinical-study-data-for-both-tri-clip-s2023-04-06T12:28:18.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-shares-positive-results-from-imfinzi-trial2023-04-06T13:54:18.000Zweekly0.6https://www.pharmafocus.com/articles/astra-zeneca-signs-63m-agreement-for-gastric-cancer-treatment2023-04-06T13:50:13.000Zweekly0.6https://www.pharmafocus.com/articles/benevolent-ai-appoints-marcello-damiani-to-its-board-of-directors2023-04-06T11:44:00.000Zweekly0.6https://www.pharmafocus.com/articles/biotech-centre-focusing-on-gene-therapies-opens-in-bristol-uk2023-04-06T13:49:19.000Zweekly0.6https://www.pharmafocus.com/articles/bristol-myers-squibb-and-viz-ai-sign-multi-year-partnership-for2023-04-06T12:03:56.000Zweekly0.6https://www.pharmafocus.com/articles/c179670e-d461-11ed-9e1c-42010a80000d2023-04-06T13:51:09.000Zweekly0.6https://www.pharmafocus.com/articles/compounded-medication-what-do-we-need-to-know2023-04-06T11:53:03.000Zweekly0.6https://www.pharmafocus.com/articles/csl-receives-cma-from-the-european-c-ommission-for-haemophilia-b2023-04-06T12:36:04.000Zweekly0.6https://www.pharmafocus.com/articles/deepak-singh-appointed-as-cn-bio-s-vice-president-of-sales-and-m2023-04-06T11:43:16.000Zweekly0.6https://www.pharmafocus.com/articles/edb1ebb7-d462-11ed-9e1c-42010a80000d2023-04-06T12:41:22.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lilly-caps-consumer-insulin-costs-at-352023-04-06T12:34:25.000Zweekly0.6https://www.pharmafocus.com/articles/elon-musk-s-neuralink-rejected-by-fda-for-human-trials2023-04-06T12:02:53.000Zweekly0.6https://www.pharmafocus.com/articles/fda-grants-de-novo-approval-to-neuromod-s-tinnitus-device2023-04-06T12:33:40.000Zweekly0.6https://www.pharmafocus.com/articles/fda-sued-by-us-states-over-abortion-pill-access2023-04-06T12:32:57.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-about-reproductive-health2023-04-06T13:59:00.000Zweekly0.6https://www.pharmafocus.com/articles/funding-to-increase-access-to-early-phase-clinical-trials-given2023-04-06T12:16:21.000Zweekly0.6https://www.pharmafocus.com/articles/gilead-sciences-wins-175m-in-ongoing-hiv-fraud-case2023-04-06T12:13:43.000Zweekly0.6https://www.pharmafocus.com/articles/horizon-therapeutics-announces-real-world-treatment-results-for2023-04-06T12:31:33.000Zweekly0.6https://www.pharmafocus.com/articles/karen-harrison-appointed-chief-operating-officer-for-avacta-s-th2023-04-06T11:42:19.000Zweekly0.6https://www.pharmafocus.com/articles/medtronic-s-extravascular-defibrillator-receives-ce-mark2023-04-06T12:12:26.000Zweekly0.6https://www.pharmafocus.com/articles/menopause-and-sleep-disruption2023-04-06T11:46:16.000Zweekly0.6https://www.pharmafocus.com/articles/menopause-legislation-charities-and-support2023-04-06T11:51:18.000Zweekly0.6https://www.pharmafocus.com/articles/merck-to-appeal-eu-rejection-of-covid-19-drug2023-04-06T12:35:22.000Zweekly0.6https://www.pharmafocus.com/articles/mhra-s-authority-restored-following-northern-ireland-brexit-deal2023-04-06T13:45:11.000Zweekly0.6https://www.pharmafocus.com/articles/moda-living-and-lloyds-pharmacy-partner-to-offer-residents-a-pres2023-04-06T12:43:11.000Zweekly0.6https://www.pharmafocus.com/articles/moderna-chooses-oxfordshire-for-new-uk-facility2023-04-06T12:10:45.000Zweekly0.6https://www.pharmafocus.com/articles/moderna-to-pay-400m-to-us-government-over-new-covid-19-vaccine2023-04-06T12:13:08.000Zweekly0.6https://www.pharmafocus.com/articles/mologic-s-covid-19-rapid-antigen-self-test-receives-fda-emergenc2023-04-06T12:30:50.000Zweekly0.6https://www.pharmafocus.com/articles/nasal-spray-that-relie-ves-migraines-in-minutes-approve-d-by-fda2023-04-06T12:21:47.000Zweekly0.6https://www.pharmafocus.com/articles/new-clinical-trial-aims-to-find-new-endometriosis-treatment2023-04-06T13:51:46.000Zweekly0.6https://www.pharmafocus.com/articles/nice-approved-bms-s-opdivo-for-lung-cancer2023-04-06T12:42:22.000Zweekly0.6https://www.pharmafocus.com/articles/regenxbio-presents-interim-phase-2-data-from-drug-developed-on-n2023-04-06T12:04:55.000Zweekly0.6https://www.pharmafocus.com/articles/richard-stedman-appointed-to-ceo-of-acg-s-engineering-division2023-04-06T11:40:23.000Zweekly0.6https://www.pharmafocus.com/articles/sooma-receives-fda-breakthrough-device-designation-for-depressio2023-04-06T12:02:08.000Zweekly0.6https://www.pharmafocus.com/articles/sun-pharma-recalls-at-least-34-000-bottles-of-generic-drug2023-04-06T12:29:46.000Zweekly0.6https://www.pharmafocus.com/articles/wearable-sensor-helps-detect-heart-attacks2023-04-06T12:24:58.000Zweekly0.6https://www.pharmafocus.com/articles/25-communique-awards-20232023-03-07T13:25:46.000Zweekly0.6https://www.pharmafocus.com/articles/abbvie-expects-37-decline-in-humira-sales-following-new-biosimilars-hitting-the-us-market2023-03-08T16:46:31.000Zweekly0.6https://www.pharmafocus.com/articles/ai-finds-liver-cancer-drug-candidate-in-only-30-days2023-03-08T16:47:18.000Zweekly0.6https://www.pharmafocus.com/articles/astrazeneca-moves-manufacturing-to-ireland-due-to-britains-tax-regime2023-03-08T16:44:19.000Zweekly0.6https://www.pharmafocus.com/articles/australias-tga-approves-psychedelics-to-treat-mental-health-conditions2023-03-08T16:19:25.000Zweekly0.6https://www.pharmafocus.com/articles/bd-showcases-newgeneration-robotic-track-system-for-microbiology-labs2023-03-08T16:41:26.000Zweekly0.6https://www.pharmafocus.com/articles/boston-scientific-fined-42m-over-patent-infringement2023-03-07T13:02:41.000Zweekly0.6https://www.pharmafocus.com/articles/cambridges-experimental-cancer-medicine-centre-to-receive-funding2023-03-08T16:04:40.000Zweekly0.6https://www.pharmafocus.com/articles/chiesi-farmaceutici-hires-new-ceo2023-03-08T16:47:57.000Zweekly0.6https://www.pharmafocus.com/articles/comment-716781830762023-03-08T17:22:08.000Zweekly0.6https://www.pharmafocus.com/articles/contents2023-03-07T15:25:31.000Zweekly0.6https://www.pharmafocus.com/articles/daiichi-sankyo-to-build-japans-first-factory-for-mrna-covid19-vaccines2023-03-08T16:46:59.000Zweekly0.6https://www.pharmafocus.com/articles/drugban-ai-expected-to-reduce-costs-and-speed-up-drug-discovery2023-03-08T16:42:29.000Zweekly0.6https://www.pharmafocus.com/articles/drugresistant-bacterium-found-in-eye-drops-has-infected-55-people-in-12-states2023-03-08T16:18:26.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lilly-and-abbvie-leave-uk-vpas-blow-to-uk-pharma-industry2023-03-08T16:05:46.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lilly-plans-to-invest-450m-at-production-site-in-research-triangle-park2023-03-07T13:00:58.000Zweekly0.6https://www.pharmafocus.com/articles/europe-plans-further-antibiotic-shortage-countermeasures2023-03-08T16:15:07.000Zweekly0.6https://www.pharmafocus.com/articles/first-indian-intranasal-covid19-vaccine-recently-launched2023-03-08T16:20:44.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-cardiovascular-disease-cvd2023-03-07T12:51:22.000Zweekly0.6https://www.pharmafocus.com/articles/garuda-therapeutics-closes-series-b-funding-with-62m2023-03-08T16:36:54.000Zweekly0.6https://www.pharmafocus.com/articles/genoscience-pharma-received-orphan-drug-designation-for-hepatocellular-carcinoma-drug2023-03-08T16:16:35.000Zweekly0.6https://www.pharmafocus.com/articles/improving-cardiovascular-disease-care-and-awareness2023-03-08T17:25:04.000Zweekly0.6https://www.pharmafocus.com/articles/ingenza-appoints-dr-mark-chadwick-as-strategic-business-advisor2023-03-07T12:53:48.000Zweekly0.6https://www.pharmafocus.com/articles/intron-confirms-efficacy-of-inhalation-anthraxfighting-drug2023-03-08T16:43:45.000Zweekly0.6https://www.pharmafocus.com/articles/johnson-johnson-scale-back-covid19-vaccination-production2023-03-08T16:40:06.000Zweekly0.6https://www.pharmafocus.com/articles/johnson-johnson-subsidiary-loses-us-bankruptcy-bid2023-03-08T16:45:15.000Zweekly0.6https://www.pharmafocus.com/articles/johnson-johnsons-ethicon-undertakes-first-robotassisted-kidney-stone-removal2023-03-08T16:29:16.000Zweekly0.6https://www.pharmafocus.com/articles/medivir-ab-appoints-pia-baumann-as-chief-medical-officer2023-03-07T12:53:15.000Zweekly0.6https://www.pharmafocus.com/articles/mercks-london-research-hub-to-begin-construction-in-april-20232023-03-07T13:22:13.000Zweekly0.6https://www.pharmafocus.com/articles/nhs-to-offer-artificial-pancreas-to-type-1-diabetes-patients2023-03-08T16:11:09.000Zweekly0.6https://www.pharmafocus.com/articles/nice-recommends-more-digital-mental-health-therapies-for-nhs-use2023-03-08T16:42:55.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-4616781830782023-03-08T16:48:42.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-216781830762023-03-07T13:26:49.000Zweekly0.6https://www.pharmafocus.com/articles/pharmatimes2023-03-07T12:57:39.000Zweekly0.6https://www.pharmafocus.com/articles/removing-uncertainty-in-the-supply-chain2023-03-07T12:55:46.000Zweekly0.6https://www.pharmafocus.com/articles/samedan2023-03-07T12:55:07.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-ltd2023-03-07T13:24:42.000Zweekly0.6https://www.pharmafocus.com/articles/scottish-biotech-aims-to-cure-common-cold2023-03-07T13:21:17.000Zweekly0.6https://www.pharmafocus.com/articles/stand-up-to-cancer-announces-four-teams-dedicated-to-increasing-diversity-in-clinical-trials2023-03-08T16:27:39.000Zweekly0.6https://www.pharmafocus.com/articles/synaptixbio-secures-fda-rare-paediatric-disease-designation-to-develop-treatments-for-tubb4a-leukodystrophy2023-03-08T16:49:55.000Zweekly0.6https://www.pharmafocus.com/articles/the-patient-voice-in-autoimmune-conditions2023-03-07T12:56:39.000Zweekly0.6https://www.pharmafocus.com/articles/theracosbios-oral-drug-approved-by-fda-for-adults-with-type-2-diabetes2023-03-08T16:45:57.000Zweekly0.6https://www.pharmafocus.com/articles/ucl-to-begin-new-trial-to-assess-cough-medicines-impact-on-parkinsons-disease2023-03-08T16:12:40.000Zweekly0.6https://www.pharmafocus.com/articles/vishal-kapoor-appointed-to-jasper-therapeutics-board-of-directors2023-03-07T12:52:33.000Zweekly0.6https://www.pharmafocus.com/articles/who-issues-a-call-to-action-after-cough-syrup-deaths2023-03-08T16:28:38.000Zweekly0.6https://www.pharmafocus.com/articles/22m-raised-by-pbs-biotech-to-expand-singleuse-manufacturing-products-and-ser-vices-for-cell-therapy-clients2023-03-02T05:48:13.000Zweekly0.6https://www.pharmafocus.com/articles/ada3e045-a2e2-11ed-8b37-42010a80000b2023-02-03T15:57:30.000Zweekly0.6https://www.pharmafocus.com/articles/ai-model-predicts-cvd-risk-from-single-chest-radiograph2023-03-02T05:47:56.000Zweekly0.6https://www.pharmafocus.com/articles/anumana-and-pfizer-team-up-on-aienabled-ecg-algorithm-for-detection-of-cardiovascular-disease2023-03-02T05:48:13.000Zweekly0.6https://www.pharmafocus.com/articles/astrazeneca-set-to-buy-cincor2023-03-02T05:47:59.000Zweekly0.6https://www.pharmafocus.com/articles/astrazeneca-shares-two-new-drug-approvals-in-the-eu2023-03-02T05:48:16.000Zweekly0.6https://www.pharmafocus.com/articles/belharra-therapeutics-and-genentech-join-forces-for-small-molecule-medicine-development2023-03-02T05:48:11.000Zweekly0.6https://www.pharmafocus.com/articles/biogen-appoints-priya-singhal-as-executive-vice-president-and-head-of-de-velopment2023-03-02T05:48:03.000Zweekly0.6https://www.pharmafocus.com/articles/biontech-and-uk-government-announce-strategic-partnership-to-provide-mrna-cancer-immunotherapies2023-03-02T05:48:12.000Zweekly0.6https://www.pharmafocus.com/articles/biontech-begins-phase-1-trial-for-malaria-vaccine2023-03-02T05:48:14.000Zweekly0.6https://www.pharmafocus.com/articles/comment2023-03-02T05:48:08.000Zweekly0.6https://www.pharmafocus.com/articles/communique2023-03-02T05:48:12.000Zweekly0.6https://www.pharmafocus.com/articles/cost-of-over-350-drugs-expected-to-increase-in-20232023-03-02T05:48:06.000Zweekly0.6https://www.pharmafocus.com/articles/covid19-antiviral-treatment-shown-to-speed-up-recovery-in-trial2023-03-02T05:48:17.000Zweekly0.6https://www.pharmafocus.com/articles/dawn-sauro-appointed-to-chief-operating-officer-at-elligo-health2023-03-02T05:47:57.000Zweekly0.6https://www.pharmafocus.com/articles/elaine-sun-appointed-to-the-board-of-directors-at-asher-bio2023-03-02T05:48:15.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lilly-and-sosei-heptares-enter-into-multitarget-collaboration-and-licence-agreement-for-diabetes-and-metabolic-diseases2023-03-02T05:48:07.000Zweekly0.6https://www.pharmafocus.com/articles/european-commission-approves-dupixent-as-the-first-and-only-targeted-medicine-for-prurigo-nodularis2023-03-02T05:47:53.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-eisaibiogens-lec-anemab-for-alzheimers-disease2023-03-02T05:48:09.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-first-gene-therapy-to-treat-patients-with-highrisk-nonmuscleinvasive-bladder-cancer2023-03-02T05:48:04.000Zweekly0.6https://www.pharmafocus.com/articles/fda-expands-access-to-abortion-pills2023-03-02T05:48:09.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-prostate-cancer2023-03-02T05:48:13.000Zweekly0.6https://www.pharmafocus.com/articles/flypharma-middleeast2023-03-02T05:48:10.000Zweekly0.6https://www.pharmafocus.com/articles/gambian-panel-recommends-maiden-pharmaceuticals-be-held-culpable-for-cough-syrup2023-03-02T05:47:54.000Zweekly0.6https://www.pharmafocus.com/articles/glaxosmithkline-enters-into-3-3bn-pact-with-wave-life-sciences2023-03-02T05:48:18.000Zweekly0.6https://www.pharmafocus.com/articles/gsk-chooses-londons-west-end-for-new-headquarters2023-03-02T05:48:00.000Zweekly0.6https://www.pharmafocus.com/articles/lumiradx-receives-14m-in-funding-for-pointofcare-tb-test2023-03-02T05:48:01.000Zweekly0.6https://www.pharmafocus.com/articles/maha-radhakrishnan-appointed-as-minovia-therapeutics-board-member2023-03-02T05:48:00.000Zweekly0.6https://www.pharmafocus.com/articles/moderna-agrees-first-acquisition-for-85m2023-03-02T05:47:55.000Zweekly0.6https://www.pharmafocus.com/articles/new-blood-test-appears-to-detect-hidden-cancer2023-03-02T05:48:08.000Zweekly0.6https://www.pharmafocus.com/articles/new-study-shares-effectiveness-of-asthma-drug-compared-to-standard-of-care2023-03-02T05:47:55.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-4116752682082023-03-02T05:48:19.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile2023-03-02T05:48:02.000Zweekly0.6https://www.pharmafocus.com/articles/pharmafile-3316752682082023-03-02T05:48:19.000Zweekly0.6https://www.pharmafocus.com/articles/prostate-c-ancer-in-europe-the-time-to-act-is-now2023-03-02T05:48:18.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-516752682082023-03-02T05:48:20.000Zweekly0.6https://www.pharmafocus.com/articles/sanofi-plans-ecofriendly-additions-to-brisbane-manufacturing-campus2023-03-02T05:48:15.000Zweekly0.6https://www.pharmafocus.com/articles/sarepta-therapeutics-and-catalent-sign-manufacturing-deal-for-dmd-gene-therapy-approval2023-03-02T05:48:03.000Zweekly0.6https://www.pharmafocus.com/articles/ser-vblock-secures-eu-funding-for-pharma-manufacturing-data-space2023-03-02T05:48:05.000Zweekly0.6https://www.pharmafocus.com/articles/tamiflu-manufacturers-report-shortages-during-high-point-of-flu-season2023-03-02T05:48:10.000Zweekly0.6https://www.pharmafocus.com/articles/two-biotech-ceos-charged-with-defrauding-investors-over-investigational-hiv-drug2023-03-02T05:48:05.000Zweekly0.6https://www.pharmafocus.com/articles/unison-boss-states-government-adamantly-refused-to-engage-in-a-proper-discussion-on-pay-ahead-of-decembers-ambulance-strikes2023-03-02T05:47:58.000Zweekly0.6https://www.pharmafocus.com/articles/withings-announces-handsfree-connected2023-03-02T05:48:14.000Zweekly0.6https://www.pharmafocus.com/articles/amarin-appoints-scott-curley-as-general-manager-to-uk-and-ireland-team2023-03-02T05:46:45.000Zweekly0.6https://www.pharmafocus.com/articles/amgens-obesity-drug-appears-promising-with-few-side-effe-cts2023-03-08T17:13:40.000Zweekly0.6https://www.pharmafocus.com/articles/amoxicillin-shortages-and-15hour-hospital-waiting-times-for-us-patients2023-03-09T12:35:33.000Zweekly0.6https://www.pharmafocus.com/articles/astrazeneca-and-msd-launch-prostate-cancer-awareness-campaign2023-03-08T17:23:08.000Zweekly0.6https://www.pharmafocus.com/articles/astrazeneca-to-acquire-neogene-for-up-to-320m2023-03-02T05:46:34.000Zweekly0.6https://www.pharmafocus.com/articles/bayer-and-orion-corporationdeveloped-prostate-cancer-treatment-approved-by-nhs-england-and-mhra2023-03-02T05:46:44.000Zweekly0.6https://www.pharmafocus.com/articles/carbonneutral-inhaler-launched-for-adult-asthma-patients-in-the-uk2023-03-08T16:52:23.000Zweekly0.6https://www.pharmafocus.com/articles/collaboration-between-biontech-and-ryvu-therapeutics-to-develop-and-commercialise-immunomodulatory-small-molecule-candidates2023-03-08T17:09:51.000Zweekly0.6https://www.pharmafocus.com/articles/contents-616742077012023-03-02T05:46:49.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lilly-loses-billions-on-stock-valuation-after-fake-account-verified-by-twitter2023-03-07T17:19:12.000Zweekly0.6https://www.pharmafocus.com/articles/eli-lillys-covid19-drug-bebtelovimab-loses-fda-authorisation2023-03-07T17:25:41.000Zweekly0.6https://www.pharmafocus.com/articles/elon-musks-neuralink-to-conduct-human-trials-in-20232023-03-02T05:46:36.000Zweekly0.6https://www.pharmafocus.com/articles/eu-approval-recommended-for-three-drugs-from-astrazeneca2023-03-09T13:05:27.000Zweekly0.6https://www.pharmafocus.com/articles/european-commission-gives-orphan-status-to-selinexor-to-treat-myelofribrosis2023-03-09T13:00:33.000Zweekly0.6https://www.pharmafocus.com/articles/fda-grants-approval-to-wise-for-neuromonitoring-cortical-strip2023-03-02T05:46:43.000Zweekly0.6https://www.pharmafocus.com/articles/fda-hopes-to-make-opioid-overdose-medication-available-without-prescriptions2023-03-08T17:22:07.000Zweekly0.6https://www.pharmafocus.com/articles/five-facts-about-vaccines2023-03-07T17:05:06.000Zweekly0.6https://www.pharmafocus.com/articles/flypharma-middle-east2023-03-02T05:46:43.000Zweekly0.6https://www.pharmafocus.com/articles/fulllife-technologies-to-acquire-focusx-therapeutics2023-03-08T17:03:45.000Zweekly0.6https://www.pharmafocus.com/articles/haemophilia-drug-costing-3-5m-per-dose-has-been-approved2023-03-02T05:46:41.000Zweekly0.6https://www.pharmafocus.com/articles/innovations-in-pharmaceutical-technology-116742077012023-03-02T05:46:47.000Zweekly0.6https://www.pharmafocus.com/articles/innovations-in-pharmaceutical-technology-316742077012023-03-02T05:46:46.000Zweekly0.6https://www.pharmafocus.com/articles/merck-donates-ebola-vaccines-for-testing-on-resistant-strain2023-09-18T09:06:45.000Zweekly0.6https://www.pharmafocus.com/articles/molecure-sees-positive-outcomes-in-clinical-trials-and-announces-financial-results2023-03-09T12:56:45.000Zweekly0.6https://www.pharmafocus.com/articles/new-alzheimers-drug-lecanemab-slows-disease-but-divides-opinions2023-03-08T17:18:52.000Zweekly0.6https://www.pharmafocus.com/articles/new-insights-into-hiv-vaccine-revealed-by-researchers2023-03-08T17:07:50.000Zweekly0.6https://www.pharmafocus.com/articles/nhs-nurses-vote-to-strike-on-15-and-20-december2023-03-02T05:46:39.000Zweekly0.6https://www.pharmafocus.com/articles/nice-recommends-cabometyx-cabozantinib-for-hepatocellular-carcinoma2023-03-02T05:46:45.000Zweekly0.6https://www.pharmafocus.com/articles/novo-nordisks-smart-connected-pens-made-compatible-with-abbotts-freestyle-librelink-app2023-03-07T17:16:47.000Zweekly0.6https://www.pharmafocus.com/articles/over-90-of-vaccines-in-uk-imported-from-flanders2023-03-02T05:46:46.000Zweekly0.6https://www.pharmafocus.com/articles/oxford-astrazeneca-vaccine-team-turns-to-malaria2023-03-02T05:46:35.000Zweekly0.6https://www.pharmafocus.com/articles/oxford-biomedica-appoints-dr-frank-mathias-as-ceo2023-03-07T17:08:57.000Zweekly0.6https://www.pharmafocus.com/articles/parthenon-therapeutics-and-imaginab-announce-licence-and-supply-agreement2023-03-07T17:30:14.000Zweekly0.6https://www.pharmafocus.com/articles/peter-williams-appointed-general-manager-incyte-biosciences-uk-and-ireland2023-03-07T17:07:37.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-role-3516742077012023-03-02T05:46:48.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-4216742077012023-03-02T05:46:48.000Zweekly0.6https://www.pharmafocus.com/articles/pulmonx-secures-japanese-approval-for-zephyr-valve-for-copdemphysema2023-03-08T17:16:36.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-ltd-516742077012023-03-02T05:46:47.000Zweekly0.6https://www.pharmafocus.com/articles/siemens-healthineers-and-atrium-health-team-up-in-140m-deal2023-03-08T17:07:29.000Zweekly0.6https://www.pharmafocus.com/articles/stem-cell-transplants-could-be-offered-to-ms-patients-in-new-trial2023-03-02T05:46:35.000Zweekly0.6https://www.pharmafocus.com/articles/the-future-of-follicular-lymphoma-treatment2023-03-02T05:46:44.000Zweekly0.6https://www.pharmafocus.com/articles/upstaza-given-marketing-authorisation-for-aadc-deficiency-by-mhra2023-03-02T05:46:34.000Zweekly0.6https://www.pharmafocus.com/articles/words-from-the-editor2023-03-02T05:46:37.000Zweekly0.6https://www.pharmafocus.com/articles/5-neurological-phenomenons-4616744418822023-03-02T05:46:45.000Zweekly0.6https://www.pharmafocus.com/articles/baby-sticky-tape-skin-test-could-1516744418822023-03-06T16:02:46.000Zweekly0.6https://www.pharmafocus.com/articles/bio-innovation-institute-reveals-new-cohort-entering-3516744418822023-03-02T05:46:51.000Zweekly0.6https://www.pharmafocus.com/articles/biovac-produces-first-pfizer-covid-19-vaccine-3116744418822023-03-02T05:46:37.000Zweekly0.6https://www.pharmafocus.com/articles/brainomix-and-bridge-biotherapeutics-enter-ai-partnership2023-03-02T05:46:30.000Zweekly0.6https://www.pharmafocus.com/articles/china-approves-worlds-first-inhaled-covid19-vaccine-for-emergency-use2023-03-06T15:43:17.000Zweekly0.6https://www.pharmafocus.com/articles/contents-716744418822023-03-07T17:02:36.000Zweekly0.6https://www.pharmafocus.com/articles/digital-platforms-and-the-world-of-oncology2023-03-02T05:46:35.000Zweekly0.6https://www.pharmafocus.com/articles/dime-reveals-digital-measures-for-treatment-of-atopic-dermatitis2023-03-02T05:46:32.000Zweekly0.6https://www.pharmafocus.com/articles/genetically-modified-herpes-virus-delivers-one-two-916744418822023-03-07T16:54:24.000Zweekly0.6https://www.pharmafocus.com/articles/half-of-global-health-care-facilities-2116744418822023-03-06T15:39:46.000Zweekly0.6https://www.pharmafocus.com/articles/imfinzi-dur-valumab-approved-for-advanced-biliary-cancer-treatment-in-the-us2023-03-06T15:45:13.000Zweekly0.6https://www.pharmafocus.com/articles/iveric-bio-announces-positive-topline-data-2216744418822023-03-06T15:32:39.000Zweekly0.6https://www.pharmafocus.com/articles/jrs-pharma-plans-18-million-manufacturing-3216744418822023-03-02T05:46:51.000Zweekly0.6https://www.pharmafocus.com/articles/katharine-knobil-joins-pliant-therapeutics-board-4316744418822023-03-02T05:46:45.000Zweekly0.6https://www.pharmafocus.com/articles/kelai-pharmaceutical-partners-with-nutrasource-to-2716744418822023-03-06T14:20:25.000Zweekly0.6https://www.pharmafocus.com/articles/landmark-partnership-to-improve-scotland-s-health-1116744418822023-03-06T16:08:49.000Zweekly0.6https://www.pharmafocus.com/articles/lytix-biopharma-recruits-stephen-worsley-as-chief-business-officer2023-03-02T05:46:29.000Zweekly0.6https://www.pharmafocus.com/articles/measles-outbreak-in-zimbabwe-kills-almost-1716744418822023-03-06T15:50:57.000Zweekly0.6https://www.pharmafocus.com/articles/merck-supports-orna-s-development-of-o-rna-2616744418822023-03-06T14:27:25.000Zweekly0.6https://www.pharmafocus.com/articles/millions-invited-for-covid-19-booster-jabs-816744418822023-03-07T16:57:06.000Zweekly0.6https://www.pharmafocus.com/articles/mind-matters-how-ai-is-evolving-research-into-parkinsons2023-03-02T05:46:36.000Zweekly0.6https://www.pharmafocus.com/articles/nervgen-pharma-appoints-dr-matvey-lukashev-as-vice-president-of-research2023-03-02T05:46:29.000Zweekly0.6https://www.pharmafocus.com/articles/novo-nordisk-and-microsoft-join-forces-3716744418822023-03-02T05:46:49.000Zweekly0.6https://www.pharmafocus.com/articles/pfizer-buys-global-blood-therapeutics-for-2816744418822023-03-06T14:14:25.000Zweekly0.6https://www.pharmafocus.com/articles/pfizer-finds-rsv-vaccine-is-effective-2516744418822023-03-06T14:28:48.000Zweekly0.6https://www.pharmafocus.com/articles/pharmaceutical-companies-record-year-low-of-robotics-3316744418822023-03-02T05:46:48.000Zweekly0.6https://www.pharmafocus.com/articles/roche-agrees-to-buy-good-therapeutics-1416744418822023-03-06T16:07:15.000Zweekly0.6https://www.pharmafocus.com/articles/routine-hospital-care-postponed-due-to-national-bank-hol-iday2023-03-07T17:01:01.000Zweekly0.6https://www.pharmafocus.com/articles/smc-accepts-jazz-pharmaceuticals-sativex-for-1216744418822023-03-06T16:08:24.000Zweekly0.6https://www.pharmafocus.com/articles/spectrum-x-upgrades-facilities-to-kickstart-clinical-2916744418822023-03-02T05:46:41.000Zweekly0.6https://www.pharmafocus.com/articles/storm-therapeutics-appoints-dr-jerry-mc-mahon-4116744418822023-03-02T05:46:40.000Zweekly0.6https://www.pharmafocus.com/articles/takeda-splashes-300-million-to-expand-3016744418822023-03-02T05:46:41.000Zweekly0.6https://www.pharmafocus.com/articles/triall-partners-with-mayo-clinic-to-2416744418822023-03-06T14:39:11.000Zweekly0.6https://www.pharmafocus.com/articles/uk-covid-19-infections-lowest-since-last-016744418822023-03-07T17:02:07.000Zweekly0.6https://www.pharmafocus.com/articles/university-of-california-develops-new-technology-2316744418822023-03-06T15:36:07.000Zweekly0.6https://www.pharmafocus.com/articles/valeo-pharma-appoints-kyle-steiger-to-4416744418822023-03-02T05:46:44.000Zweekly0.6https://www.pharmafocus.com/articles/words-from-the-editor-616744418822023-03-07T17:02:48.000Zweekly0.6https://www.pharmafocus.com/articles/yeast-cells-engineered-to-fight-cancer-1616744418822023-03-06T15:58:24.000Zweekly0.6https://www.pharmafocus.com/articles/ypsomed-and-sidekick-seek-digital-solution-to-selfinjection-anxiety2023-03-07T16:58:58.000Zweekly0.6https://www.pharmafocus.com/articles/10-steps-closer-to-the-patient-3916691069892023-03-02T05:43:25.000Zweekly0.6https://www.pharmafocus.com/articles/5-examples-of-personalised-medicine-4816691069892023-03-02T05:43:24.000Zweekly0.6https://www.pharmafocus.com/articles/70-million-in-fines-for-pharma-1116691069882023-03-02T05:43:18.000Zweekly0.6https://www.pharmafocus.com/articles/access-all-areas-increasing-health-e-3816691069892023-03-02T05:43:26.000Zweekly0.6https://www.pharmafocus.com/articles/cdmo-wins-tech-transfer-and-production-3016691069882023-03-02T05:43:15.000Zweekly0.6https://www.pharmafocus.com/articles/chris-tower-joins-euromed-usa-as-4616691069882023-03-02T05:43:19.000Zweekly0.6https://www.pharmafocus.com/articles/cognito-s-light-and-sound-therapy-slows-brain-tissue-3216691069882023-03-02T05:43:16.000Zweekly0.6https://www.pharmafocus.com/articles/compass-pathways-appoints-kabir-nath-as-4516691069882023-03-02T05:43:03.000Zweekly0.6https://www.pharmafocus.com/articles/digital-physical-therapy-app-one-step-launches-3316691069892023-03-02T05:43:20.000Zweekly0.6https://www.pharmafocus.com/articles/ema-round-up-1416691069882023-03-02T05:43:02.000Zweekly0.6https://www.pharmafocus.com/articles/f2-g-announce-development-and-commercialisation-for-3116691069892023-03-02T05:43:22.000Zweekly0.6https://www.pharmafocus.com/articles/fda-round-up-1916691069892023-03-02T05:43:23.000Zweekly0.6https://www.pharmafocus.com/articles/first-diseasemodifying-treatment-for-aadc-deficiency-116691069882023-03-02T05:43:10.000Zweekly0.6https://www.pharmafocus.com/articles/global-monkeypox-cases-rise-to-26-000-1816691069882023-03-02T05:43:19.000Zweekly0.6https://www.pharmafocus.com/articles/health-track-rx-develops-monkeypox-specific-pcr-2016691069882023-03-02T05:43:17.000Zweekly0.6https://www.pharmafocus.com/articles/home-based-brain-stimulation-study-on-stroke-2416691069882023-03-02T05:43:04.000Zweekly0.6https://www.pharmafocus.com/articles/immunisation-or-hospitalisation-what-rwe-tells-4116691069892023-03-02T05:43:24.000Zweekly0.6https://www.pharmafocus.com/articles/initiative-to-improve-next-generation-cancer-2316691069892023-03-02T05:43:20.000Zweekly0.6https://www.pharmafocus.com/articles/janssen-promoted-maria-walsh-to-business-4416691069882023-03-02T05:43:17.000Zweekly0.6https://www.pharmafocus.com/articles/m-ps-warn-nhs-england-facing-worst-916691069892023-03-02T05:43:20.000Zweekly0.6https://www.pharmafocus.com/articles/medics-in-ukraine-work-amid-shelling-1616691069882023-03-02T05:43:08.000Zweekly0.6https://www.pharmafocus.com/articles/micronesia-s-first-covid-19-outbreak-sees-steep-2116691069882023-03-02T05:43:19.000Zweekly0.6https://www.pharmafocus.com/articles/miro-bio-to-be-acquired-by-gilead-2616691069892023-03-02T05:43:22.000Zweekly0.6https://www.pharmafocus.com/articles/monkeypox-declared-global-health-emergency-1716691069892023-03-02T05:43:22.000Zweekly0.6https://www.pharmafocus.com/articles/new-method-involving-musical-tests-can-2516691069892023-03-02T05:43:23.000Zweekly0.6https://www.pharmafocus.com/articles/new-reforms-aim-for-better-nhs-1316691069882023-03-02T05:43:09.000Zweekly0.6https://www.pharmafocus.com/articles/nice-issues-positive-appraisal-for-advanced-1516691069892023-03-02T05:43:21.000Zweekly0.6https://www.pharmafocus.com/articles/pci-pharma-services-announces-multi-milliondollar-expansion-2916691069882023-03-02T05:43:07.000Zweekly0.6https://www.pharmafocus.com/articles/personalised-healthcare-is-key-to-a-3516691069892023-03-02T05:43:24.000Zweekly0.6https://www.pharmafocus.com/articles/potential-shortage-of-140-000-nurses-in-1016691069872023-03-02T05:43:01.000Zweekly0.6https://www.pharmafocus.com/articles/recent-hepatitis-linked-to-adeno-associated-virus-2216691069892023-03-02T05:43:23.000Zweekly0.6https://www.pharmafocus.com/articles/res-med-buys-mementor-for-prescription-digital-3416691069882023-03-02T05:43:18.000Zweekly0.6https://www.pharmafocus.com/articles/sanofi-makes-300-million-investment-in-2816691069882023-03-02T05:43:16.000Zweekly0.6https://www.pharmafocus.com/articles/the-evolving-landscape-of-ra-treatments-4016691069892023-03-02T05:43:21.000Zweekly0.6https://www.pharmafocus.com/articles/uk-scientists-say-they-have-found-1216691069882023-03-02T05:43:14.000Zweekly0.6https://www.pharmafocus.com/articles/up-close-and-personal-the-potential-3616691069892023-03-02T05:43:25.000Zweekly0.6https://www.pharmafocus.com/articles/us-government-buys-66-million-doses-2716691069882023-03-02T05:43:18.000Zweekly0.6https://www.pharmafocus.com/articles/words-from-the-editor-716691069882023-03-02T05:43:15.000Zweekly0.6https://www.pharmafocus.com/articles/monkeypox-antiviral-tecovirimat-put-to-the-016691069882023-03-02T05:43:09.000Zweekly0.6https://www.pharmafocus.com/articles/4-25-million-grant-for-uk-wide-effort-1316691065152023-03-02T05:43:23.000Zweekly0.6https://www.pharmafocus.com/articles/4bn-nhs-covid-19-ppe-to-be-1116691065152023-03-02T05:43:23.000Zweekly0.6https://www.pharmafocus.com/articles/astellas-opens-100-million-us-based-production-3416691065142023-03-02T05:43:02.000Zweekly0.6https://www.pharmafocus.com/articles/astorg-to-acquire-med-comms-platform-3116691065142023-03-02T05:43:06.000Zweekly0.6https://www.pharmafocus.com/articles/bristol-myers-squibb-to-acquire-cancer-3016691065142023-03-02T05:43:01.000Zweekly0.6https://www.pharmafocus.com/articles/contents-516691065152023-03-02T05:43:19.000Zweekly0.6https://www.pharmafocus.com/articles/covid-19-vaccine-scheme-for-low-income-countries-2416691065152023-03-02T05:43:22.000Zweekly0.6https://www.pharmafocus.com/articles/cutting-through-the-noise-data-science-4116691065162023-03-02T05:43:24.000Zweekly0.6https://www.pharmafocus.com/articles/dfe-pharma-recruits-new-global-hr-4616691065142023-03-02T05:43:04.000Zweekly0.6https://www.pharmafocus.com/articles/eagle-pharmaceuticals-completes-104-million-acquisition-2916691065152023-03-02T05:43:15.000Zweekly0.6https://www.pharmafocus.com/articles/efforts-to-eliminate-african-trypanosomiasis-continue-2516691065152023-03-02T05:43:17.000Zweekly0.6https://www.pharmafocus.com/articles/ema-s-releases-first-critical-medicines-list-1516691065152023-03-02T05:43:12.000Zweekly0.6https://www.pharmafocus.com/articles/fda-approves-measles-vaccine-2116691065152023-03-02T05:43:20.000Zweekly0.6https://www.pharmafocus.com/articles/five-exciting-studies-on-diabetes-4916691065152023-03-02T05:43:23.000Zweekly0.6https://www.pharmafocus.com/articles/flypharma-conference-216691065152023-03-02T05:43:09.000Zweekly0.6https://www.pharmafocus.com/articles/hundreds-of-thousands-to-benefit-from-916691065152023-03-02T05:43:13.000Zweekly0.6https://www.pharmafocus.com/articles/leaked-data-reveals-nhs-will-miss-1216691065152023-03-02T05:43:18.000Zweekly0.6https://www.pharmafocus.com/articles/living-with-4416691065152023-03-02T05:43:24.000Zweekly0.6https://www.pharmafocus.com/articles/lucl-sargood-5016691065152023-03-02T05:43:14.000Zweekly0.6https://www.pharmafocus.com/articles/malnutrition-relate-d-form-of-diab-etes-2316691065152023-03-02T05:43:22.000Zweekly0.6https://www.pharmafocus.com/articles/metrion-biosciences-appoints-dr-benedetta-montagnini-4516691065152023-03-02T05:43:10.000Zweekly0.6https://www.pharmafocus.com/articles/new-cancer-drug-trial-achie-016691065152023-03-02T05:43:24.000Zweekly0.6https://www.pharmafocus.com/articles/new-genetic-eye-disease-discovered-2616691065152023-03-02T05:43:16.000Zweekly0.6https://www.pharmafocus.com/articles/new-moderna-covid-19-vaccine-five-times-more-effective2023-08-25T09:37:42.000Zweekly0.6https://www.pharmafocus.com/articles/ox-sonics-appoints-dr-marianna-lalla-as-4716691065152023-03-02T05:43:15.000Zweekly0.6https://www.pharmafocus.com/articles/pharma-times-3816691065152023-03-02T05:43:08.000Zweekly0.6https://www.pharmafocus.com/articles/pharmatimes-3916691065152023-03-02T05:43:17.000Zweekly0.6https://www.pharmafocus.com/articles/pm-416691065152023-03-02T05:43:21.000Zweekly0.6https://www.pharmafocus.com/articles/pmlive-4816691065152023-03-02T05:43:11.000Zweekly0.6https://www.pharmafocus.com/articles/polio-virus-detected-in-sewage-from-1416691065152023-03-02T05:43:15.000Zweekly0.6https://www.pharmafocus.com/articles/positive-data-from-genentech-s-blood-cancer-1816691065152023-03-02T05:43:14.000Zweekly0.6https://www.pharmafocus.com/articles/positive-phase-iii-data-released-from-1616691065152023-03-02T05:43:21.000Zweekly0.6https://www.pharmafocus.com/articles/regenxbio-opens-gene-therapy-manufacturing-facility-3216691065152023-03-02T05:43:17.000Zweekly0.6https://www.pharmafocus.com/articles/researchers-create-transformer-style-robot-that-travels-316691065142023-03-02T05:43:02.000Zweekly0.6https://www.pharmafocus.com/articles/researchers-u-ncover-origins-of-black-116691065142023-03-02T05:43:03.000Zweekly0.6https://www.pharmafocus.com/articles/samedan-816691065152023-03-02T05:43:22.000Zweekly0.6https://www.pharmafocus.com/articles/seqiris-completes-156-million-expansion-for-3316691065142023-03-02T05:43:05.000Zweekly0.6https://www.pharmafocus.com/articles/simple-eye-exam-could-predict-heart-2716691065152023-03-02T05:43:13.000Zweekly0.6https://www.pharmafocus.com/articles/smart-technology-can-halve-the-risk-3616691065152023-03-02T05:43:20.000Zweekly0.6https://www.pharmafocus.com/articles/somerset-nhs-foundation-trust-uses-ai-3716691065152023-03-02T05:43:20.000Zweekly0.6https://www.pharmafocus.com/articles/telemedicine-driving-smarter-healthcare-solutions-in-4316691065162023-03-02T05:43:25.000Zweekly0.6https://www.pharmafocus.com/articles/the-importance-of-testing-in-the-4216691065162023-03-02T05:43:25.000Zweekly0.6https://www.pharmafocus.com/articles/tiziana-life-sciences-announces-positive-results-2016691065152023-03-02T05:43:19.000Zweekly0.6https://www.pharmafocus.com/articles/type-2-diabetes-may-speed-up-2816691065142023-03-02T05:43:03.000Zweekly0.6https://www.pharmafocus.com/articles/uk-covid-19-expert-monkeypox-requires-substantial-1016691065152023-03-02T05:43:07.000Zweekly0.6https://www.pharmafocus.com/articles/uk-warns-of-major-cholera-outbreak-1716691065152023-03-02T05:43:18.000Zweekly0.6https://www.pharmafocus.com/articles/veeva-la-vida-a-roundup-of-4016691065162023-03-02T05:43:26.000Zweekly0.6https://www.pharmafocus.com/articles/words-from-the-editor-616691065152023-03-02T05:43:12.000Zweekly0.6https://www.pharmafocus.com/articles/you-tube-feature-could-help-users-find-3516691065152023-03-02T05:43:18.000Zweekly0.6https://www.pharmafocus.com/categories/uk-pharma-news2025-02-12T17:29:18.000Zweekly0.6https://www.pharmafocus.com/categories/general-news2025-03-13T13:13:12.000Zweekly0.6https://www.pharmafocus.com/categories/approvals2025-03-13T13:09:42.000Zweekly0.6https://www.pharmafocus.com/categories/research-and-development2025-03-13T13:07:57.000Zweekly0.6https://www.pharmafocus.com/categories/industry-facts2025-04-29T14:19:11.000Zweekly0.6https://www.pharmafocus.com/categories/mergers-acquisitions2025-03-13T13:05:42.000Zweekly0.6https://www.pharmafocus.com/categories/manufacturing-production2025-02-05T12:33:54.000Zweekly0.6https://www.pharmafocus.com/categories/industry-insights2025-03-13T12:58:06.000Zweekly0.6https://www.pharmafocus.com/categories/appointments2025-03-13T13:03:58.000Zweekly0.6https://www.pharmafocus.com/categories/insider-interviews2024-11-11T22:49:57.000Zweekly0.6https://www.pharmafocus.com/categories/features2025-03-13T13:14:48.000Zweekly0.6https://www.pharmafocus.com/categories/clinical-trials2025-03-13T13:11:26.000Zweekly0.6https://www.pharmafocus.com/collectionsdaily0.5https://www.pharmafocus.com/collections/pharmafocus-april-may-20252025-05-02T09:32:14.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/tau-rx-builds-on-its-alzheimer-s-momentum-after-tablet-found-to-s2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/european-biotech-project-aims-to-develop-next-generation-targete2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/communique-awards-2025-a8da2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/pharma-role-e6982025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/contents-75652025-05-02T09:02:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/comment-95482025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/galapagos-confirms-new-leadership-as-planned-company-split-nears2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/five-european-countries-account-for-68-of-the-region-s-pharma2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/green-light-for-moderna-to-upscale-uk-m-rna-vaccine-manufacturing2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/new-hormonal-treatment-launched-to-help-prevent-miscarriage2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/potential-rare-eye-disease-treatment-sees-phase-1-success2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/novo-s-rybelsus-found-to-reduce-major-adverse-cardiovascular-eve2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/johnson-johnson-s-darzalex-gains-boost-over-conventional-chemo2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/corcept-s-relacorilant-improves-ovarian-cancer-survival-in-phase2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/gri-bio-wins-europe-and-japan-patents2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/dupixent-approved-in-japan-as-first-biologic-medicine-for-copd2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/sanofi-s-chlamydia-vaccine-put-on-fda-fast-track2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/scottish-medicines-consortium-approves-ipsen-s-iqirvo2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/curium-pharma-s-deal-with-monrol-boosts-its-position-in-nuclear2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/mehilainen-strikes-deal-with-regina-maria-and-medi-group2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/cold-chain-technologies-acquires-global-cold-chain-solutions2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/samedan-pharmaceutical-publishers2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/gergely-sved-to-move-to-ellab-as-its-new-chief-executive-officer2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/shane-olwill-joins-asgard-as-chief-development-officer2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/pro-bio-gen-promotes-alfred-merz-to-chief-executive-officer2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/aax-recruits-ionut-gabriel-dumitru-and-kushal-sejwal2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/cluepoints-selects-usama-dar-as-new-chief-product-and-technology2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/the-unbearable-lightness-of-creativity2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/mind-the-gap-men-s-health-and-the-need-for-progress2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/gary-lyons-joins-coronado-as-evp-medical-affairs2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/the-landscape-of-menopause-care-in-the-uk2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/eu-regulatory-momentum-could-catalyse-clinical-trial-innovation2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/flypharma-amsterdam2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/five-facts-about-mental-health-20252025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-may-2025/aaps-national-biotechnology-conference-1e3e2025-04-30T07:17:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-20252025-03-13T15:39:34.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/rishi-sunak-supports-national-screening-programme-as-prostate-ca2025-03-13T13:14:48.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/university-of-manchester-launches-british-heart-foundation-centr2025-03-13T13:14:21.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/communique-awards-20252025-03-13T13:14:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/pharma-role-19372025-03-13T13:13:53.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/comment-72522025-03-13T13:13:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/contents-3ccb2025-03-13T11:52:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/edx-medical-reveals-new-test-for-prostate-cancer2025-03-13T13:13:12.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/clinical-registry-for-adolescent-alopecia-areata-launched-by-the2025-03-13T13:12:51.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/uk-government-announces-national-cancer-plan-for-england2025-03-13T13:12:30.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/fly-pharma-f7bb2025-03-13T13:11:52.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/pulse-sight-therapeutics-closes-series-a-financing-for-dry-amd-ph2025-03-13T13:10:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/emalex-bioscience-s-candidate-for-tourette-syndrome-meets-phase2025-03-13T13:10:35.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/recce-pharmaceuticals-reports-positive-phase-2-data-for-skin-inf2025-03-13T13:11:25.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/data-shows-long-term-success-for-biosimilar-switch-in-ibd2025-03-13T13:10:14.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/bridge-bio-announces-ec-approval-for-acoramidis-in-attr-cm2025-03-13T13:08:54.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/fda-approves-samsung-bioepis-denosumab-biosimilars2025-03-13T13:08:30.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/ucb-s-fintepla-receives-nice-recommendation-for-lennox-gastaut-s2025-03-13T13:09:41.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/mhra-approves-telix-s-prostate-cancer-imaging-agent-illuccix2025-03-13T13:08:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/sanofi-s-bullous-pemphigoid-treatment-given-fda-priority-review2025-03-13T13:07:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/ai-powered-authentication-solution-launched-by-systech2025-03-13T13:06:43.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/rznomics-confirms-fda-fast-track-designation-for-liver-cancer-tr2025-03-13T13:07:56.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/eikon-therapeutics-closes-series-d-funding-round-with-350-7m2025-03-13T13:06:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/product-life-group-acquires-herax-life-science-to-boost-r-d-and-i2025-03-13T13:05:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/solventum-s-purification-and-filtration-business-sold-to-thermo2025-03-13T13:04:56.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/acquisition-of-exploristics-by-mms-reinforces-its-biostatistics2025-03-13T13:05:41.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/samedan-99ee2025-03-13T13:04:11.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/vi-centra-appoints-tom-arnold-as-chief-executive-officer2025-03-13T13:03:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/eleva-appoints-martin-bauer-as-chief-medical-officer2025-03-13T13:03:58.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/novo-nordisk-uk-appoints-sebnem-avsar-tuna-as-general-manager2025-03-13T13:03:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/glox-appoints-michael-murray-as-chair-and-nel-moore-as-scientifi2025-03-13T13:03:00.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/sapio-appoints-mike-hampton-as-chief-commercial-officer2025-03-13T13:02:16.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/nuclera-appoints-seth-benson-as-chief-financial-officer2025-03-13T13:02:37.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/what-awaits-attendees-at-bio-europe-in-milan-this-spring2025-03-13T12:59:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/covid-19-five-years-later-successes-and-remaining-challenges2025-03-13T12:58:06.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/menopause-in-the-workplace-why-you-should-care2025-03-13T12:56:10.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/successfully-navigating-the-complexity-of-market-access-across-e2025-03-13T12:53:53.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/empowering-women-leaders-a-journey-into-stem2025-03-13T12:55:01.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/get-in-touch-pharmafocus2025-03-13T12:51:50.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/world-vaccine-congress2025-03-13T12:51:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/five-facts-about-women-s-health-b38a2025-03-13T12:52:28.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march-2025/aaps-national-biotechnology-conference2025-03-13T12:50:33.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-20252025-02-13T12:33:02.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/moderna-named-the-largest-industry-sponsor-of-clinical-trials-in2025-02-12T17:31:52.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/prenatal-care-could-be-revolutionised-suggests-studies-from-brig2025-02-12T17:30:59.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/pharma-role-209f2025-02-12T17:29:56.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/pmlive-d85f2025-02-12T17:31:05.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/contents-9bcd2025-02-12T17:29:50.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/salary-survey2025-02-12T17:29:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/university-of-sheffield-trial-highlights-immunotherapy-related-i2025-02-12T17:29:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/european-commission-launches-new-biotech-and-biomanufacturing-hu2025-02-12T17:28:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/alvogen-issues-voluntary-us-recall-of-fentanyl-patch-amid-concer2025-02-12T17:28:01.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/comment-f7172025-02-12T17:29:41.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/7m-financing-announced-to-further-clinical-trials-in-thrombo-in2025-02-12T17:18:06.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/nda-in-china-receives-priority-review-status-for-lung-cancer-tre2025-02-12T17:26:37.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/fly-pharma-europe22025-02-13T12:42:40.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/ana-cardio-raises-19m-in-funding-round-for-heart-failure-candida2025-02-12T17:16:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/combination-first-in-line-treatment-approved-for-patients-with-n2025-02-12T17:07:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/positive-topline-results-announced-in-phase-2-alcohol-use-disord2025-02-12T17:12:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/results-from-novadip-phase-1b-2a-trial-reveal-88-efficacy2025-02-12T17:14:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/mhra-grants-marketing-authorisation-to-andembry-for-hereditary-a2025-02-12T17:08:51.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/nice-issues-positive-final-guidance-for-treatment-of-duchenne-mu2025-02-12T17:05:40.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/university-of-southern-denmark-pairs-with-argobio-to-launch-next2025-02-12T17:04:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/mhra-approves-new-treatment-combo-for-transplant-ineligible-mult2025-02-12T17:06:35.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/research-collaboration-announced-between-oxford-university-and-g2025-02-12T17:00:54.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/candor-bioscience-acquired-by-medix-biochemica2025-02-12T16:48:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/new-7m-sterile-manufacturing-plant-opens-in-nottingham-uk2025-02-12T16:57:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/biomarkers-used-in-trial-to-prevent-systematic-onset-of-disease2025-02-12T16:59:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/phillips-medisize-closes-acquisition-of-vectura-group-ltd2025-02-12T16:50:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/the-future-of-pharma-how-ai-will-reshape-drug-development-and-p2025-02-12T16:44:04.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/stragen-services-acquired-by-product-life-group2025-02-12T16:47:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/how-digital-researchers-will-transform-drug-discovery2025-02-12T16:41:00.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/opportunities-to-reduce-steroid-toxicity-and-embrace-new-treatme2025-02-12T16:37:10.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/samedanltd-5de92025-02-12T16:44:51.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/terrapinn2025-02-12T16:35:28.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/solving-common-challenges-in-rare-disease-trials2025-02-12T16:34:56.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/iddi-announces-two-new-appointments-to-its-leadership-team2025-02-12T16:30:26.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/david-loose-appointed-ceo-of-essex-management2025-02-12T16:31:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/jerome-berger-announced-as-strategy-and-finance-executive-at-vec2025-02-12T16:07:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/precision-life-appoints-new-leadership-member-bill-keating-as-c2025-02-12T16:13:08.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/dr-joerg-moeller-appointed-ceo-of-antag-therapeutics2025-02-12T16:04:01.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/samedanltd-38982025-02-12T16:00:28.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/national-biotechnology-conference2025-02-12T15:58:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/five-facts-on-clinical-trials-in-the-uk2025-02-12T16:00:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-february-2025/pmlive-a8212025-02-12T15:58:08.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-media-20252025-06-19T11:36:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-20242025-01-03T15:28:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/solas-cure-partners-with-us-army-for-better-wound-care-technology2024-12-06T14:41:42.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/spinal-cord-stimulator-with-ai-technology-receives-ce-mark-certi2024-12-10T09:38:41.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/pharma-role-72f92024-12-06T14:41:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/communique-11802024-12-06T14:41:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/comment-aed62024-12-06T14:40:02.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/contents-16032024-12-06T14:41:01.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/antibacterial-peptides-instrumental-in-efficiency-against-resist2024-12-06T14:38:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/ozempic-potentially-dethroned-by-cagri-sema-but-weight-loss-stil2024-12-06T14:37:47.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/cytomos-raises-5m-for-scale-up-process2025-02-05T12:35:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/pharma-role-salary-survey-81592024-12-06T14:38:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/pharma-times-c7342024-12-06T14:38:01.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/revolutionary-alzheimer-s-diagnostic-blood-test-launches-in-the2025-02-05T12:36:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/adipo-pharma-secures-funding-for-clinical-trial-into-its-insulin2024-12-06T14:37:07.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/gsk-s-linerixibat-shows-positive-phase-3-results-for-cholestatic2024-12-06T14:37:01.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/puma-biotechnology-initiates-phase-2-trial-for-breast-cancer-dru2024-12-06T14:36:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/phase-2b-results-announced-by-barinthus-biotherapeutics-for-hbv02024-12-06T14:36:53.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/johnson-johnson-receives-mhra-approval-for-balversa2024-12-06T14:36:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/theramex-receives-recommendation-for-yselty-in-scotland2024-12-06T14:35:33.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/mhra-greenlights-adapted-nuvaxovid-jn-1-covid-19-vaccine-for-age2024-12-06T14:35:43.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/aravax-expands-to-oxford-science-park-boosting-uk-pharma-manufa2024-12-06T14:34:05.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/j-j-seeks-approval-for-first-drug-to-treat-high-risk-smouldering2024-12-06T14:34:56.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/new-center-for-bioprocess-innovation-opens-in-us2024-12-06T14:34:14.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/infrareal-acquires-former-takeda-pharma-and-biotech-site-in-aust2024-12-06T14:34:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/double-acquisition-by-astoriom-helps-cement-its-uk-and-us-presen2024-12-06T14:33:58.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/michael-garrett-appointed-as-new-chief-executive-officer-at-exe-v2024-12-06T14:33:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/samedan-6b132024-12-06T14:33:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/improving-the-patient-experience-insights-from-uganda-the-uk-a2024-12-06T14:33:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/double-hiring-strengthens-biosynth-upper-management2024-12-06T14:32:27.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/veronica-gambillara-fonck-nominated-as-chair-of-minerva-x-s-board2024-12-06T14:32:34.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/pharmafocus-d96f2024-12-06T14:32:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/interphex-18622024-12-06T14:31:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/five-facts-about-medical-maggot-therapy2024-12-06T14:31:51.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2024/pharma-times-a1622024-12-06T14:31:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-20242025-02-05T12:33:52.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/survey-from-roche-finds-worryingly-low-understandings-about-hpv-a2ec2024-11-15T12:49:04.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/pmea-a57b2024-11-15T12:48:10.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/best-in-class-ai-model-from-bioptimus-integrated-into-proscia-s-5dd52024-11-15T15:37:30.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/contents-823e2024-11-15T12:45:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/pharma-role-f2a82024-11-15T12:46:04.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/pharma-role-salary-survey-8feb2024-11-15T12:45:32.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/comment-bb4a2024-11-15T12:45:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/almirall-s-immunoskin-event-returns-for-a-third-year-discussing-cab82024-11-15T15:31:33.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/eco-vadis-platinum-medal-given-to-liveo-research-s-singapore-phar-2ff82024-11-15T15:30:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/hutchmed-set-to-receive-20m-in-funding-from-takeda-for-colorect-ebe12024-11-15T12:43:30.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/exhibitor-numbers-for-cphi-india-grow-for-third-year-in-a-row-w-ee822024-11-15T12:41:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/pac-bio-announces-update-to-sequencing-system-to-bring-down-cost-7ecd2024-11-15T12:39:10.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/hiv-vaccine-candidate-successfully-optimised-for-industrial-prod-07d52024-11-15T15:28:02.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/disrupting-drug-discovery-to-take-on-the-impossible2024-11-18T15:59:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/bayer-and-liveo-research-pair-to-launch-new-sustainable-blister-4a152024-11-15T12:35:27.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/nrg-therapeutics-secures-funding-for-development-of-treatment-fo-35cf2024-11-15T12:36:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/aravax-successfully-recruits-for-phase-3-peanut-allergy-treatmen-0fe62024-11-15T12:28:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/chiesi-announces-phase-3-results-from-enzyme-replacement-study-c9962024-11-15T15:14:58.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/valiant-phase-3-trial-results-highlight-potential-treatment-for-f5772024-11-15T15:13:38.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/rallybio-s-application-for-a-phase-2-trial-in-pregnant-women-app-13872024-11-15T15:11:59.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/nice-gives-positive-recommendation-for-santen-s-roclanda-e19d2024-11-15T12:22:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/chmp-adopts-positive-opinion-for-new-breast-cancer-drug-kisqual-db012024-11-15T12:24:30.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/eplontersen-recommended-for-eu-approval-by-chmp-for-treatment-of-aaa62024-11-15T12:19:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/cytex-ortho-receives-fda-greenlight-for-clinical-trials-into-join-f46a2024-11-15T12:16:08.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/automated-drug-screening-laboratory-jointly-launched-in-china-by-19692024-11-15T12:14:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/biosynth-opens-new-state-of-the-art-biotech-facility-in-suzhou-44a92024-11-15T12:13:46.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/axol-bioscience-acquires-phenocell-b8ea2024-11-15T12:12:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/stelis-strides-and-steriscience-merge-to-form-new-cdmo-b1942024-11-15T12:11:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/darrin-schellin-appointed-new-ceo-at-pharma-tech-industries-cc9c2024-11-15T11:25:14.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/university-of-edinburgh-spinout-kynos-therapeutics-acquire-d-by-4e3c2024-11-15T15:00:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/clue-points-appoint-richard-young-as-chief-strategy-officer-94fe2024-11-15T11:22:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/dr-souad-kechairi-appointed-chief-medical-officer-at-pll-therape-d0392024-11-15T14:57:04.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/shawn-cross-appointed-as-chief-financial-officer-for-pacira-bios-f0ba2024-11-15T11:21:02.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/five-facts-about-artificial-intelligence-ai-13732024-11-15T11:19:21.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/interphex-eaa12024-11-15T11:17:54.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-november-2024/pharma-times-b8892024-11-15T11:17:37.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-20242025-02-05T12:33:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/fda-approves-first-drug-in-50-years-for-treatment-of-schizophren2024-10-11T12:08:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/research-collaboration-between-fda-and-owlstone-medical-set-to-s2024-10-10T16:31:08.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/pmea-731a2024-10-10T16:33:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/pharma-role-acaf2024-10-10T16:33:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/comment-9b0e2024-10-10T16:31:56.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/pharma-role-93282024-10-10T16:34:37.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/third-application-for-orion-s-prostate-cancer-drug-submitted-by2024-10-11T12:08:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/strategic-alliance-announced-between-recipharm-and-exela-for-ste2024-10-11T09:17:44.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/santhera-pharmaceuticals-announces-lionheart-study-results-for-c2024-10-11T12:08:21.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/clue-points-launches-medical-safety-review-msr-software-for-c2024-10-11T13:39:54.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/headlands-research-opens-new-clinical-trials-site-in-el-paso-te2024-11-11T10:46:34.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/johnson-johnson-innovative-medicine-s-carvykti-significantly-e2024-10-11T12:04:44.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/biologic-medicine-dupixent-approved-by-fda-for-copd-patients-in2024-10-11T12:05:04.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/tiziana-life-sciences-awarded-4m-grant-by-nih-to-study-anti-cd32024-10-11T12:04:58.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/european-commission-approves-astellas-pharma-s-gej-adenocarcinom2024-10-11T12:05:11.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/ministry-of-health-labour-and-welfare-of-japan-approves-new-dru2024-10-11T12:07:41.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/hemgenix-approved-for-national-reimbursement-in-spain2024-10-11T12:07:35.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/next-generation-sequencing-partnership-announced-between-angle-p2024-10-11T12:08:04.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/new-collaboration-agreement-announced-between-emih-association-a2024-10-11T12:07:50.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/preclinical-development-started-for-pol-treg-s-car-treg-neuroinfl2024-10-11T11:14:05.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/us-ftc-urged-by-anti-monopoly-group-to-stop-major-oncology-acqui2024-10-11T11:25:28.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/genentech-agrees-to-acquire-regor-s-next-gen-cdk-inhibitors2024-10-11T11:33:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/part-of-3m-cystic-fibrosis-programme-fund-awarded-to-oxford-dru2024-10-11T11:23:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/uncovering-a-lesser-known-cause-of-heart-failure2024-10-16T10:45:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/samedan-d6222024-10-11T11:33:53.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/genomics-has-a-diversity-deficit-it-s-time-to-fix-it2024-10-11T11:55:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/looking-ahead-the-future-of-corneal-transplants2024-10-11T13:53:16.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/prilenia-appoints-new-staff-to-advance-company-s-development-and2024-10-11T11:55:31.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/steriline-s-founder-passes-torch-to-children-with-ceo-and-cso2024-10-11T11:43:07.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/five-facts-about-diversity-equity-and-inclusion-in-pharma2024-10-11T11:54:30.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/eli-lilly-expands-with-two-senior-hires-in-public-affairs-and-co2024-10-11T11:46:46.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/dr-anada-gubbi-appointed-by-sfa-therapeutics-as-director-of-bios2024-10-11T11:51:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/pharma-focus2024-10-11T11:54:43.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/interphex-895c2024-10-11T11:54:50.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/pharma-times-f17f2024-10-11T11:54:57.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2024/162f4770-86f9-11ef-8b79-42010a8000172024-10-10T16:33:56.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-20242025-02-05T12:32:54.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/first-nasal-spray-for-treatment-of-anaphylaxis-approved-by-fda2024-09-06T16:34:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/pmea-47052024-09-06T16:34:26.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/fda-approves-drug-for-primary-biliary-cholangitis2024-09-10T12:19:04.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/pharma-role-340f2024-09-10T12:18:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/contents-93722024-09-06T16:35:12.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/comment-68232024-09-06T16:35:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/sameda-nl2024-09-06T16:35:32.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/novo-holdings-invests-in-oxford-nanopore-technologies2024-09-06T16:36:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/cresset-collaborates-with-enamine-to-enable-the-design-of-new-ta2024-09-09T10:27:50.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/first-oral-treatment-for-hormone-sensitive-prostate-cancer-recom2024-09-09T10:27:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/verisense-announce-opening-of-digital-biobank2024-09-09T10:28:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/positive-results-announced-for-levicept-s-moderate-to-severe-ost2024-09-09T10:29:16.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/calliditas-therapeutics-announces-positive-phase-2b-data-in-prim2024-09-09T10:29:35.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/chmp-gives-positive-opinion-for-merck-s-keytruda-for-unresectabl2024-09-09T10:31:46.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/clinical-trials-for-personalised-cancer-vaccine-used-to-tackle-a2024-09-09T10:32:16.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/the-national-institute-for-health-and-care-excellence-announce-t2024-09-09T10:33:22.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/marketer2024-09-06T16:38:52.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/european-commission-approves-combination-chemotherapy-for-treatm2024-09-09T10:34:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/adaptimmune-receives-us-fda-accelerated-approval-for-engineered2024-09-09T10:34:53.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/eisai-and-eco-navi-sta-enter-dementia-collaboration2024-09-09T10:35:10.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/johnson-johnson-s-med-tech-announce-orthopaedics-receives-501k2024-09-09T10:36:44.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/merck-and-daiichi-sankyo-expand-development-and-commericalisatio2024-09-09T10:37:16.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/abb-vie-acquires-cerevel-therap-eutics2024-09-09T10:38:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/merck-to-acquire-curon-biopharmaceutical-s-b-cell-depletion-ther2024-09-09T10:39:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/collaboration-between-global-cancer-center-and-absci-to-use-gene2024-09-09T10:41:05.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/interphex2024-09-06T16:40:47.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/dive-into-the-heart-of-pharma-at-cphi-milan-20242024-09-09T10:43:42.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/unmet-needs-in-primary-biliary-cholangitis-understanding-challe2024-09-09T10:44:32.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/precision-medicine-and-the-role-of-pathologists-in-multidiscipli2024-09-09T10:45:25.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/how-the-surging-interest-in-oral-peptides-is-opening-new-horizon2024-09-09T10:45:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/fly-pharma-europe-00e22024-09-06T16:41:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/david-wheadon-appointed-to-board-of-directors-at-seaport-therape2024-09-06T16:41:38.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/five-facts-about-primary-biliary-cholangitis2024-09-06T16:42:03.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/richmond-promotes-liz-romano-as-new-director-of-communications-a2024-09-06T16:41:49.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/get-in-touch2024-09-06T16:42:12.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2024/postersindustry-partners2024-09-06T16:41:56.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-20242024-07-18T11:52:24.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/ec-approves-astra-zeneca-s-tagrisso-for-lung-cancer-treatment2024-07-18T11:52:13.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/pharma-times-63a02024-07-18T11:51:22.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/oxolife-announces-phase-2-trial-results-for-infertility-drug2024-07-18T11:51:11.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/contents-2c152024-07-18T11:50:12.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/samedan-bdf32024-07-18T11:49:35.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/pharma-role-e9732024-07-18T11:50:23.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/eisai-and-biogen-s-leqembi-launched-for-ad-in-china-d7602024-07-18T11:49:19.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/comment-4aea2024-07-18T11:49:46.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/chmp-grants-positive-opinion-to-abb-vie-s-tepkinly-for-follicular2024-07-18T11:48:25.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/eli-lilly-and-unicef-extend-partnership-for-risk-of-non-communic2024-07-18T11:47:39.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/fda-grants-expanded-odd-to-immunotherapy-created-at-roswell-park2024-07-18T11:46:37.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/takeda-announces-phase-3-results-from-trial-of-cipd-treatment2024-07-18T11:44:11.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/sanofi-announces-phase-2-data-from-trial-for-frexalimab-for-ms-t2024-07-18T11:43:14.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/neuro-sense-provides-update-for-als-treatment-programme2024-07-18T11:42:47.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/cphi2024-07-18T11:43:34.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/gilead-announces-data-from-phase-3-hiv-prevention-trial-e2262024-07-18T11:44:52.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/pharma-times-ce282024-07-18T11:42:05.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/merck-s-capvaxive-approved-by-fda-for-prevention-of-pneumococcal2024-07-18T11:41:53.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/fda-approves-eli-lilly-s-kisunla-for-alzheimer-s-treatment-b1c22024-07-18T11:39:41.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/abb-vie-s-skyrizi-approved-by-fda-for-uc-treatment2025-02-17T18:35:52.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/iptonline-70fa2024-07-18T11:36:30.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/fda-expands-approval-for-sarepta-therapeutics-dmd-treatment2024-07-18T11:36:01.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/gsk-and-cure-vac-announce-licensing-agreement-following-collabora2024-07-18T11:32:06.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/evotec-provides-update-in-bristol-myers-squibb-neuroscience-coll2024-07-18T11:31:24.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/pmea-65442024-07-18T11:30:48.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/syngene-announces-launch-of-new-protein-production-platform2024-07-18T11:28:46.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/eye-bio-to-be-acquired-by-merck-for-an-upfront-1-3bn2024-07-18T11:28:18.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/innovate-uk-provides-nuclera-with-1-14m-funding2024-07-18T11:30:34.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/chemaxon-to-be-acquired-by-certara-for-drug-discovery2024-07-18T11:27:16.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/icon-group-acquires-pharmaxo-as-part-of-strategic-partnership2024-07-18T11:25:09.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/sustainable-drug-delivery-devices-striking-a-balance-between-fu2024-07-18T11:10:12.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/exploring-disease-modification-to-change-the-future-of-epilepsy2024-07-18T11:13:34.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/the-role-of-ai-in-patient-support2024-07-18T11:05:02.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/the-infe-cte-d-blood-sc-andal-a-timeline2024-07-18T11:03:41.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/flypharma-vienna-20242024-07-18T10:57:00.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/pharmafocus-09992024-07-18T11:03:54.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/curve-therapeutics-bolsters-its-leadership-team-with-appointment2024-07-18T10:55:59.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/adam-rosenberg-replaces-dr-carlo-incerti-as-new-chair-of-the-boa2024-07-18T10:55:07.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/dr-jonathan-appleby-appointed-by-mogrify-as-chief-scientific-off2024-07-18T10:54:16.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/five-facts-about-blood-transfusions2024-07-18T10:50:10.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/move-of-the-month-75bc2024-07-18T10:52:23.000Zweekly0.6https://www.pharmafocus.com/collections/july-august-2024/pharmafocus-5bab2024-07-18T10:49:36.000Zweekly0.6https://www.pharmafocus.com/collections/june-20242024-06-05T13:52:49.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/fda-approves-pfizer-s-beqvez-for-treatment-of-haemophilia-b2024-06-05T13:52:35.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/sanofi-formation-bio-and-open-ai-announce-new-ai-collaboration2024-06-05T13:51:01.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/pharma-times-5ecd2024-06-05T13:51:47.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/contents-a2b52024-06-05T13:49:28.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/pharma-role-6ec32024-06-05T13:50:03.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/astra-zeneca-invests-1-5bn-to-build-adc-facility-in-singapore2024-06-05T13:45:32.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/gsk-invests-45m-with-fleming-initiative-to-combat-amr2024-06-05T13:48:17.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/eli-lilly-increases-investment-for-manufacturing-to-9bn-at-new2024-06-05T13:44:34.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/comment-69f32024-06-05T13:48:53.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/samedan-98912024-06-05T13:48:39.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/boehringer-ingelheim-and-ose-immunotherapeutics-to-collaborate-o2024-06-05T13:43:28.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/j-j-s-tremfya-meets-endpoints-in-uc-study2024-06-05T13:41:58.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/gsk-announces-positive-outcome-from-phase-3-trials-for-asthma-tr2024-06-05T13:41:11.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/communique-9d362024-06-05T13:40:20.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/astra-zeneca-announces-data-from-covid-19-prevention-drug-phase-32024-06-05T13:40:03.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/circular-genomics-shares-study-results-predicting-patient-respon2024-06-05T13:37:55.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/niea2024-06-05T13:36:48.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/roche-s-hpv-self-collection-screening-option-approved-by-fda2024-06-05T13:36:34.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/amgen-s-imdelltra-approved-by-fda-for-extensive-stage-small-cell2024-06-05T13:35:16.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/chmp-grants-positive-opinion-for-j-j-s-rybrevant-for-lung-cancer2024-06-05T13:34:15.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/mhra-approves-ascendis-pharma-s-yorvipath-for-hypoparathyroidism2024-06-05T12:31:11.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/sanofi-and-novavex-sign-exclusive-licensing-agreement-to-commerc2024-06-05T12:30:05.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/pmea-open2024-06-05T12:28:39.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/pharmatimes-93f92024-06-05T12:30:23.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/bayer-and-evote-cannounce-collaboration-for-precision-cardiology2024-06-05T12:28:08.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/astra-zeneca-and-benevolent-ai-add-new-heart-failure-target-throug2024-06-05T12:27:07.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/beckman-coulter-life-sciences-and-watchmaker-genomics-to-collabo2024-06-05T12:26:31.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/human-immunology-biosciences-to-be-aquired-by-biogen-for-1-15bn2024-06-05T12:25:04.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/iptonline2024-06-05T12:25:22.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/nexus-pharmaceuticals-manufacturing-facility-acquired-by-eli-li2024-06-05T12:23:26.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/asco-20242024-06-05T12:22:16.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/mirus-bio-to-be-acquired-by-merck-for-600m2024-06-05T12:24:00.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/20-years-of-egfr-in-nsclc-how-precision-medicine-helps-navigate2024-06-05T14:00:50.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/paediatric-clinical-trials-for-obesity-treatment2024-06-05T13:58:44.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/pharmafocus-26052024-06-05T12:20:52.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/fly-pharma2024-06-05T12:18:50.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/pride-month-and-lgbtq-healthcare2024-06-05T13:56:00.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/enhanc3d-genomics-appoints-hazel-jones-as-ceo2024-06-05T12:18:29.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/closed-loop-medicine-appoints-paul-johnson-as-non-executive-dire2024-06-05T12:16:11.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/sphere-fluidics-appoints-curtis-nicholson-as-director-of-sales-e2024-06-05T12:17:38.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/five-facts-about-lgbtq-healthcare2024-06-05T13:53:37.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/move-of-the-month-dr-alison-evans-appointed-head-of-education-an2024-06-18T11:20:28.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/pharmafocus-fc662024-06-05T12:13:50.000Zweekly0.6https://www.pharmafocus.com/collections/june-2024/6a1c97bd-44ed-11ef-8060-42010a8000162024-07-18T10:06:40.000Zweekly0.6https://www.pharmafocus.com/collections/may-20242024-04-29T11:05:22.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/abb-vie-s-migraine-treatment-recommended-by-nice-for-nhs-use2024-04-29T11:05:13.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/eko-health-s-ai-for-heart-failure-detection-approved-by-fda2024-04-29T11:04:08.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/medincell-and-abb-vie-collaborate-for-next-generation-injectables2024-04-29T11:02:05.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/astra-zeneca-and-daiichi-sankyo-s-bla-for-datopotamab-deruxtecan2024-04-29T11:01:38.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/candel-therapeutics-pancreatic-cancer-treatment-granted-odd-by2024-04-29T10:59:49.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/comment-00dc2024-04-29T11:02:18.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/ucb-s-s-bla-for-bimzelx-accepted-by-fda-for-hs-treatment2024-04-29T11:00:23.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/sanofi-announces-data-from-phase-3-luna-3-trial-for-immune-throm2024-04-29T10:59:15.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/gsk-announces-results-from-phase-3-gonorrhoea-treatment-trial2024-04-29T10:58:44.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/novartis-announces-phase-3-results-for-fabhalta-for-ig-an-treatme2024-04-29T10:53:07.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/eli-lilly-shares-results-from-phase-3-trial-for-tirzepatide-in-r2024-04-29T10:58:11.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/fda-accepts-gsk-s-meningococcal-vaccine-candidate-bla-for-review2024-04-29T10:51:51.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/fda-approves-roche-s-alecensa-lung-cancer-treatment2024-04-29T10:51:10.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/pfizer-s-emblaveo-approved-in-eu-for-multidrug-resistant-infecti2024-04-29T10:50:42.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/immunity-bio-s-anktiva-bladder-cancer-treatment-approved-by-fda2024-04-29T10:50:14.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/neurolentech-and-kaerus-bioscience-collaborate-on-neurodevelopme2024-04-29T10:49:01.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/ardena-gains-first-gmp-approval-and-announces-20m-expansion2024-04-29T10:48:29.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/ironic-biotech-gains-1m-funding-for-development-of-iron-deficie2024-04-29T10:47:36.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/landos-biopharma-to-be-acquired-by-abb-vie-for-approximately-1372024-04-29T10:45:22.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/curve-therapeutics-cso-publishes-research-on-hif-inhibition-for2024-04-29T10:47:04.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/alpine-immune-sciences-to-be-acquired-by-vertex-for-4-9bn2024-04-29T10:41:38.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/epilepsy-and-brain-health-a-call-for-global-action-and-unity2024-04-30T11:24:16.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/johnson-johnson-announces-acquisition-of-shockwave-medical-for2024-04-29T10:44:36.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/rare-disease-clinical-trials-the-urgent-need-for-patients-to-be2024-04-30T14:10:44.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/psychedelic-medicines-and-the-treatment-of-neurological-conditio2024-04-29T11:20:12.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/psychoactives-in-mental-health-treatment2024-04-29T11:18:28.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/margrethe-s-rgaard-appointed-senior-vice-president-of-clinical-o2024-04-29T10:35:40.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/jaap-stuut-appointed-as-president-and-general-manager-of-sakura2024-04-29T10:34:13.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/meenu-chhabra-karson-appointed-board-chair-of-harness-therapeuti2024-04-29T10:33:39.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/sustainability-in-pharma2024-04-29T11:14:00.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/bob-kain-joins-single-technologies-as-advisor2024-04-29T10:32:54.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/five-facts-about-sustainability-in-the-pharma-industry2024-04-29T11:11:12.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/us-croy2024-04-29T11:04:29.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/ef9eae1d-03a9-11ef-84d3-42010a8000152024-04-29T11:03:11.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/pharmarole-12024-04-29T11:02:48.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/pharmatimes-msea-awards-12024-04-29T10:52:22.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/pharmatimes-msea-awards2024-04-29T10:49:31.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/samedanltd-20242024-04-29T10:48:03.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/ipt-online-20242024-04-29T10:46:03.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/yourway-20242024-04-29T10:38:48.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/flypharma-vienna2024-04-29T10:36:16.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/pharmafile-may2024-04-29T10:30:52.000Zweekly0.6https://www.pharmafocus.com/collections/may-2024/communique-awards-12024-04-29T11:03:40.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-20242024-04-08T13:54:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/rezdiffra-approved-by-fda-as-first-treatment-for-liver-scarring2024-04-08T13:54:07.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/gilead-and-merck-share-new-data-from-phase-2-hiv-treatment-trial2024-04-08T13:53:10.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/pharma-times-83f12024-04-08T13:53:27.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/communique-awards-20242024-04-08T13:51:54.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/contents-fea42024-04-08T13:51:32.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/comment-433f2024-04-08T13:51:04.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/pharma-role-cd262024-04-08T13:50:40.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/ema-accepts-two-applications-for-datopotamab-deruxtecan-for-onco2024-04-08T13:47:10.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/fda-grants-ind-clearance-to-spero-therapeutics-bacterial-infect2024-04-08T13:46:03.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/amneal-and-zambon-biotech-to-collaborate-for-parkinson-s-treatme2024-04-08T13:45:02.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/roche-announces-new-data-for-continuous-glucose-monitoring-syste-693d2024-04-08T13:47:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/gsk-announces-data-from-phase-3-trial-for-jemperli-combinations-5d112024-04-08T13:43:49.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/merck-announces-data-from-phase-3-trial-for-keytruda-in-cervical2024-04-08T13:43:12.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/sanofi-announces-results-from-phase-2b-for-dermatitis-treatment2024-04-08T13:42:33.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/sosei-heptares-announces-first-patient-dosed-in-trial-for-ibd-tr2024-04-08T13:41:08.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/i-nizio2024-04-08T13:40:22.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/j-j-s-opsy-nv-i-approve-d-in-us-for-pah-tre-atment2024-04-08T12:30:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/novo-nordisk-s-awiqli-recommended-by-chmp-for-diabetes-treatment2024-04-08T12:29:01.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/astra-zeneca-s-ultomiris-approved-by-fda-for-nmosd-treatment2024-04-08T13:39:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/takeda-s-hyqvia-gains-mhra-marketing-authorisation-for-chronic-i2024-04-08T12:27:51.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/medical-scientific-excellence-awards2024-04-08T12:26:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/bayer-and-aignostics-enter-partnership-for-ai-oncology-research2024-04-08T12:24:50.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/j-j-med-tech-and-nvidia-to-col-lab-or-ate-for-surgic-al-ai2024-04-08T12:25:53.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/merck-announces-plans-for-hpv-vaccines-trials2024-04-08T12:23:53.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/fusion-pharmaceuticals-to-be-acquired-by-astra-zeneca-for-approxi2024-04-08T12:22:05.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/harpoon-therapeutics-acquired-by-merck-for-650m2024-04-08T12:21:27.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/allumiqs-and-prolytix-to-collaborate-for-drug-discovery-and-deve2024-04-08T12:23:05.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/samedan-44d72024-04-08T12:24:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/innovations-in-pharmaceutical-technology-d2ab2024-04-08T12:22:28.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/ambrx-biopharma-acquired-by-j-j-for-approximately-2bn2024-04-08T12:20:35.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/yourway2024-04-09T10:31:11.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/compliant-connections-making-instant-messaging-work-for-biophar2024-04-08T14:17:40.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/gen-ai-and-pharma-the-future-is-now2024-04-15T11:51:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/international-women-s-day-remains-a-key-platform-to-keep-inspiri2024-04-08T14:02:25.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/an-overview-of-women-s-health-in-20242024-04-08T13:58:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/reducing-unintended-pregnancy-rates-how-innovation-in-contracep2024-04-08T14:07:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/flypharma-europe-12024-04-09T10:32:00.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/joseph-bertelsen-appointed-cco-of-nuclera2024-04-08T12:07:25.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/dr-james-malone-appointed-cto-at-benevolent-ai2024-04-08T12:10:07.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/vynamic-appoints-new-head-of-life-sciences-europe2024-04-08T12:03:35.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/parexel-announces-new-ceo2024-04-08T12:06:37.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/five-facts-about-women-s-health2024-04-08T13:55:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/pharmafocus-76f72024-04-08T12:01:31.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-april-2024/pharmafile-be352024-04-08T12:00:46.000Zweekly0.6https://www.pharmafocus.com/collections/march-20242024-03-06T16:03:18.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/fda-approves-astra-zeneca-s-tagrisso-for-lung-cancer-treatment2024-03-06T15:28:09.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/pharma-times-8be62024-03-06T15:27:09.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/254m-funding-raised-by-freenome-for-early-cancer-detection2024-03-06T15:26:57.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/samedan-d71e2024-03-06T15:26:23.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/contents-42ea2024-03-06T15:25:38.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/fda-grants-fast-track-designation-to-gsk-s-chronic-hepatitis-b-t2024-03-06T15:24:34.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/comment-79462024-03-06T15:25:12.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/pharma-role-f42b2024-03-06T15:24:49.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/fda-grants-breakthrough-therapy-designation-for-j-j-s-nipocalima2024-03-06T15:23:53.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/fda-accepts-argenx-s-bla-for-vyvgart-hytrulo-for-cidp-treatment2024-03-06T15:22:58.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/domainex-announces-opening-of-new-biology-centre-of-excellence-i2024-03-06T15:22:28.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/roche-announces-results-from-phase-3-study-of-allergy-treatment2024-03-06T15:21:34.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/vii-v-healthcare-announces-interim-results-from-phase-3-trial-for2024-03-06T15:20:07.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/first-patient-enrolled-in-tenax-therapeutics-phase-3-trial-for2024-03-06T15:17:35.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/boehringer-ingelheim-shares-data-from-liver-disease-phase-2-tria2024-03-06T15:20:51.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/european-commission-approves-pfizer-s-velsipity-for-ulcerative-c2024-03-06T15:12:23.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/flypharma2024-03-06T15:12:37.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/ipsen-s-onivyde-approved-by-fda-for-treatment-of-pancreatic-aden2024-03-06T15:11:48.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/abb-vie-s-tepkinly-recommended-by-nice-for-sc-treatment-of-dlbcl2024-03-06T15:08:22.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/vertex-s-casgevy-for-sickle-cell-disease-treatment-approved-by-e2024-03-06T15:07:38.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/pharmafile-0b062024-03-06T15:10:30.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/abb-vie-and-tentarix-announce-oncology-and-immunology-collaborati2024-03-06T15:05:50.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/astellas-and-kelonia-therapeutics-announce-agreement-for-immunoo2024-03-06T15:05:14.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/communique-49872024-03-06T15:06:04.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/bio-n-tech-and-autolus-collaborate-for-car-t-cell-therapies2024-03-06T15:04:11.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/4-9m-raised-for-development-of-vivet-therapeutics-gene-therapi2024-03-06T15:03:22.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/morpho-sys-to-be-acquired-by-novartis-for-2-7bn2024-03-06T15:02:41.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/eli-lilly-s-cialis-and-alimta-to-be-acquired-by-zuellig-pharma-i2024-03-06T15:02:07.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/jazz-pharmaceuticals-to-acquire-rights-to-redx-pharma-s-kras-inh2024-03-06T15:00:11.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/samedan-920f2024-03-06T15:04:24.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/next-generation-treatments-and-clinical-trials-for-non-small-cel2024-03-06T16:03:07.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/bridging-science-and-data-a-new-era-in-cancer-clinical-trials2024-03-06T15:56:57.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/community-pharmacies-need-more-support-to-deliver-pharmacy-first2024-03-06T15:38:04.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/the-landscape-of-blood-cancer-treatments-in-the-uk2024-03-06T15:48:12.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/pharma-times-e3542024-03-06T14:58:40.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/measles-the-uk-s-next-epidemic2024-03-06T15:32:47.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/streamlining-patient-support-programmes-a-five-step-approach2024-03-06T15:35:14.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/amylyx-pharmaceuticals-appoints-andrew-caldwell-as-general-manag2024-03-06T14:51:49.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/georges-rawadi-appointed-ceo-of-stroma-care2024-03-06T14:50:56.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/samedan-35192024-03-06T14:52:06.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/adhere-tech-appoints-paul-sekhri-to-board-of-directors2024-03-06T14:49:15.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/cuttsy-cuttsy-announces-appointment-of-jon-hume-as-commercial-di2024-03-06T14:50:03.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/five-facts-about-measles2024-03-06T15:29:31.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/get-in-touch-pharmafocu2024-03-06T14:46:31.000Zweekly0.6https://www.pharmafocus.com/collections/march-2024/pharmafile-f4522024-03-06T14:45:41.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-20242024-02-07T13:01:54.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/measles-outbreak-possible-advises-ukhsa2024-02-07T13:01:03.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/fda-approves-skin-cancer-ai-detection-device2024-02-07T13:00:17.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/pharma-times-cfa72024-02-07T13:00:31.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/samedan-7e3c2024-02-07T12:59:40.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/comment-17782024-02-07T12:58:32.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/contents-jan-feb-242024-02-07T12:59:07.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/bio-n-tech-s-rwanda-vaccine-manufacturing-site-achieves-milestone2024-02-07T12:57:50.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/digital-healthcare-platform-launched-by-eli-lilly2024-02-07T12:57:01.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/astra-zeneca-pays-c4x-an-11m-milestone-payment2024-02-07T12:56:18.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/pharma-role-cee62024-02-07T12:58:04.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/fda-grants-fast-track-designation-for-verastem-s-combination-nsc2024-02-07T12:55:04.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/gsk-s-jemperli-plus-zejula-combination-performs-well-in-trial-as2024-02-07T12:54:15.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/daiichi-sankyo-shares-data-from-clinical-trial-for-ezharmia-as-l2024-02-07T12:52:36.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/novo-nordisk-announces-data-from-combine-3-phase-3a-trial2024-02-07T12:53:14.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/regeneron-shares-results-from-trial-for-multiple-myeloma-treatme2024-02-07T12:50:13.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/merck-s-keytruda-with-chemoradiotherapy-approved-by-fda-as-treat2024-02-07T12:47:53.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/j-j-s-balversa-approved-by-fda-for-bladder-cancer-treatment2024-02-07T12:47:02.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/fly-pharma-europe2024-02-07T12:48:14.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/pharmafile-2c202024-02-07T12:46:01.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/astra-zeneca-and-ionis-s-wainua-approved-by-fda2024-02-07T12:45:47.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/fda-approves-calliditas-therapeutics-tarpeyo-to-reduce-loss-of2024-02-07T12:44:52.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/gilead-and-compugen-announce-new-agreement-for-immunotherapy-pro2024-02-07T12:43:45.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/genetech-and-nvidia-announce-collaboration-using-ai-for-drug-dis2024-02-07T12:42:18.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/communique-8c362024-02-07T12:44:05.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/owkin-and-merck-collaborate-on-cancer-diagnostics-powered-by-ai2024-02-07T12:41:03.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/aiolos-bio-to-be-acquired-by-gsk-for-1bn2024-02-07T12:38:18.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/alphamab-oncology-and-3d-medicines-announce-licensing-agreement-w2024-02-07T12:40:07.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/samedan-60de2024-02-07T12:41:15.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/inhibrx-to-be-acquired-by-sanofi-for-approximately-1-7bn2024-02-07T12:39:09.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/harpoon-therapeutics-set-to-be-acquired-by-merck-for-approximate2024-02-07T12:37:34.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/don-t-settle-for-black-box-why-only-explainable-ai-is-built-for2024-02-07T13:20:56.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/the-risk-of-replicating-social-bias-in-synthetic-patient-data2024-02-07T13:22:10.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/2024-a-tipping-point-for-progress-in-rare-diseases2024-02-07T13:17:04.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/the-impact-of-climate-change-on-respiratory-health2024-02-07T13:13:25.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/paediatrics-in-the-review-of-the-eu-general-pharmaceutical-legis2024-02-09T16:26:14.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/our-winter-of-discontent-nhs-strikes-and-missed-targets2024-02-07T13:09:49.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/ageing-populations-and-geographical-health-disparities-in-the-uk2024-02-07T13:11:48.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/pharmatimes-e2242024-02-07T12:33:32.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/samedanltd2024-02-07T12:20:58.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/dr-joerg-moeller-appointed-ceo-of-benevolent-ai2024-02-07T12:14:40.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/sosei-group-appoints-toshihiro-maeda-as-coo2024-02-07T12:11:40.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/x-chem-announces-new-ceo-and-cso2024-02-07T12:11:47.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/peter-crossley-appointed-coo-of-cellular-origins2024-02-07T12:09:37.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/five-facts-about-the-nhs2024-02-07T13:07:32.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/pharmafocus-24142024-02-07T12:05:26.000Zweekly0.6https://www.pharmafocus.com/collections/january-february-2024/pharmafile-99ec2024-02-07T12:04:38.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-20242024-01-05T15:02:48.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-2024/pharmafocus-a9b02024-01-05T15:02:30.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-2024/forward-features-list-20242024-01-05T15:01:51.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-2024/readership-a2a92024-01-05T15:01:27.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-2024/pharmafile-com-a15c2024-01-05T15:01:08.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-2024/working-with-us-bf6d2024-01-05T15:02:10.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-2024/digital-offerings-2bb62024-01-05T15:00:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-2024/increase-your-brand-awareness-9c1c2024-01-05T14:58:57.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-2024/digital-rates-89672024-01-05T14:58:36.000Zweekly0.6https://www.pharmafocus.com/collections/december-20232023-11-24T13:12:06.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/viro-cell-and-great-ormand-street-hospital-receive-mhra-manufactu2023-11-24T13:07:51.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/astrazenecas-truqap-plus-faslodex-approved-by-fda-for-treatment-of-breast-cancer2023-11-24T13:11:12.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/samedan-836f2023-11-24T13:06:43.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/contents-5cde2023-11-24T13:06:24.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/pharma-role-bf852023-11-24T13:05:54.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/chmp-shares-positive-opinion-for-gsk-s-momelotinib-for-myelofibr2023-11-24T13:05:17.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/novo-nordisk-invests-42bn-danish-kroner-in-manufacturing-facilit2023-11-24T13:03:35.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/autifony-and-jazz-pharmaceuticals-enter-global-licence-and-colla2023-11-24T13:02:12.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/cell-therapy-pipeline-shared-by-bit-bio2023-11-24T13:02:51.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/gsk-s-ventolin-low-carbon-inhaler-to-progress-to-phase-3-trials2023-11-24T13:01:20.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/new-data-shared-for-leqembi-as-alzheimer-s-treatment2023-11-24T12:56:12.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/astra-zeneca-s-imfinzi-meets-primary-endpoint-for-liver-cancer-tr2023-11-24T12:59:07.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/boan-biotech-enrols-first-patient-for-nivolumab-phase-3-trial-in2023-11-24T12:55:04.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/merck-s-keytruda-approved-by-fda-for-gastric-cancer-treatment2023-11-24T12:52:47.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/bms-s-augtyro-approved-by-fda-for-lung-cancer-treatment2023-11-24T12:50:38.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/pharma-times-84052023-11-24T12:54:29.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/ec-approved-daiichi-sankyo-s-vanflyta-for-acute-myeloid-leukaemi2023-11-24T12:45:59.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/pharmafile-f5112023-11-24T12:49:29.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/fda-approved-eli-lilly-s-zepbound-for-chronic-weight-management2023-11-24T12:44:43.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/evotec-and-dewpoint-therapeutics-announce-that-they-will-enter-s2023-11-24T12:35:38.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/j-j-plans-to-submit-surgical-robot-to-regulators-in-20242023-11-24T12:43:20.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/astra-zeneca-and-cellectis-announce-collaboration-for-cell-therap2023-11-24T12:38:54.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/propella-therapeutics-to-be-acquired-by-astellas-pharma-for-1752023-11-24T12:30:49.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/halozyme-and-acumen-pharmaceuticals-collaborate-for-alzheimer-s2023-11-24T12:33:10.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/roche-to-acquire-telavant-for-7-1bn2023-11-24T12:31:41.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/fresenius-kabi-s-manufacturing-site-to-be-acquired-by-prange-gro2023-11-24T12:30:05.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/innovations-in-pharmaceutical-technology-e4852023-11-24T12:32:00.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/embracing-technological-advancements-revolutionising-clinical-t2023-11-24T12:27:16.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/anti-counterfeiting-the-battle-against-fake-pharmaceuticals2023-11-24T12:26:12.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/samedan-ed5c2023-11-24T12:29:08.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/international-fertility-experts-appointed-to-oxolife-s-scientifi2023-11-24T12:12:28.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/notable-tech-enabled-solutions-advancing-clinical-trials-with-al2023-11-24T12:16:48.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/io-biotech-appoints-helen-collins-to-board-of-directors2023-11-24T11:53:05.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/nano-syrinx-appoints-anthony-johnson-as-non-executive-director2023-11-24T12:10:09.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/hazel-jones-appointed-as-enhanc3d-genomics-chief-operating-offi2023-11-24T12:08:56.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/the-biggest-news-of-20232023-11-27T11:18:31.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/five-facts-about-antimicrobial-resistance2023-11-24T11:50:47.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/pharmafocus-90682023-11-24T11:50:12.000Zweekly0.6https://www.pharmafocus.com/collections/december-2023/pharmafile-de9a2023-11-24T11:49:32.000Zweekly0.6https://www.pharmafocus.com/collections/november-232023-11-02T15:21:16.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/janssen-and-sanofi-partner-for-e-coli-vaccine-programme2023-11-02T15:20:36.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/sun-pharma-s-nda-for-deuruxolitinib-accepted-by-fda2023-11-02T15:19:11.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/samedan-f11a2023-11-02T15:17:06.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/pmea-181e2023-11-02T15:19:24.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/contents-nov-232023-11-02T15:16:51.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/comment-nov-232023-11-02T15:16:18.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/fda-accepts-regeneron-and-sanofi-s-s-bla-for-dupixent-for-priorit2023-11-02T15:09:18.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/pharmafocus-79e42023-11-02T15:11:26.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/175m-raised-by-avalyn-pharma-in-series-c-financing-for-inhalati2023-11-02T15:05:57.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/45m-series-b-funding-raised-by-acesion-pharma2023-11-02T15:04:07.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/karuna-therapeutics-nda-submitted-to-fda-for-schizophrenia-trea2023-11-02T15:06:44.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/genentech-announces-results-from-two-phase-3-trials-of-retinal-v2023-11-02T15:02:35.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/sanofi-announces-long-term-efficacy-data-for-nexviazyme-for-pomp2023-11-02T14:53:02.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/international-clinical-researcher2023-11-02T13:39:32.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/astra-zeneca-and-daiichi-sankyo-share-results-from-phase-3-trial2023-11-02T13:37:08.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/moderna-announces-clinical-trial-results-for-combination-flu-and2023-11-02T13:39:14.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/biogen-s-tofidence-biosimilar-gains-fda-approval2023-11-02T13:30:56.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/eli-lilly-and-boehringer-ingelheim-s-jardiance-approved-by-fda-f2023-11-02T13:28:10.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/pfizer-s-rsv-vaccine-provisionally-recommended-by-cdc-advisory-c2023-11-02T13:29:22.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/new-vaccine-for-pre-vention-of-malaria-in-paediatric-patients-re2023-11-02T13:30:14.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/gsk-and-zhifei-announce-partnership-for-promotion-of-shingles-va2023-11-02T12:45:24.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/sanofi-and-teva-announce-partnership-for-development-of-inflamma2023-11-02T12:42:16.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/dna-test-for-predisposition-to-certain-cancers-granted-marketing2023-11-02T12:34:47.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/mirati-therapeutics-to-be-acquire-d-by-bms-for-4-8bn2023-11-02T12:30:59.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/bacti-vac-shared-development-of-bacterial-vaccines-to-prevent-inf2023-11-02T12:32:49.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/point-biopharma-to-be-acquired-by-eli-lilly-for-1-4bn2023-11-02T12:29:11.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/innovations-in-pharmaceutical-technology-ea062023-11-02T12:35:35.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/alfasigma-acquires-intercept-pharmaceuticals-for-approximately2023-11-02T12:25:45.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/from-the-margins-a-book-review2023-11-02T15:47:42.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/the-role-of-digital-therapeutics-in-central-nervous-system-clini2023-11-02T15:47:01.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/samedan-41e92023-11-02T12:16:45.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/konstantinos-vlassis-appointed-as-closed-loop-medicine-s-chief-t2023-11-02T12:14:04.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/fujifilm-diosynth-biotechnologies-appoints-maja-pedersen-as-chie2023-11-02T12:13:15.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/invizius-appoints-bernard-canaud-to-clinical-advisory-board2023-11-02T12:12:20.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/pharma-role-77472023-11-02T12:14:24.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/pheon-appoints-arvin-yang-as-chief-medical-officer2023-11-02T12:11:38.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/pharmafocus-9b172023-11-02T12:07:11.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/five-facts-about-health-inequalities2023-11-02T15:33:08.000Zweekly0.6https://www.pharmafocus.com/collections/november-23/pharmafile-acb02023-11-02T12:05:27.000Zweekly0.6https://www.pharmafocus.com/collections/october-20232023-10-09T14:17:49.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/janssen-s-talvey-approved-by-fda-for-the-treatment-of-multiple-m2023-10-06T12:09:20.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/regeneron-announces-two-year-results-from-pulsar-trial-for-wet-a2023-10-06T12:07:43.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/pmea-59b32023-10-06T12:07:57.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/pharmatimes-d1bb2023-10-06T12:07:08.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/comment-3d0b2023-10-06T12:06:24.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/pfizer-s-maternal-vaccine-approved-by-fda-for-prevention-of-rsv2023-10-06T12:05:39.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/novo-nordisk-s-wegovy-semaglutide-injection-made-available-in2023-10-06T12:03:47.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/astellas-plans-opening-of-new-facilities-in-cambridge-massachus2023-10-06T12:02:13.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/contents-72fc2023-10-06T12:06:56.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/pharmafocus-1f6c2023-10-06T12:06:02.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/promising-results-announced-from-gsk-s-shingles-trial-in-china2023-10-06T11:58:32.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/fda-grants-odd-to-faron-pharmaceuticals-bexmarilimab-for-aml-tr2023-10-06T11:57:53.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/ema-accepts-iveric-bio-s-maa-for-avacincaptad-pegol-for-treatmen2023-10-06T11:56:23.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/roche-s-genentech-announces-results-from-phase-3-alk-positive-ea2023-10-06T11:53:34.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/eli-lilly-s-retevmo-produces-positive-results-in-libretto-531-tr2023-10-06T11:49:27.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/astra-zeneca-and-daiichi-sankyo-announce-results-from-destiny-lun2023-10-06T11:47:47.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/merck-s-phase-3-litespark-005-trial-of-welireg-met-primary-endpo2023-10-06T11:46:19.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/valneva-and-pfizer-s-lyme-disease-vaccine-candidate-performs-wel2023-10-06T11:44:49.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/cyma-bay-announces-results-from-response-trial-of-seladelpar-for2023-10-06T11:44:05.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/roche-s-evrysdi-approved-by-ec-for-babies-under-two-months-with2023-10-06T11:39:25.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/bms-s-reblozyl-gains-fda-approval-for-anaemia-treatment-in-adult2023-10-06T11:38:27.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/mhra-grants-marketing-authorisation-to-abb-vie-s-aquipta-for-migr2023-10-06T11:40:09.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/novartis-sandoz-gains-fda-approval-for-tyruko-biosimilar-to-tre2023-10-06T11:32:08.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/pharma-role-a0e62023-10-06T11:42:29.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/mhra-clears-amicus-therapeutics-pompe-disease-treatment-for-use2023-10-06T11:21:56.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/fda-approves-new-vyvanse-generics-for-adhd-and-bed-treatment-ami2023-10-06T11:28:28.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/pharmacy-app-charac-receives-1-2m-funding-from-npa-and-pharmacy2023-10-06T11:19:49.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/sandoz-shares-exclusive-deal-to-commercialise-biosimilar-ustekin2023-10-06T11:16:04.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/nice-publishes-draft-guidance-surrounding-the-use-of-ai-use-in-r2023-10-06T11:08:30.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/abbott-shares-plans-to-acquire-bigfoot-biomedical2023-10-06T11:04:04.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/tempus-companion-diagnostic-test-gains-breakthrough-device-desi2023-10-06T11:13:15.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/novo-nordisk-acquires-embark-biotech2023-10-06T11:04:51.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/how-ai-can-advance-today-s-complex-biopharma-launch-landscape2023-10-06T10:56:25.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/takeda-and-immuno-gen-announce-collaboration-for-development-and2023-10-06T10:58:53.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/unlocking-science-to-discover-novel-solutions-for-breast-cancer2023-10-06T10:55:44.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/flypharma-europe-e7262023-10-06T10:57:43.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/using-genomics-to-uncover-the-causes-of-rare-diseases-and-improv2023-10-06T10:54:59.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/focusing-on-world-mental-health-day2023-10-06T10:45:12.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/pharmaceutical-technology2023-10-06T10:44:39.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/hansa-biopharma-appoints-dr-hitto-kaufmann-as-chief-scientific-o2023-10-06T10:41:33.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/chris-tovey-appointed-as-destiny-pharma-s-new-ceo2023-10-06T10:43:20.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/move-of-the-month-a6532023-10-06T10:44:11.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/dr-tomasz-kostrzewski-introduced-as-cn-bio-s-new-chief-scientifi2023-10-06T10:40:46.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/five-facts-about-mental-health2023-10-06T10:38:18.000Zweekly0.6https://www.pharmafocus.com/collections/october-2023/pharmafile-1e172023-10-06T10:35:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-20232023-09-20T12:43:01.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/gsk-s-rsv-vaccine-approved-by-mhra2023-08-25T14:40:48.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/pmea-49cb2023-08-25T14:39:50.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/pharma-times-communications-awards2023-08-25T14:36:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/ukhsa-opens-new-vaccine-research-centre-in-wiltshire-to-prepare2023-08-25T14:39:33.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/comment-55022023-08-25T14:34:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/contents-39732023-08-25T14:35:41.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/pharmafocus-e8872023-08-25T14:33:49.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/merck-s-ebola-vaccine-ervebo-approved-by-fda-for-children2023-08-25T14:43:34.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/treatment-programme-for-cvd-to-be-developed-as-part-of-partnership-between-novartis-and-ionis2023-08-25T14:32:42.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/contaminated-cough-syrup-leads-to-who-medical-product-alert2023-08-25T14:31:22.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/rnai-treatment-for-hypertension-developed-by-alnylam-and-roche2023-08-25T14:29:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/new-open-innovation-hub-opened-by-astellas-for-tumour-microenvironment-research2023-08-25T14:27:21.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/gsk-s-novel-gonorrhoea-vaccine-gains-fast-track-designation-from2023-08-25T14:28:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/data-from-eli-lilly-s-two-phase-3-tirzepatide-studies-shared2023-08-25T14:26:06.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/study-shows-wegovy-by-novo-nordisk-reduces-cardiovascular-risk2023-08-25T14:24:27.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/first-official-long-covid-19-treatment-could-emerge-from-the-nih2023-08-25T14:25:30.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/phase-3-trial-results-for-datopotamab-deruxtecan-for-nsclc-treatment-announced-by-astrazeneca2023-08-25T14:22:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/phase-2-trial-data-from-gbs-maternal-vaccine-candidate-shared-by-pfizer2023-08-25T14:23:30.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/breast-cancer-treatment-phase-3-trial-results-shared-by-merck2023-08-25T14:20:50.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/jemperli-by-gsk-approved-to-treat-endometrial-cancer2023-08-25T14:17:06.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/alzheimer-s-disease-drug-leqembi-given-full-approval-by-fda2023-08-25T14:12:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/first-over-the-counter-contraceptive-pill-approved-by-fda2023-08-25T14:10:58.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/pharma-role-63e52023-08-25T14:18:40.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/fda-approves-first-cellular-therapy-for-treatment-of-patients-wiith-type-1-diabetes2023-08-25T14:06:27.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/chmp-grants-positive-opinion-to-vii-v-healthcare-s-cabotegravir-for-hiv-prevention2023-08-25T13:51:28.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/bristol-myers-squibb-s-sotyktu-recommended-to-treat-adult-patients-with-psoriasis-on-the-nhs2023-08-25T14:09:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/data-shared-by-sanofi-about-new-drug-for-treatment-of-haemophilia-a-in-children2023-08-25T13:41:42.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/new-crohns-disease-treatment-could-come-from-neonatal-stem-cell-research-shows2023-08-25T13:35:32.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/ai-enabled-drug-discovery-developments-trigger-partnership-between-recursion-and-nvidia2023-08-25T12:20:27.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/american-heart-association-grants-2-1m-for-research-into-possible-link-between-cvd-migraines-and-stroke2023-08-25T13:37:01.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/beclu-carbon-neutral-asthma-inhaler-launched-by-lupin-healthcare2023-08-25T12:25:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/3d-printed-pills-to-enable-time-controlled-release-in-development2023-08-25T12:13:07.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/biogen-plans-to-acquire-reata-pharmaceuticals-for-7-3bn2023-08-25T12:10:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/rare-disease-treatments-to-be-researched-in-partnership-between-pfizer-and-astrazenecas-alexion2023-08-25T12:11:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/eli-lilly-shares-plans-to-acquire-versanis-bio-for-1-9bn2023-08-25T12:05:26.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/indication-based-agreements-a-key-enabler-of-uk-access-to-combination-therapies-in-oncology2023-08-25T14:59:11.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/how-statistical-and-data-analysis-can-support-research-innovations-in-rare-diseases2023-08-25T14:54:48.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/flypharma-europe-a8322023-08-25T12:03:02.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/seven-ways-to-boost-hcp-engagement-through-field-behavioural-change2023-08-30T10:34:50.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/why-are-so-many-community-pharmacies-closing-and-what-does-this-mean-for-local-communities2023-08-25T14:48:08.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/innovations-in-pharmaceutical-technology2023-08-25T11:46:26.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/pharma-times-19c02023-08-25T11:54:06.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/alfonso-quintas-cardama-to-join-foghorn-therapeutics-as-new-chief-medical-officer2023-08-25T11:38:42.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/helmholtz-centre-for-infection-research-appoints-josef-penninger-to-new-scientific-director2023-08-25T11:43:02.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/olav-hellebo-to-join-cytovation-s-board-of-directors2023-08-25T11:44:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/five-facts-about-rare-diseases2023-08-25T11:25:04.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/reacta-appoints-kevin-hawkins-as-new-head-of-regulatory-affairs2023-08-25T11:45:58.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/tweet-us-pharmafocus-13f22023-08-25T11:24:10.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2023/pharmafile-9ad52023-08-25T11:23:48.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-20232023-09-20T12:45:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/fda-approves-first-oral-antiviral-to-treat-adult-patients-with-covid-192023-08-25T09:39:46.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/pharma-time2023-07-04T14:56:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/pharmarole2023-07-04T14:59:16.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/nice-recommends-nine-digital-treatment-options-for-depression-and-anxiety2023-08-25T09:28:33.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/contents-july2023-07-04T14:54:26.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/european-parliament-shares-goal-to-tackle-antimicrobial-resistan2023-07-04T14:51:00.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/report-finds-nhs-may-miss-out-on-new-drugs-due-to-rising-costs2023-07-04T14:52:22.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/fda-relaxes-blood-donation-regulations-for-msm2023-07-04T14:49:03.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/pharmafocus-58882023-07-04T14:52:35.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/comment-july2023-07-04T14:54:42.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/grail-and-university-of-oxford-showcase-first-prospective-study2023-07-04T14:47:43.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/merck-invests-35m-in-biosafety-testing-in-scotland2023-07-04T14:46:08.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/more-infections-from-contaminated-eyedrops-in-us-increase-death2023-07-04T14:44:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/astra-zeneca-announces-positive-results-from-phase-3-trial-for-ta2023-07-04T14:42:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/us-based-bellerophon-shares-top-line-data-from-phase-3-trial-of2023-07-04T14:39:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/isa-pharmaceuticals-highlights-positive-clinical-data-at-asco2023-07-04T14:38:38.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/snipr-biome-reports-positive-findings-for-first-in-human-crispr2023-07-04T14:37:28.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/sanofi-announces-positive-phase-2-data-for-ms-drug-frexalimab2023-07-04T14:40:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/gsk-receives-fda-file-acceptance-for-jemperli-plus-chemotherapy2023-07-04T14:34:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/fda-approves-pfizer-s-rsv-vaccine-for-older-adults2023-07-04T14:24:01.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/radio-medix-and-orano-med-complete-patient-enrolment-for-neuroend2023-07-04T14:36:01.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/bristol-myers-squibb-s-nda-accepted-by-fda2023-07-04T14:22:51.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/fda-approves-new-insulin-pump-and-algorithm-software-for-enhance2023-07-04T14:20:37.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/fda-committee-votes-in-favour-of-pfizer-s-rsv-vaccine-for-matern2023-07-04T14:18:07.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/fda-approves-prescription-nasal-spray-for-opioid-overdose-treatm2023-07-04T14:21:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/fda-approves-abbott-s-assert-iq-insertable-cardiac-monitor2023-07-04T14:19:30.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/l-a-nova-medicines-and-astra-zeneca-sign-global-exclusive-licence2023-07-04T14:16:44.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/scientists-at-mit-and-mc-master-university-use-ai-to-find-new-ant2023-07-04T14:15:42.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/servier-and-aitia-enter-into-r-d-collaboration-for-pancreatic-ca2023-07-04T14:12:16.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/asieris-pharmaceuticals-and-uro-viu-announce-strategic-collaborat2023-07-04T14:11:32.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/us-based-nemours-children-s-health-selected-to-conduct-first-gen2023-07-04T14:07:50.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/lonza-to-acquire-sy-naffix-to-strengthen-adc-de-velopment2023-07-04T14:01:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/astellas-and-sony-enter-collaborative-research-agreement2023-07-04T14:00:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/flypharma-conference-europe2023-07-04T13:56:49.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/pharmanovia-and-stealth-bio-therapeutics-enter-new-licensing-agre2023-07-04T14:00:00.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/pmea2023-07-04T13:55:06.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/alzheimer-s-disease-and-age-related-macular-degeneration-how-a2023-07-04T15:47:56.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/what-are-biomolecular-condensates-and-will-they-be-a-breakthrou2023-07-04T15:10:26.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/the-impact-of-the-cost-of-living-crisis-on-health2023-07-04T15:03:58.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/move-of-the-month2023-07-04T13:48:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/immodulon-appoints-josefine-roemmler-zehrer-as-chief-medical-off2023-07-04T13:39:52.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/ken-mariash-appointed-as-sinaptica-s-chief-executive-officer2023-07-04T13:46:42.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/pharma-times-2da82023-07-04T13:48:54.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/engimmune-therapeutics-appoints-annalisa-d-andrea-to-board-of-di2023-07-04T13:36:53.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/five-facts-about-income-and-health2023-07-04T12:20:05.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2023/pharmafile-b2ea2023-07-04T12:08:57.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-20232023-09-20T12:45:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/companies-showcase-innovative-biotech-at-american-association-fo2023-05-31T07:26:40.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/fda-approves-world-s-first-rsv-vaccine2023-05-26T14:32:05.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/25-communique-awards-2023-a84d2023-05-26T14:31:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/pharma-role-4ace2023-05-26T14:32:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/june-2023-contents2023-05-31T07:25:21.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/eli-lilly-s-tirzepatide-achieves-15-7-weight-loss-in-adult-pati2023-06-05T14:23:53.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/june-2023-comment2023-05-26T14:29:49.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/pharmafocus-3f9f2023-05-26T14:29:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/fda-issues-update-around-changes-to-covid-19-vaccines-eu-as2023-06-05T14:23:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/johnson-johnson-warns-of-dangers-of-benadryl-tik-tok-challenge2023-05-26T14:26:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/liberal-states-begin-stockpiling-abortion-medications-following2023-06-05T14:22:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/trade-union-unite-calls-for-gsk-staff-walkouts-over-pay-increase2023-06-05T14:20:52.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/pharmacists-in-england-given-wider-prescribing-powers-to-relieve2023-05-26T14:23:53.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/astra-zeneca-and-ionis-share-positive-results-from-phase-3-trial2023-06-05T14:12:46.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/abb-vie-shares-results-from-phase-3-trial-for-atogepant-migraine2023-06-05T14:14:57.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/eli-lilly-shares-positive-results-from-phase-3-study-of-donanema2023-06-02T16:22:49.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/gsk-announces-positive-data-from-phase-3-trial-for-new-uti-antib2023-06-02T16:21:30.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/vicore-announces-initiation-of-proof-of-concept-study-for-endoth2023-06-02T16:15:48.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/merck-s-relapsing-multiple-sclerosis-trial-put-on-fda-partial-cl2023-05-26T14:16:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/astra-zeneca-s-farxiga-approved-to-reduce-risk-of-cardiovascular2023-06-02T16:14:46.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/fda-approves-first-orally-administered-faecal-microbiota-product2023-06-02T16:03:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/fda-approves-pfizer-s-pneumococcal-conjugate-vaccine-for-infants2023-06-02T16:00:43.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/nice-recommends-otsuka-s-lupkynis-voclosporin-in-combination-t2023-06-02T15:58:06.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/neuspera-medical-receives-fda-approval-for-peripheral-nerve-pain2023-05-26T14:06:11.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/nice-recommends-two-car-t-treatments-for-blood-cancers-to-the-ca2023-06-02T15:57:07.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/3b-pharmaceuticals-and-novartis-enter-into-licensing-agreement-f2023-06-02T15:52:44.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/boehringer-ingelheim-and-ginkgo-bioworks-collaborate-over-406m2023-05-26T13:49:44.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/diabeloop-announces-collaboration-with-novo-nordisk-for-connecte2023-06-02T15:51:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/national-institutes-of-health-awards-grant-for-gamma-core-clinica2023-05-26T13:46:49.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/retin-ai-and-boehringer-ingelheim-partner-over-ai-treatments-for2023-06-02T15:49:51.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/thermo-fisher-and-pfizer-collaborate-on-ngs-based-cancer-tests2023-06-02T15:46:27.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/gilead-acquires-xin-thera-to-strengthen-pipeline-in-oncology-and2023-06-02T15:44:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/gsk-enters-into-1-6bn-deal-to-acquire-bellus-health2023-05-26T12:43:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/sobi-acquires-cti-bio-pharma-corporation-for-1-7bn2023-06-02T15:43:44.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/flypharma-europe-vienna-20232023-05-26T12:35:57.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/the-climate-crisis-what-is-it-and-is-pharma-to-blame2023-05-30T12:01:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/why-modelling-patient-heterogeneity-is-crucial-in-drug-developme2023-05-26T14:56:25.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/how-regulators-are-keeping-pace-with-technology2023-05-30T12:25:57.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/could-climate-change-along-with-pandemics-equal-a-recipe-for-dis2023-05-26T15:58:59.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/pharma-times2023-05-26T11:47:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/ishwaria-subbiah-appointed-as-scri-s-executive-director-for-canc2023-05-26T11:42:43.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/leon-appoints-dr-setu-kasera-as-cso2023-05-26T11:38:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/patrick-johnson-appointed-to-aviceda-therapeutics-board-of-dire2023-05-26T11:37:26.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/five-facts-about-climate-change-and-health2023-05-26T11:33:38.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/alex-c-sapir-appointed-as-fulcrum-therapeutics-ceo2023-05-26T11:36:26.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/tweet-us-pharmafocus-969a2023-05-26T11:30:59.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-june-2023/pharmafile-91492023-05-26T11:30:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-20232023-09-20T12:46:14.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/alzheimer-s-drug-leqembi-expected-to-generate-12-9bn-in-sales-b2023-05-05T14:34:47.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/european-commission-delays-release-of-major-changes-to-pharma-le2023-05-05T14:34:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/magazine-pharmafile2023-05-05T14:32:26.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/bristol-myers-squibb-works-with-space-x-to-study-biomanufacturing2023-05-05T14:31:57.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/pmlive-a9572023-05-05T14:30:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/astra-zeneca-s-nmosd-treatment-recommended-marketing2023-05-05T14:26:11.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/sanofi-to-cut-insulin-prices-by-78-starting-january-20242023-05-05T14:17:26.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/molecular-templates-announces-hold-for-phase-1-study2023-05-05T14:11:27.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/novo-nordisk-to-cut-insulin-prices-by-up-to-75-in-20242023-05-05T14:12:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/seamless-therapeutics-launches-with-12-5m-in-financing2023-05-05T14:10:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/pharmatimes-efec2023-05-05T14:05:04.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/astra-zeneca-reports-positive-results-of-drug-combination-in-late2023-05-05T14:04:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/ca-nbridge-pharmaceuticals-reports-positive-long-term-data-for-gl2023-05-05T14:03:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/gsk-shares-promising-clinical-trial-results-for-endometrial-canc2023-05-05T14:03:03.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/inno-care-announced-first-subject-dosed2023-05-05T14:01:58.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/nanoscope-therapeutics-announces-positive-results-from-phase-2b2023-05-05T13:59:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/promising-ovarian-cancer-drug-enters-phase-3-trial2023-05-05T13:58:34.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/abbott-gains-fda-approval-for-epic-max-tissue-valve-for-the-trea2023-05-05T13:57:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/astra-zeneca-s-lynparza-approved-by-nhs-england2023-05-05T13:56:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/fda-approves-novartis-tafinlar-and-mekinist-combination2023-05-05T13:55:28.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/merck-receives-fda-approval-for-keytruda-in-combination-with-pad2023-05-05T13:54:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/first-over-the-counter-opioid-overdose-treatment-approved-by-fda2023-05-05T13:54:51.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/neuro-rpm-announces-fda-clearance-for-ai-monitoring-app-for-parki2023-05-05T13:52:25.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/kite-s-yescarta-car-t-cell-therapy-shows-statistically-significa2023-05-05T13:49:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/abb-vie-shares-results-from-study-for-new-psoriasis-therapy2023-05-05T13:50:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/roche-and-eli-lilly-collaborate-on-alzheimer-s-disease-blood-tes2023-05-05T13:45:31.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/oxford-nanopore-and-4bases-collaborate-on-kit-for-brca1-and-brca2023-05-05T13:48:05.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/janssen-reports-new-rybrevant-data-for-patients-with-advanced-no2023-05-05T13:44:42.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/a-vaxzi-pen-announces-positive-data-for-multiple-diseases-with-nov2023-05-05T13:37:22.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/bio-n-tech-and-onco-c4-to-partner-for-development-and-commercialisa2023-05-05T12:28:05.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/pfizer-signs-43bn-deal-to-buy-seagen2023-05-05T12:22:53.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/thea-open-innovation-and-galimedix-announce-partnership-for-deve2023-05-05T12:20:02.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/flypharma-europe2023-05-05T12:17:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/connected-drug-delivery-devices-considerations-for-developing-d2023-05-10T14:10:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/the-cough-syrup-investigation-a-timeline2023-05-09T11:46:59.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/pharma-role2023-05-05T12:11:27.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/optibrium-appoints-dr-hamed-tabatabaei-ghomi-as-head-of-research2023-05-05T12:10:47.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/roz-bekker-appointed-managing-director-of-janssen-uk-and-ireland2023-05-05T12:09:58.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/steve-jones-appointed-as-ingenza-s-chief-financial-officer2023-05-05T12:07:38.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/syncona-appoints-roel-bulthuis-as-managing-partner2023-05-05T11:56:27.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/five-health-facts-about-the-gambia-uzbekistan-and-indonesia2023-07-04T11:41:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/samedan-984b2023-05-05T11:49:31.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/fe2ea85f-eb29-11ed-9e1c-42010a80000d2023-05-05T14:29:00.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-may-2023/7e21ecbe-eb2a-11ed-9e1c-42010a80000d2023-05-05T14:27:29.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial2023-09-20T12:46:53.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/astra-zeneca-shares-positive-results-from-imfinzi-trial2023-04-06T13:54:18.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/new-clinical-trial-aims-to-find-new-endometriosis-treatment2023-04-06T13:51:46.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/mhra-s-authority-restored-following-northern-ireland-brexit-deal2023-04-06T13:45:11.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/biotech-centre-focusing-on-gene-therapies-opens-in-bristol-uk2023-04-06T13:49:19.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/astra-zeneca-signs-63m-agreement-for-gastric-cancer-treatment2023-04-06T13:50:13.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/moda-living-and-lloyds-pharmacy-partner-to-offer-residents-a-pres2023-04-06T12:43:11.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/nice-approved-bms-s-opdivo-for-lung-cancer2023-04-06T12:42:22.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/abb-vie-gains-positive-chmp-opinion-for-upadacitinib-for-the-trea2023-04-06T12:37:36.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/csl-receives-cma-from-the-european-c-ommission-for-haemophilia-b2023-04-06T12:36:04.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/merck-to-appeal-eu-rejection-of-covid-19-drug2023-04-06T12:35:22.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/eli-lilly-caps-consumer-insulin-costs-at-352023-04-06T12:34:25.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/fda-sued-by-us-states-over-abortion-pill-access2023-04-06T12:32:57.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/fda-grants-de-novo-approval-to-neuromod-s-tinnitus-device2023-04-06T12:33:40.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/horizon-therapeutics-announces-real-world-treatment-results-for2023-04-06T12:31:33.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/sun-pharma-recalls-at-least-34-000-bottles-of-generic-drug2023-04-06T12:29:46.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/mologic-s-covid-19-rapid-antigen-self-test-receives-fda-emergenc2023-04-06T12:30:50.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/abbott-announces-positive-clinical-study-data-for-both-tri-clip-s2023-04-06T12:28:18.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/wearable-sensor-helps-detect-heart-attacks2023-04-06T12:24:58.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/nasal-spray-that-relie-ves-migraines-in-minutes-approve-d-by-fda2023-04-06T12:21:47.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/funding-to-increase-access-to-early-phase-clinical-trials-given2023-04-06T12:16:21.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/gilead-sciences-wins-175m-in-ongoing-hiv-fraud-case2023-04-06T12:13:43.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/moderna-to-pay-400m-to-us-government-over-new-covid-19-vaccine2023-04-06T12:13:08.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/medtronic-s-extravascular-defibrillator-receives-ce-mark2023-04-06T12:12:26.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/moderna-chooses-oxfordshire-for-new-uk-facility2023-04-06T12:10:45.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/regenxbio-presents-interim-phase-2-data-from-drug-developed-on-n2023-04-06T12:04:55.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/bristol-myers-squibb-and-viz-ai-sign-multi-year-partnership-for2023-04-06T12:03:56.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/sooma-receives-fda-breakthrough-device-designation-for-depressio2023-04-06T12:02:08.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/elon-musk-s-neuralink-rejected-by-fda-for-human-trials2023-04-06T12:02:53.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/compounded-medication-what-do-we-need-to-know2023-04-06T11:53:03.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/menopause-legislation-charities-and-support2023-04-06T11:51:18.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/menopause-and-sleep-disruption2023-04-06T11:46:16.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/benevolent-ai-appoints-marcello-damiani-to-its-board-of-directors2023-04-06T11:44:00.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/deepak-singh-appointed-as-cn-bio-s-vice-president-of-sales-and-m2023-04-06T11:43:16.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/karen-harrison-appointed-chief-operating-officer-for-avacta-s-th2023-04-06T11:42:19.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/richard-stedman-appointed-to-ceo-of-acg-s-engineering-division2023-04-06T11:40:23.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/five-facts-about-about-reproductive-health2023-04-06T13:59:00.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/c179670e-d461-11ed-9e1c-42010a80000d2023-04-06T13:51:09.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/edb1ebb7-d462-11ed-9e1c-42010a80000d2023-04-06T12:41:22.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/a6b1f885-d465-11ed-9e1c-42010a80000d2023-04-06T12:00:40.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/07da23b1-d469-11ed-9e1c-42010a80000d2023-04-06T11:45:32.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/12bb0e63-d46b-11ed-9e1c-42010a80000d2023-04-06T11:36:31.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/58719d6e-d46b-11ed-9e1c-42010a80000d2023-05-05T14:47:54.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/0085bebf-d46d-11ed-9e1c-42010a80000d2023-04-06T13:52:39.000Zweekly0.6https://www.pharmafocus.com/collections/astra-zeneca-shares-positive-results-from-imfinzi-trial/6377f02e-d46d-11ed-9e1c-42010a80000d2023-04-06T13:53:05.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march232023-09-20T12:47:21.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/pharmafile-216781830762023-03-07T13:26:49.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/nice-recommends-more-digital-mental-health-therapies-for-nhs-use2023-03-08T16:42:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/intron-confirms-efficacy-of-inhalation-anthraxfighting-drug2023-03-08T16:43:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/25-communique-awards-20232023-03-07T13:25:46.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/contents2023-03-07T15:25:31.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/samedan-ltd2023-03-07T13:24:42.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/comment-716781830762023-03-08T17:22:08.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/eli-lilly-and-abbvie-leave-uk-vpas-blow-to-uk-pharma-industry2023-03-08T16:05:46.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/mercks-london-research-hub-to-begin-construction-in-april-20232023-03-07T13:22:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/cambridges-experimental-cancer-medicine-centre-to-receive-funding2023-03-08T16:04:40.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/nhs-to-offer-artificial-pancreas-to-type-1-diabetes-patients2023-03-08T16:11:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/scottish-biotech-aims-to-cure-common-cold2023-03-07T13:21:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/ucl-to-begin-new-trial-to-assess-cough-medicines-impact-on-parkinsons-disease2023-03-08T16:12:40.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/europe-plans-further-antibiotic-shortage-countermeasures2023-03-08T16:15:07.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/astrazeneca-moves-manufacturing-to-ireland-due-to-britains-tax-regime2023-03-08T16:44:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/genoscience-pharma-received-orphan-drug-designation-for-hepatocellular-carcinoma-drug2023-03-08T16:16:35.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/first-indian-intranasal-covid19-vaccine-recently-launched2023-03-08T16:20:44.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/australias-tga-approves-psychedelics-to-treat-mental-health-conditions2023-03-08T16:19:25.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/drugresistant-bacterium-found-in-eye-drops-has-infected-55-people-in-12-states2023-03-08T16:18:26.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/johnson-johnson-subsidiary-loses-us-bankruptcy-bid2023-03-08T16:45:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/who-issues-a-call-to-action-after-cough-syrup-deaths2023-03-08T16:28:38.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/stand-up-to-cancer-announces-four-teams-dedicated-to-increasing-diversity-in-clinical-trials2023-03-08T16:27:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/synaptixbio-secures-fda-rare-paediatric-disease-designation-to-develop-treatments-for-tubb4a-leukodystrophy2023-03-08T16:49:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/theracosbios-oral-drug-approved-by-fda-for-adults-with-type-2-diabetes2023-03-08T16:45:57.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/johnson-johnsons-ethicon-undertakes-first-robotassisted-kidney-stone-removal2023-03-08T16:29:16.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/boston-scientific-fined-42m-over-patent-infringement2023-03-07T13:02:41.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/garuda-therapeutics-closes-series-b-funding-with-62m2023-03-08T16:36:54.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/abbvie-expects-37-decline-in-humira-sales-following-new-biosimilars-hitting-the-us-market2023-03-08T16:46:31.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/johnson-johnson-scale-back-covid19-vaccination-production2023-03-08T16:40:06.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/eli-lilly-plans-to-invest-450m-at-production-site-in-research-triangle-park2023-03-07T13:00:58.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/daiichi-sankyo-to-build-japans-first-factory-for-mrna-covid19-vaccines2023-03-08T16:46:59.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/ai-finds-liver-cancer-drug-candidate-in-only-30-days2023-03-08T16:47:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/drugban-ai-expected-to-reduce-costs-and-speed-up-drug-discovery2023-03-08T16:42:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/bd-showcases-newgeneration-robotic-track-system-for-microbiology-labs2023-03-08T16:41:26.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/pharmatimes2023-03-07T12:57:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/improving-cardiovascular-disease-care-and-awareness2023-03-08T17:25:04.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/the-patient-voice-in-autoimmune-conditions2023-03-07T12:56:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/chiesi-farmaceutici-hires-new-ceo2023-03-08T16:47:57.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/samedan2023-03-07T12:55:07.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/removing-uncertainty-in-the-supply-chain2023-03-07T12:55:46.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/ingenza-appoints-dr-mark-chadwick-as-strategic-business-advisor2023-03-07T12:53:48.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/medivir-ab-appoints-pia-baumann-as-chief-medical-officer2023-03-07T12:53:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/vishal-kapoor-appointed-to-jasper-therapeutics-board-of-directors2023-03-07T12:52:33.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/five-facts-about-cardiovascular-disease-cvd2023-03-07T12:51:22.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-march23/pharma-times-4616781830782023-03-08T16:48:42.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-20232023-09-20T12:48:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/european-commission-approves-dupixent-as-the-first-and-only-targeted-medicine-for-prurigo-nodularis2023-03-02T05:47:53.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/gambian-panel-recommends-maiden-pharmaceuticals-be-held-culpable-for-cough-syrup2023-03-02T05:47:54.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/new-study-shares-effectiveness-of-asthma-drug-compared-to-standard-of-care2023-03-02T05:47:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/moderna-agrees-first-acquisition-for-85m2023-03-02T05:47:55.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/ai-model-predicts-cvd-risk-from-single-chest-radiograph2023-03-02T05:47:56.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/dawn-sauro-appointed-to-chief-operating-officer-at-elligo-health2023-03-02T05:47:57.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/unison-boss-states-government-adamantly-refused-to-engage-in-a-proper-discussion-on-pay-ahead-of-decembers-ambulance-strikes2023-03-02T05:47:58.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/astrazeneca-set-to-buy-cincor2023-03-02T05:47:59.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/gsk-chooses-londons-west-end-for-new-headquarters2023-03-02T05:48:00.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/maha-radhakrishnan-appointed-as-minovia-therapeutics-board-member2023-03-02T05:48:00.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/lumiradx-receives-14m-in-funding-for-pointofcare-tb-test2023-03-02T05:48:01.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/pharmafile2023-03-02T05:48:02.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/sarepta-therapeutics-and-catalent-sign-manufacturing-deal-for-dmd-gene-therapy-approval2023-03-02T05:48:03.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/biogen-appoints-priya-singhal-as-executive-vice-president-and-head-of-de-velopment2023-03-02T05:48:03.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/fda-approves-first-gene-therapy-to-treat-patients-with-highrisk-nonmuscleinvasive-bladder-cancer2023-03-02T05:48:04.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/ser-vblock-secures-eu-funding-for-pharma-manufacturing-data-space2023-03-02T05:48:05.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/two-biotech-ceos-charged-with-defrauding-investors-over-investigational-hiv-drug2023-03-02T05:48:05.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/cost-of-over-350-drugs-expected-to-increase-in-20232023-03-02T05:48:06.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/eli-lilly-and-sosei-heptares-enter-into-multitarget-collaboration-and-licence-agreement-for-diabetes-and-metabolic-diseases2023-03-02T05:48:07.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/comment2023-03-02T05:48:08.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/new-blood-test-appears-to-detect-hidden-cancer2023-03-02T05:48:08.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/fda-expands-access-to-abortion-pills2023-03-02T05:48:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/fda-approves-eisaibiogens-lec-anemab-for-alzheimers-disease2023-03-02T05:48:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/flypharma-middleeast2023-03-02T05:48:10.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/tamiflu-manufacturers-report-shortages-during-high-point-of-flu-season2023-03-02T05:48:10.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/belharra-therapeutics-and-genentech-join-forces-for-small-molecule-medicine-development2023-03-02T05:48:11.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/biontech-and-uk-government-announce-strategic-partnership-to-provide-mrna-cancer-immunotherapies2023-03-02T05:48:12.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/communique2023-03-02T05:48:12.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/five-facts-about-prostate-cancer2023-03-02T05:48:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/22m-raised-by-pbs-biotech-to-expand-singleuse-manufacturing-products-and-ser-vices-for-cell-therapy-clients2023-03-02T05:48:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/anumana-and-pfizer-team-up-on-aienabled-ecg-algorithm-for-detection-of-cardiovascular-disease2023-03-02T05:48:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/withings-announces-handsfree-connected2023-03-02T05:48:14.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/biontech-begins-phase-1-trial-for-malaria-vaccine2023-03-02T05:48:14.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/sanofi-plans-ecofriendly-additions-to-brisbane-manufacturing-campus2023-03-02T05:48:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/elaine-sun-appointed-to-the-board-of-directors-at-asher-bio2023-03-02T05:48:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/astrazeneca-shares-two-new-drug-approvals-in-the-eu2023-03-02T05:48:16.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/covid19-antiviral-treatment-shown-to-speed-up-recovery-in-trial2023-03-02T05:48:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/glaxosmithkline-enters-into-3-3bn-pact-with-wave-life-sciences2023-03-02T05:48:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/prostate-c-ancer-in-europe-the-time-to-act-is-now2023-03-02T05:48:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/pharmafile-3316752682082023-03-02T05:48:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/pharma-times-4116752682082023-03-02T05:48:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/samedan-516752682082023-03-02T05:48:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-january-2023/ada3e045-a2e2-11ed-8b37-42010a80000b2023-02-03T15:57:30.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-20222023-09-20T12:48:53.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/molecure-sees-positive-outcomes-in-clinical-trials-and-announces-financial-results2023-03-09T12:56:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/eli-lillys-covid19-drug-bebtelovimab-loses-fda-authorisation2023-03-07T17:25:41.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/eli-lilly-loses-billions-on-stock-valuation-after-fake-account-verified-by-twitter2023-03-07T17:19:12.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/european-commission-gives-orphan-status-to-selinexor-to-treat-myelofribrosis2023-03-09T13:00:33.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/eu-approval-recommended-for-three-drugs-from-astrazeneca2023-03-09T13:05:27.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/merck-donates-ebola-vaccines-for-testing-on-resistant-strain2023-09-18T09:06:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/new-alzheimers-drug-lecanemab-slows-disease-but-divides-opinions2023-03-08T17:18:52.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/upstaza-given-marketing-authorisation-for-aadc-deficiency-by-mhra2023-03-02T05:46:34.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/astrazeneca-to-acquire-neogene-for-up-to-320m2023-03-02T05:46:34.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/stem-cell-transplants-could-be-offered-to-ms-patients-in-new-trial2023-03-02T05:46:35.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/oxford-astrazeneca-vaccine-team-turns-to-malaria2023-03-02T05:46:35.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/new-insights-into-hiv-vaccine-revealed-by-researchers2023-03-08T17:07:50.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/elon-musks-neuralink-to-conduct-human-trials-in-20232023-03-02T05:46:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/parthenon-therapeutics-and-imaginab-announce-licence-and-supply-agreement2023-03-07T17:30:14.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/words-from-the-editor2023-03-02T05:46:37.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/carbonneutral-inhaler-launched-for-adult-asthma-patients-in-the-uk2023-03-08T16:52:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/pulmonx-secures-japanese-approval-for-zephyr-valve-for-copdemphysema2023-03-08T17:16:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/novo-nordisks-smart-connected-pens-made-compatible-with-abbotts-freestyle-librelink-app2023-03-07T17:16:47.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/nhs-nurses-vote-to-strike-on-15-and-20-december2023-03-02T05:46:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/astrazeneca-and-msd-launch-prostate-cancer-awareness-campaign2023-03-08T17:23:08.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/siemens-healthineers-and-atrium-health-team-up-in-140m-deal2023-03-08T17:07:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/amgens-obesity-drug-appears-promising-with-few-side-effe-cts2023-03-08T17:13:40.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/fulllife-technologies-to-acquire-focusx-therapeutics2023-03-08T17:03:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/peter-williams-appointed-general-manager-incyte-biosciences-uk-and-ireland2023-03-07T17:07:37.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/haemophilia-drug-costing-3-5m-per-dose-has-been-approved2023-03-02T05:46:41.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/collaboration-between-biontech-and-ryvu-therapeutics-to-develop-and-commercialise-immunomodulatory-small-molecule-candidates2023-03-08T17:09:51.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/oxford-biomedica-appoints-dr-frank-mathias-as-ceo2023-03-07T17:08:57.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/fda-grants-approval-to-wise-for-neuromonitoring-cortical-strip2023-03-02T05:46:43.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/flypharma-middle-east2023-03-02T05:46:43.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/amoxicillin-shortages-and-15hour-hospital-waiting-times-for-us-patients2023-03-09T12:35:33.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/the-future-of-follicular-lymphoma-treatment2023-03-02T05:46:44.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/bayer-and-orion-corporationdeveloped-prostate-cancer-treatment-approved-by-nhs-england-and-mhra2023-03-02T05:46:44.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/five-facts-about-vaccines2023-03-07T17:05:06.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/amarin-appoints-scott-curley-as-general-manager-to-uk-and-ireland-team2023-03-02T05:46:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/nice-recommends-cabometyx-cabozantinib-for-hepatocellular-carcinoma2023-03-02T05:46:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/innovations-in-pharmaceutical-technology-316742077012023-03-02T05:46:46.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/over-90-of-vaccines-in-uk-imported-from-flanders2023-03-02T05:46:46.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/fda-hopes-to-make-opioid-overdose-medication-available-without-prescriptions2023-03-08T17:22:07.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/samedan-ltd-516742077012023-03-02T05:46:47.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/innovations-in-pharmaceutical-technology-116742077012023-03-02T05:46:47.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/pharma-role-3516742077012023-03-02T05:46:48.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/pharma-times-4216742077012023-03-02T05:46:48.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-december-2022/contents-616742077012023-03-02T05:46:49.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-20222023-09-20T12:49:30.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/ypsomed-and-sidekick-seek-digital-solution-to-selfinjection-anxiety2023-03-07T16:58:58.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/lytix-biopharma-recruits-stephen-worsley-as-chief-business-officer2023-03-02T05:46:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/nervgen-pharma-appoints-dr-matvey-lukashev-as-vice-president-of-research2023-03-02T05:46:29.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/brainomix-and-bridge-biotherapeutics-enter-ai-partnership2023-03-02T05:46:30.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/routine-hospital-care-postponed-due-to-national-bank-hol-iday2023-03-07T17:01:01.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/dime-reveals-digital-measures-for-treatment-of-atopic-dermatitis2023-03-02T05:46:32.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/imfinzi-dur-valumab-approved-for-advanced-biliary-cancer-treatment-in-the-us2023-03-06T15:45:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/yeast-cells-engineered-to-fight-cancer-1616744418822023-03-06T15:58:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/china-approves-worlds-first-inhaled-covid19-vaccine-for-emergency-use2023-03-06T15:43:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/digital-platforms-and-the-world-of-oncology2023-03-02T05:46:35.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/mind-matters-how-ai-is-evolving-research-into-parkinsons2023-03-02T05:46:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/genetically-modified-herpes-virus-delivers-one-two-916744418822023-03-07T16:54:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/samedan-516744418822023-03-02T05:46:37.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/biovac-produces-first-pfizer-covid-19-vaccine-3116744418822023-03-02T05:46:37.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/pm-li-ve-1016744418822023-03-02T05:46:38.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/words-from-the-editor-616744418822023-03-07T17:02:48.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/magloft-test-publications-216744418822023-03-02T05:46:38.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/roche-agrees-to-buy-good-therapeutics-1416744418822023-03-06T16:07:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/millions-invited-for-covid-19-booster-jabs-816744418822023-03-07T16:57:06.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/merck-supports-orna-s-development-of-o-rna-2616744418822023-03-06T14:27:25.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/storm-therapeutics-appoints-dr-jerry-mc-mahon-4116744418822023-03-02T05:46:40.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/takeda-splashes-300-million-to-expand-3016744418822023-03-02T05:46:41.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/spectrum-x-upgrades-facilities-to-kickstart-clinical-2916744418822023-03-02T05:46:41.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/iveric-bio-announces-positive-topline-data-2216744418822023-03-06T15:32:39.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/uk-covid-19-infections-lowest-since-last-016744418822023-03-07T17:02:07.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/pfizer-finds-rsv-vaccine-is-effective-2516744418822023-03-06T14:28:48.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/round-up-1316744418822023-03-02T05:46:43.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/pfizer-buys-global-blood-therapeutics-for-2816744418822023-03-06T14:14:25.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/baby-sticky-tape-skin-test-could-1516744418822023-03-06T16:02:46.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/valeo-pharma-appoints-kyle-steiger-to-4416744418822023-03-02T05:46:44.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/smc-accepts-jazz-pharmaceuticals-sativex-for-1216744418822023-03-06T16:08:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/katharine-knobil-joins-pliant-therapeutics-board-4316744418822023-03-02T05:46:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/5-neurological-phenomenons-4616744418822023-03-02T05:46:45.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/tweet-us-pharmafocus-4716744418822023-03-02T05:46:46.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/kelai-pharmaceutical-partners-with-nutrasource-to-2716744418822023-03-06T14:20:25.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/pm-li-ve-316744418822023-03-02T05:46:47.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/measles-outbreak-in-zimbabwe-kills-almost-1716744418822023-03-06T15:50:57.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/pharma-times-3916744418822023-03-02T05:46:48.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/triall-partners-with-mayo-clinic-to-2416744418822023-03-06T14:39:11.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/pharmaceutical-companies-record-year-low-of-robotics-3316744418822023-03-02T05:46:48.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/novo-nordisk-and-microsoft-join-forces-3716744418822023-03-02T05:46:49.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/samedan-4816744418822023-03-02T05:46:49.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/university-of-california-develops-new-technology-2316744418822023-03-06T15:36:07.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/contents-716744418822023-03-07T17:02:36.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/half-of-global-health-care-facilities-2116744418822023-03-06T15:39:46.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/bio-innovation-institute-reveals-new-cohort-entering-3516744418822023-03-02T05:46:51.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/jrs-pharma-plans-18-million-manufacturing-3216744418822023-03-02T05:46:51.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/landmark-partnership-to-improve-scotland-s-health-1116744418822023-03-06T16:08:49.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-october-2022/round-up-1916744418822023-03-02T05:46:52.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-20222023-09-20T12:49:53.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/potential-shortage-of-140-000-nurses-in-1016691069872023-03-02T05:43:01.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/contents-516691069872023-03-02T05:43:02.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/ema-round-up-1416691069882023-03-02T05:43:02.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/compass-pathways-appoints-kabir-nath-as-4516691069882023-03-02T05:43:03.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/home-based-brain-stimulation-study-on-stroke-2416691069882023-03-02T05:43:04.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/ergomed-4216691069882023-03-02T05:43:04.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/samedan-816691069882023-03-02T05:43:06.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/pharmatimes-3716691069882023-03-02T05:43:06.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/fly-pharma-conference-europe-216691069882023-03-02T05:43:06.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/pci-pharma-services-announces-multi-milliondollar-expansion-2916691069882023-03-02T05:43:07.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/medics-in-ukraine-work-amid-shelling-1616691069882023-03-02T05:43:08.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/new-reforms-aim-for-better-nhs-1316691069882023-03-02T05:43:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/monkeypox-antiviral-tecovirimat-put-to-the-016691069882023-03-02T05:43:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/first-diseasemodifying-treatment-for-aadc-deficiency-116691069882023-03-02T05:43:10.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/fly-pharma-conference-europe-4316691069882023-03-02T05:43:10.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/samedan-4916691069882023-03-02T05:43:11.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/pmlive-4716691069882023-03-02T05:43:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/communique-416691069882023-03-02T05:43:14.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/uk-scientists-say-they-have-found-1216691069882023-03-02T05:43:14.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/cdmo-wins-tech-transfer-and-production-3016691069882023-03-02T05:43:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/words-from-the-editor-716691069882023-03-02T05:43:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/sanofi-makes-300-million-investment-in-2816691069882023-03-02T05:43:16.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/cognito-s-light-and-sound-therapy-slows-brain-tissue-3216691069882023-03-02T05:43:16.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/health-track-rx-develops-monkeypox-specific-pcr-2016691069882023-03-02T05:43:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/future-focus-316691069882023-03-02T05:43:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/janssen-promoted-maria-walsh-to-business-4416691069882023-03-02T05:43:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/res-med-buys-mementor-for-prescription-digital-3416691069882023-03-02T05:43:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/70-million-in-fines-for-pharma-1116691069882023-03-02T05:43:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/us-government-buys-66-million-doses-2716691069882023-03-02T05:43:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/micronesia-s-first-covid-19-outbreak-sees-steep-2116691069882023-03-02T05:43:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/global-monkeypox-cases-rise-to-26-000-1816691069882023-03-02T05:43:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/chris-tower-joins-euromed-usa-as-4616691069882023-03-02T05:43:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/m-ps-warn-nhs-england-facing-worst-916691069892023-03-02T05:43:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/digital-physical-therapy-app-one-step-launches-3316691069892023-03-02T05:43:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/initiative-to-improve-next-generation-cancer-2316691069892023-03-02T05:43:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/nice-issues-positive-appraisal-for-advanced-1516691069892023-03-02T05:43:21.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/the-evolving-landscape-of-ra-treatments-4016691069892023-03-02T05:43:21.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/miro-bio-to-be-acquired-by-gilead-2616691069892023-03-02T05:43:22.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/monkeypox-declared-global-health-emergency-1716691069892023-03-02T05:43:22.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/f2-g-announce-development-and-commercialisation-for-3116691069892023-03-02T05:43:22.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/fda-round-up-1916691069892023-03-02T05:43:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/new-method-involving-musical-tests-can-2516691069892023-03-02T05:43:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/recent-hepatitis-linked-to-adeno-associated-virus-2216691069892023-03-02T05:43:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/5-examples-of-personalised-medicine-4816691069892023-03-02T05:43:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/immunisation-or-hospitalisation-what-rwe-tells-4116691069892023-03-02T05:43:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/personalised-healthcare-is-key-to-a-3516691069892023-03-02T05:43:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/10-steps-closer-to-the-patient-3916691069892023-03-02T05:43:25.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/up-close-and-personal-the-potential-3616691069892023-03-02T05:43:25.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-september-2022/access-all-areas-increasing-health-e-3816691069892023-03-02T05:43:26.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-20222023-09-20T12:50:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/bristol-myers-squibb-to-acquire-cancer-3016691065142023-03-02T05:43:01.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/researchers-create-transformer-style-robot-that-travels-316691065142023-03-02T05:43:02.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/astellas-opens-100-million-us-based-production-3416691065142023-03-02T05:43:02.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/type-2-diabetes-may-speed-up-2816691065142023-03-02T05:43:03.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/researchers-u-ncover-origins-of-black-116691065142023-03-02T05:43:03.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/dfe-pharma-recruits-new-global-hr-4616691065142023-03-02T05:43:04.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/seqiris-completes-156-million-expansion-for-3316691065142023-03-02T05:43:05.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/astorg-to-acquire-med-comms-platform-3116691065142023-03-02T05:43:06.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/uk-covid-19-expert-monkeypox-requires-substantial-1016691065152023-03-02T05:43:07.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/pharma-times-3816691065152023-03-02T05:43:08.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/flypharma-conference-216691065152023-03-02T05:43:09.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/metrion-biosciences-appoints-dr-benedetta-montagnini-4516691065152023-03-02T05:43:10.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/pmlive-4816691065152023-03-02T05:43:11.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/ema-s-releases-first-critical-medicines-list-1516691065152023-03-02T05:43:12.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/words-from-the-editor-616691065152023-03-02T05:43:12.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/simple-eye-exam-could-predict-heart-2716691065152023-03-02T05:43:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/hundreds-of-thousands-to-benefit-from-916691065152023-03-02T05:43:13.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/positive-data-from-genentech-s-blood-cancer-1816691065152023-03-02T05:43:14.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/lucl-sargood-5016691065152023-03-02T05:43:14.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/eagle-pharmaceuticals-completes-104-million-acquisition-2916691065152023-03-02T05:43:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/ox-sonics-appoints-dr-marianna-lalla-as-4716691065152023-03-02T05:43:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/polio-virus-detected-in-sewage-from-1416691065152023-03-02T05:43:15.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/new-genetic-eye-disease-discovered-2616691065152023-03-02T05:43:16.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/pharmatimes-3916691065152023-03-02T05:43:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/regenxbio-opens-gene-therapy-manufacturing-facility-3216691065152023-03-02T05:43:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/efforts-to-eliminate-african-trypanosomiasis-continue-2516691065152023-03-02T05:43:17.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/new-moderna-covid-19-vaccine-five-times-more-effective2023-08-25T09:37:42.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/leaked-data-reveals-nhs-will-miss-1216691065152023-03-02T05:43:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/uk-warns-of-major-cholera-outbreak-1716691065152023-03-02T05:43:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/you-tube-feature-could-help-users-find-3516691065152023-03-02T05:43:18.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/contents-516691065152023-03-02T05:43:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/tiziana-life-sciences-announces-positive-results-2016691065152023-03-02T05:43:19.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/fda-approves-measles-vaccine-2116691065152023-03-02T05:43:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/smart-technology-can-halve-the-risk-3616691065152023-03-02T05:43:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/somerset-nhs-foundation-trust-uses-ai-3716691065152023-03-02T05:43:20.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/pm-416691065152023-03-02T05:43:21.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/positive-phase-iii-data-released-from-1616691065152023-03-02T05:43:21.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/malnutrition-relate-d-form-of-diab-etes-2316691065152023-03-02T05:43:22.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/covid-19-vaccine-scheme-for-low-income-countries-2416691065152023-03-02T05:43:22.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/samedan-816691065152023-03-02T05:43:22.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/4-25-million-grant-for-uk-wide-effort-1316691065152023-03-02T05:43:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/4bn-nhs-covid-19-ppe-to-be-1116691065152023-03-02T05:43:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/five-exciting-studies-on-diabetes-4916691065152023-03-02T05:43:23.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/living-with-4416691065152023-03-02T05:43:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/new-cancer-drug-trial-achie-016691065152023-03-02T05:43:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/cutting-through-the-noise-data-science-4116691065162023-03-02T05:43:24.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/telemedicine-driving-smarter-healthcare-solutions-in-4316691065162023-03-02T05:43:25.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/the-importance-of-testing-in-the-4216691065162023-03-02T05:43:25.000Zweekly0.6https://www.pharmafocus.com/collections/pharmafocus-july-august-2022/veeva-la-vida-a-roundup-of-4016691065162023-03-02T05:43:26.000Zweekly0.6